Search Results

Cancer LncRNAID LncRNAName SubpathwayID PathwayName GeneNumber t Pvalue pAdj Cytoscape
GBM ENSG00000268895 A1BG-AS1 path:00760_1 Nicotinate and nicotinamide metabolism 20 -4.08058033047396 0.000214825918450342 0.00714296178847388
GBM ENSG00000268895 A1BG-AS1 path:04012_31 ErbB signaling pathway 53 -3.31104682676839 0.00134109664696 0.0334435976335649
GBM ENSG00000268895 A1BG-AS1 path:04015_98 Rap1 signaling pathway 44 -4.16690092050392 0.000103160657312055 0.00374191838795543
GBM ENSG00000268895 A1BG-AS1 path:04020_152 Calcium signaling pathway 23 -3.79787641919299 0.000247441220500115 0.00759454207534969
GBM ENSG00000268895 A1BG-AS1 path:04020_78 Calcium signaling pathway 53 -3.3044500297853 0.00221360823514865 0.0441614842912156
GBM ENSG00000268895 A1BG-AS1 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.79793327221435 4.08009771682249e-06 0.000406989747253044
GBM ENSG00000268895 A1BG-AS1 path:04066_95 HIF-1 signaling pathway 14 -4.26214242703253 4.16587544789515e-05 0.00166218430371016
GBM ENSG00000268895 A1BG-AS1 path:04115_1 p53 signaling pathway 65 -5.04218397896927 1.46822120919462e-06 0.000195273420822885
GBM ENSG00000268895 A1BG-AS1 path:04144_8 Endocytosis 37 -5.39935506425027 2.66153256144335e-07 0.00010619514920159
GBM ENSG00000268895 A1BG-AS1 path:04713_105 Circadian entrainment 18 -3.68468669863445 0.000554157753582715 0.0157934959771074
GBM ENSG00000268895 A1BG-AS1 path:04750_68 Inflammatory mediator regulation of TRP channels 19 -3.23924048769146 0.00220461093197183 0.0441614842912156
GBM ENSG00000268895 A1BG-AS1 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -3.40198037810152 0.00217441008573082 0.0441614842912156
GBM ENSG00000268895 A1BG-AS1 path:04912_55 GnRH signaling pathway 9 -4.69688560688882 6.48857635359176e-06 0.000517788393016622
GBM ENSG00000268895 A1BG-AS1 path:04915_101 Estrogen signaling pathway 12 -4.43578208939096 2.0261489105873e-05 0.00101054176915542
GBM ENSG00000268895 A1BG-AS1 path:04921_178 Oxytocin signaling pathway 8 -3.42852158050982 0.00163093943545138 0.0382791079261823
GBM ENSG00000268895 A1BG-AS1 path:05120_8 Epithelial cell signaling in Helicobacter pylori infection 17 -5.12568397858956 1.07130211978659e-06 0.000195273420822885
GBM ENSG00000268895 A1BG-AS1 path:05160_41 Hepatitis C 6 -4.61565950216344 8.75327540086718e-06 0.000582092814157667
GBM ENSG00000268895 A1BG-AS1 path:05214_27 Glioma 17 -4.65149002811612 1.40668635683234e-05 0.000801811223394436
GBM ENSG00000268895 A1BG-AS1 path:05215_17 Prostate cancer 65 -3.45152670967051 0.000961774511807392 0.0255832020140766
GBM ENSG00000268895 A1BG-AS1 path:05223_63 Non-small cell lung cancer 8 -4.30896803695558 3.16073947523895e-05 0.00140126116735594
GBM ENSG00000268266 AC003005.2 path:00760_1 Nicotinate and nicotinamide metabolism 20 -4.09958318904765 0.000270574628122514 0.00890641484236608
GBM ENSG00000268266 AC003005.2 path:04012_31 ErbB signaling pathway 53 -3.40747340756034 0.00108842887857785 0.030709243359875
GBM ENSG00000268266 AC003005.2 path:04015_98 Rap1 signaling pathway 44 -4.20970001974488 0.000107215364860955 0.00385000628364337
GBM ENSG00000268266 AC003005.2 path:04060_29 Cytokine-cytokine receptor interaction 2 -5.00995852281333 1.63449474343543e-06 0.000209385001067378
GBM ENSG00000268266 AC003005.2 path:04066_95 HIF-1 signaling pathway 14 -4.40207367788122 2.58747244136e-05 0.0010220516143372
GBM ENSG00000268266 AC003005.2 path:04115_1 p53 signaling pathway 65 -4.91618084656197 3.00609454377527e-06 0.000209385001067378
GBM ENSG00000268266 AC003005.2 path:04144_8 Endocytosis 37 -5.63538943246069 8.77927905906997e-08 3.46781522833264e-05
GBM ENSG00000268266 AC003005.2 path:04713_105 Circadian entrainment 18 -3.41128886017006 0.00157505036937974 0.0388840559940622
GBM ENSG00000268266 AC003005.2 path:04912_55 GnRH signaling pathway 9 -4.92700407235735 2.43686936725699e-06 0.000209385001067378
GBM ENSG00000268266 AC003005.2 path:04915_101 Estrogen signaling pathway 12 -4.55277489182376 1.3729142515057e-05 0.000677876411680942
GBM ENSG00000268266 AC003005.2 path:04921_178 Oxytocin signaling pathway 8 -3.68905187859486 0.000968517813653688 0.0294280412610159
GBM ENSG00000268266 AC003005.2 path:05120_8 Epithelial cell signaling in Helicobacter pylori infection 17 -5.34515703990019 4.22099190706788e-07 8.33645901645905e-05
GBM ENSG00000268266 AC003005.2 path:05160_41 Hepatitis C 6 -4.85240293404493 3.18053166178295e-06 0.000209385001067378
GBM ENSG00000268266 AC003005.2 path:05214_27 Glioma 17 -4.58840787758267 2.45875476400915e-05 0.0010220516143372
GBM ENSG00000268266 AC003005.2 path:05215_17 Prostate cancer 65 -3.42629297574164 0.001208837947199 0.0318327326095738
GBM ENSG00000268266 AC003005.2 path:05223_63 Non-small cell lung cancer 8 -4.51861258743634 1.36836241965064e-05 0.000677876411680942
GBM ENSG00000268392 AC003682.16 path:00564_41 Glycerophospholipid metabolism 28 -3.55209064343081 0.00170240662073655 0.0383041489665723
GBM ENSG00000268392 AC003682.16 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.73546729457466 0.00078391186361129 0.024421869597121
GBM ENSG00000268392 AC003682.16 path:04012_31 ErbB signaling pathway 53 -3.40747340756034 0.00108842887857785 0.0293875797216019
GBM ENSG00000268392 AC003682.16 path:04015_98 Rap1 signaling pathway 44 -4.20970001974488 0.000107215364860955 0.00394747479715333
GBM ENSG00000268392 AC003682.16 path:04020_152 Calcium signaling pathway 23 -3.77498608466707 0.000295028291021875 0.00995720482198827
GBM ENSG00000268392 AC003682.16 path:04060_29 Cytokine-cytokine receptor interaction 2 -5.00995852281333 1.63449474343543e-06 0.000214685887170349
GBM ENSG00000268392 AC003682.16 path:04066_95 HIF-1 signaling pathway 14 -4.40207367788122 2.58747244136e-05 0.0010479263387508
GBM ENSG00000268392 AC003682.16 path:04115_1 p53 signaling pathway 65 -4.91618084656197 3.00609454377527e-06 0.000214685887170349
GBM ENSG00000268392 AC003682.16 path:04144_8 Endocytosis 37 -5.63538943246069 8.77927905906997e-08 3.55560801892334e-05
GBM ENSG00000268392 AC003682.16 path:04713_105 Circadian entrainment 18 -3.41128886017006 0.00157505036937974 0.037523258799929
GBM ENSG00000268392 AC003682.16 path:04912_55 GnRH signaling pathway 9 -4.92700407235735 2.43686936725699e-06 0.000214685887170349
GBM ENSG00000268392 AC003682.16 path:04915_101 Estrogen signaling pathway 12 -4.55277489182376 1.3729142515057e-05 0.000695037839824763
GBM ENSG00000268392 AC003682.16 path:04921_178 Oxytocin signaling pathway 8 -3.68905187859486 0.000968517813653688 0.0280178367521245
GBM ENSG00000268392 AC003682.16 path:05120_8 Epithelial cell signaling in Helicobacter pylori infection 17 -5.34515703990019 4.22099190706788e-07 8.54750861181245e-05
GBM ENSG00000268392 AC003682.16 path:05160_41 Hepatitis C 6 -4.85240293404493 3.18053166178295e-06 0.000214685887170349
GBM ENSG00000268392 AC003682.16 path:05214_27 Glioma 17 -4.58840787758267 2.45875476400915e-05 0.0010479263387508
GBM ENSG00000268392 AC003682.16 path:05215_17 Prostate cancer 65 -3.42629297574164 0.001208837947199 0.0305987105384748
GBM ENSG00000268392 AC003682.16 path:05223_63 Non-small cell lung cancer 8 -4.51861258743634 1.36836241965064e-05 0.000695037839824763
GBM ENSG00000267159 AC005391.2 path:00010_96 Glycolysis / Gluconeogenesis 6 -3.20041278430815 0.00169712343176976 0.0127124151398603
GBM ENSG00000267159 AC005391.2 path:00052_2 Galactose metabolism 21 -2.69251328610703 0.00795689107316048 0.0367312297214501
GBM ENSG00000267159 AC005391.2 path:00130_1 Ubiquinone and other terpenoid-quinone biosynthesis 3 -2.80147630010981 0.00581640372171814 0.0293257695534527
GBM ENSG00000267159 AC005391.2 path:00230_148 Purine metabolism 19 -3.23586462893918 0.00150441353119722 0.0117108268997117
GBM ENSG00000267159 AC005391.2 path:00280_80 Valine, leucine and isoleucine degradation 4 2.82104174541385 0.0057533388308262 0.0293257695534527
GBM ENSG00000267159 AC005391.2 path:00450_10 Selenocompound metabolism 2 -2.86247827402534 0.00482264209238083 0.0266175098959644
GBM ENSG00000267159 AC005391.2 path:00520_34 Amino sugar and nucleotide sugar metabolism 7 -3.38494812427712 0.000914876132090681 0.00885867864487806
GBM ENSG00000267159 AC005391.2 path:00524_1 Butirosin and neomycin biosynthesis 4 -2.62262953316581 0.00967310283984011 0.0426691314157392
GBM ENSG00000267159 AC005391.2 path:00590_105 Arachidonic acid metabolism 3 -2.86291158582042 0.00481719650863266 0.0266175098959644
GBM ENSG00000267159 AC005391.2 path:00600_6 Sphingolipid metabolism 23 -2.55169053890634 0.0117974556420176 0.0493009462092736
GBM ENSG00000267159 AC005391.2 path:00601_25 Glycosphingolipid biosynthesis - lacto and neolacto series 10 -3.00605441364822 0.00311804761800245 0.0199655629733383
GBM ENSG00000267159 AC005391.2 path:00604_2 Glycosphingolipid biosynthesis - ganglio series 8 -3.27172768387136 0.00133481854900351 0.0110400617490499
GBM ENSG00000267159 AC005391.2 path:00740_1 Riboflavin metabolism 8 -2.78123590474981 0.00626491846490673 0.0307058349452836
GBM ENSG00000267159 AC005391.2 path:00750_1 Vitamin B6 metabolism 3 -2.90913806975552 0.00419348267445123 0.0256125018731867
GBM ENSG00000267159 AC005391.2 path:00980_113 Metabolism of xenobiotics by cytochrome P450 5 -3.40685562458917 0.000849218814284385 0.00847945735771545
GBM ENSG00000267159 AC005391.2 path:03013_16 RNA transport 13 2.57910353116549 0.0109238257651836 0.0466318153632031
GBM ENSG00000267159 AC005391.2 path:04010_96 MAPK signaling pathway 22 -2.7017276544981 0.00773399934151502 0.0361223263362525
GBM ENSG00000267159 AC005391.2 path:04012_47 ErbB signaling pathway 41 3.70230047337497 0.000388917846856226 0.00772001926009608
GBM ENSG00000267159 AC005391.2 path:04012_89 ErbB signaling pathway 13 2.7821518542057 0.00655003329557891 0.0317117465651808
GBM ENSG00000267159 AC005391.2 path:04015_134 Rap1 signaling pathway 18 3.16975403658445 0.00198272264593336 0.0143116525533735
GBM ENSG00000267159 AC005391.2 path:04020_132 Calcium signaling pathway 28 2.72905520314275 0.00744574106597951 0.0351899905142127
GBM ENSG00000267159 AC005391.2 path:04020_220 Calcium signaling pathway 10 3.70648207838663 0.000357966560630292 0.00772001926009608
GBM ENSG00000267159 AC005391.2 path:04060_22 Cytokine-cytokine receptor interaction 5 2.58695917635564 0.0108469128047949 0.0466318153632031
GBM ENSG00000267159 AC005391.2 path:04062_41 Chemokine signaling pathway 87 2.6180290569873 0.00987724168462124 0.0430908236131278
GBM ENSG00000267159 AC005391.2 path:04110_174 Cell cycle 9 3.45016507916763 0.000770211629992475 0.00847945735771545
GBM ENSG00000267159 AC005391.2 path:04152_3 AMPK signaling pathway 85 3.94049827324428 0.000146492557443107 0.00646194947832371
GBM ENSG00000267159 AC005391.2 path:04210_44 Apoptosis 30 2.67538115140119 0.00859843876254665 0.03923655389346
GBM ENSG00000267159 AC005391.2 path:04261_163 Adrenergic signaling in cardiomyocytes 3 3.66047630208411 0.000385687646607765 0.00772001926009608
GBM ENSG00000267159 AC005391.2 path:04261_92 Adrenergic signaling in cardiomyocytes 32 3.83718378520891 0.000219314437733751 0.00725565264835827
GBM ENSG00000267159 AC005391.2 path:04270_1 Vascular smooth muscle contraction 96 3.33809479184956 0.00113868608098178 0.0102666601426959
GBM ENSG00000267159 AC005391.2 path:04310_162 Wnt signaling pathway 7 -2.86316809132509 0.00482735695846206 0.0266175098959644
GBM ENSG00000267159 AC005391.2 path:04310_77 Wnt signaling pathway 32 3.25329630487169 0.00146018980120681 0.0115939070215821
GBM ENSG00000267159 AC005391.2 path:04330_21 Notch signaling pathway 27 3.04431407944661 0.00292019594145125 0.0190052096517401
GBM ENSG00000267159 AC005391.2 path:04370_73 VEGF signaling pathway 13 3.11582099297879 0.00235733078107282 0.0161355227601019
GBM ENSG00000267159 AC005391.2 path:04390_97 Hippo signaling pathway 19 -2.74606999492048 0.00679076285647145 0.0324811187231225
GBM ENSG00000267159 AC005391.2 path:04510_56 Focal adhesion 79 2.80946121353027 0.00583560653582559 0.0293257695534527
GBM ENSG00000267159 AC005391.2 path:04520_32 Adherens junction 40 2.93967766729834 0.00392600238244313 0.0243534835285926
GBM ENSG00000267159 AC005391.2 path:04540_1 Gap junction 81 2.78548485332476 0.00615531432919882 0.0305457473586492
GBM ENSG00000267159 AC005391.2 path:04550_89 Signaling pathways regulating pluripotency of stem cells 8 4.72168340521948 6.91110978266633e-06 0.00137185529185927
GBM ENSG00000267159 AC005391.2 path:04620_89 Toll-like receptor signaling pathway 12 3.43082388889468 0.000854353386167804 0.00847945735771545
GBM ENSG00000267159 AC005391.2 path:04630_2 Jak-STAT signaling pathway 132 3.33270771925022 0.00116372722020482 0.0102666601426959
GBM ENSG00000267159 AC005391.2 path:04660_114 T cell receptor signaling pathway 11 2.64571697688774 0.00960714334567395 0.0426691314157392
GBM ENSG00000267159 AC005391.2 path:04660_33 T cell receptor signaling pathway 44 2.82258706303339 0.00557063979814071 0.0290992631560771
GBM ENSG00000267159 AC005391.2 path:04664_60 Fc epsilon RI signaling pathway 13 3.15904900319486 0.00198089611237506 0.0143116525533735
GBM ENSG00000267159 AC005391.2 path:04668_1 TNF signaling pathway 72 3.34427694059091 0.00109259855805588 0.0100874797104229
GBM ENSG00000267159 AC005391.2 path:04670_161 Leukocyte transendothelial migration 4 2.85988778691076 0.00494238921840825 0.0268784728727133
GBM ENSG00000267159 AC005391.2 path:04713_118 Circadian entrainment 15 3.61979658477879 0.000484621222541807 0.00801644272287906
GBM ENSG00000267159 AC005391.2 path:04724_163 Glutamatergic synapse 7 3.58788578701483 0.000531748247897971 0.00811938670828824
GBM ENSG00000267159 AC005391.2 path:04726_3 Serotonergic synapse 56 3.25369929322094 0.00154858611769639 0.0118228593985666
GBM ENSG00000267159 AC005391.2 path:04726_40 Serotonergic synapse 2 3.78447373121684 0.000304005738323413 0.00772001926009608
GBM ENSG00000267159 AC005391.2 path:04728_120 Dopaminergic synapse 32 3.47075097683397 0.000730005112831461 0.00847945735771545
GBM ENSG00000267159 AC005391.2 path:04728_73 Dopaminergic synapse 46 3.33065759585413 0.0012006120314344 0.0102873750259477
GBM ENSG00000267159 AC005391.2 path:04730_49 Long-term depression 22 3.49945822189367 0.000703355069018671 0.00847945735771545
GBM ENSG00000267159 AC005391.2 path:04750_60 Inflammatory mediator regulation of TRP channels 28 3.84437225040112 0.000213808651407078 0.00725565264835827
GBM ENSG00000267159 AC005391.2 path:04910_111 Insulin signaling pathway 13 3.07230502560833 0.00259791523203865 0.0174808872393109
GBM ENSG00000267159 AC005391.2 path:04910_134 Insulin signaling pathway 8 4.51268393521478 1.562597066674e-05 0.00155087758867394
GBM ENSG00000267159 AC005391.2 path:04910_156 Insulin signaling pathway 4 2.56083293282788 0.0116994409229367 0.0493009462092736
GBM ENSG00000267159 AC005391.2 path:04911_2 Insulin secretion 52 3.45339655442942 0.000821983640169505 0.00847945735771545
GBM ENSG00000267159 AC005391.2 path:04912_47 GnRH signaling pathway 14 3.7027538086584 0.000353380964971596 0.00772001926009608
GBM ENSG00000267159 AC005391.2 path:04912_70 GnRH signaling pathway 5 3.88232272859698 0.000218912928614462 0.00725565264835827
GBM ENSG00000267159 AC005391.2 path:04917_1 Prolactin signaling pathway 72 4.16235828124087 6.16128879418032e-05 0.00407671941881598
GBM ENSG00000267159 AC005391.2 path:04918_1 Thyroid hormone synthesis 44 3.54763562160088 0.000603368077351257 0.0084029361308139
GBM ENSG00000267159 AC005391.2 path:04921_51 Oxytocin signaling pathway 73 4.42869194229972 2.8477285995004e-05 0.00226109650800332
GBM ENSG00000267159 AC005391.2 path:04921_87 Oxytocin signaling pathway 47 4.5809441774795 1.19455878314654e-05 0.00155087758867394
GBM ENSG00000267159 AC005391.2 path:04922_23 Glucagon signaling pathway 69 3.32548188527632 0.00121790082171169 0.0102873750259477
GBM ENSG00000267159 AC005391.2 path:04930_46 Type II diabetes mellitus 8 -3.14417305302997 0.00204319137192492 0.0144847674045391
GBM ENSG00000267159 AC005391.2 path:04932_3 Non-alcoholic fatty liver disease (NAFLD) 66 2.88717191656752 0.00454262301871789 0.0266175098959644
GBM ENSG00000267159 AC005391.2 path:04961_4 Endocrine and other factor-regulated calcium reabsorption 22 2.88847843072248 0.00462662611848156 0.0266175098959644
GBM ENSG00000267159 AC005391.2 path:04962_1 Vasopressin-regulated water reabsorption 19 3.70234285950776 0.000352767604521448 0.00772001926009608
GBM ENSG00000267159 AC005391.2 path:04964_2 Proximal tubule bicarbonate reclamation 3 -3.55384576699239 0.000515470684711048 0.00811938670828824
GBM ENSG00000267159 AC005391.2 path:04970_6 Salivary secretion 27 3.40234629902086 0.000973064382310535 0.00919777523279244
GBM ENSG00000267159 AC005391.2 path:04973_4 Carbohydrate digestion and absorption 11 3.07055675852715 0.00269461330803206 0.0178293580548122
GBM ENSG00000267159 AC005391.2 path:04976_1 Bile secretion 15 3.65784614969628 0.000412778209165461 0.00774463418640765
GBM ENSG00000267159 AC005391.2 path:05030_1 Cocaine addiction 42 3.53756975738667 0.00061381649318288 0.0084029361308139
GBM ENSG00000267159 AC005391.2 path:05031_42 Amphetamine addiction 14 3.53493358043621 0.000563726907687488 0.00828887342044195
GBM ENSG00000267159 AC005391.2 path:05032_1 Morphine addiction 63 2.83855737132103 0.00537606368249962 0.0285636574759616
GBM ENSG00000267159 AC005391.2 path:05034_52 Alcoholism 26 3.43598873662036 0.000848441392103165 0.00847945735771545
GBM ENSG00000267159 AC005391.2 path:05120_2 Epithelial cell signaling in Helicobacter pylori infection 26 3.6745087572356 0.000429173682873975 0.00774463418640765
GBM ENSG00000267159 AC005391.2 path:05160_24 Hepatitis C 26 3.7596164888342 0.000328558400564175 0.00772001926009608
GBM ENSG00000267159 AC005391.2 path:05161_33 Hepatitis B 52 3.4654303306994 0.000772287212902513 0.00847945735771545
GBM ENSG00000267159 AC005391.2 path:05161_34 Hepatitis B 52 3.12300462200212 0.00222242513110649 0.0154789960885838
GBM ENSG00000267159 AC005391.2 path:05164_2 Influenza A 66 2.89415110331859 0.00447042901500525 0.0266175098959644
GBM ENSG00000267159 AC005391.2 path:05166_45 HTLV-I infection 12 -2.63959396221946 0.00926831554544583 0.0418127417220681
GBM ENSG00000267159 AC005391.2 path:05169_4 Epstein-Barr virus infection 53 2.83623216108333 0.00539615695389703 0.0285636574759616
GBM ENSG00000267159 AC005391.2 path:05204_15 Chemical carcinogenesis 17 -3.57475465951483 0.000478509138202258 0.00801644272287906
GBM ENSG00000267159 AC005391.2 path:05210_11 Colorectal cancer 27 2.97269894207224 0.00354991505270205 0.0223700996178208
GBM ENSG00000267159 AC005391.2 path:05212_1 Pancreatic cancer 47 3.77815792941905 0.000277201308921854 0.00772001926009608
GBM ENSG00000267159 AC005391.2 path:05213_30 Endometrial cancer 6 4.01749504100129 0.00010529197424993 0.00522511422215276
GBM ENSG00000267159 AC005391.2 path:05214_15 Glioma 43 3.47986076246493 0.000779759132899935 0.00847945735771545
GBM ENSG00000267159 AC005391.2 path:05215_47 Prostate cancer 39 2.89411894381289 0.00456089377811948 0.0266175098959644
GBM ENSG00000267159 AC005391.2 path:05218_58 Melanoma 13 3.46206015393355 0.000809039435905554 0.00847945735771545
GBM ENSG00000267159 AC005391.2 path:05218_91 Melanoma 4 5.05387027583911 1.56949027112536e-06 0.000623087637636768
GBM ENSG00000267159 AC005391.2 path:05223_28 Non-small cell lung cancer 28 4.18482402672857 7.3737759058722e-05 0.00418198433518752
GBM ENSG00000267159 AC005391.2 path:05231_1 Choline metabolism in cancer 74 3.48592285849858 0.000710900471091584 0.00847945735771545
GBM ENSG00000267159 AC005391.2 path:05321_40 Inflammatory bowel disease (IBD) 10 -3.25324393533351 0.00143663107927081 0.0115939070215821
GBM ENSG00000267421 AC005498.3 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000267421 AC005498.3 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000267421 AC005498.3 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000267421 AC005498.3 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000267421 AC005498.3 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000267421 AC005498.3 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000267421 AC005498.3 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000267421 AC005498.3 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000267224 AC005498.4 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000267224 AC005498.4 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000267224 AC005498.4 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000267224 AC005498.4 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000267224 AC005498.4 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000267224 AC005498.4 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000267224 AC005498.4 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000267224 AC005498.4 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000267192 AC006116.12 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000267192 AC006116.12 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000267192 AC006116.12 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000267192 AC006116.12 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000267192 AC006116.12 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000267192 AC006116.12 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000267192 AC006116.12 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000267192 AC006116.12 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000267429 AC006116.15 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000267429 AC006116.15 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000267429 AC006116.15 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000267429 AC006116.15 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000267429 AC006116.15 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000267429 AC006116.15 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000267429 AC006116.15 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000267429 AC006116.15 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000267549 AC006116.17 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000267549 AC006116.17 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000267549 AC006116.17 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000267549 AC006116.17 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000267549 AC006116.17 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000267549 AC006116.17 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000267549 AC006116.17 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000267549 AC006116.17 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000267298 AC006116.19 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000267298 AC006116.19 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000267298 AC006116.19 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000267298 AC006116.19 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000267298 AC006116.19 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000267298 AC006116.19 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000267298 AC006116.19 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000267298 AC006116.19 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000267606 AC006116.21 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000267606 AC006116.21 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000267606 AC006116.21 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000267606 AC006116.21 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000267606 AC006116.21 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000267606 AC006116.21 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000267606 AC006116.21 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000267606 AC006116.21 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000267776 AC006116.24 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000267776 AC006116.24 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000267776 AC006116.24 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000267776 AC006116.24 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000267776 AC006116.24 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000267776 AC006116.24 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000267776 AC006116.24 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000267776 AC006116.24 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000269696 AC007228.11 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000269696 AC007228.11 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000269696 AC007228.11 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000269696 AC007228.11 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000269696 AC007228.11 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000269696 AC007228.11 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000269696 AC007228.11 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000269696 AC007228.11 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000268352 AC007228.5 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000268352 AC007228.5 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000268352 AC007228.5 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000268352 AC007228.5 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000268352 AC007228.5 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000268352 AC007228.5 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000268352 AC007228.5 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000268352 AC007228.5 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000268568 AC007228.9 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000268568 AC007228.9 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000268568 AC007228.9 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000268568 AC007228.9 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000268568 AC007228.9 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000268568 AC007228.9 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000268568 AC007228.9 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000268568 AC007228.9 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000267117 AC010525.4 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000267117 AC010525.4 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000267117 AC010525.4 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000267117 AC010525.4 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000267117 AC010525.4 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000267117 AC010525.4 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000267117 AC010525.4 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000267117 AC010525.4 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000249086 AC051649.12 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000249086 AC051649.12 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000249086 AC051649.12 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000249086 AC051649.12 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000249086 AC051649.12 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000249086 AC051649.12 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000249086 AC051649.12 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000249086 AC051649.12 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000249086 AC051649.12 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000249086 AC051649.12 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000249086 AC051649.12 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000249086 AC051649.12 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000249086 AC051649.12 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000249086 AC051649.12 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000229512 AC068580.5 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000229512 AC068580.5 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000229512 AC068580.5 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000229512 AC068580.5 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000229512 AC068580.5 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000229512 AC068580.5 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000229512 AC068580.5 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000229512 AC068580.5 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000229512 AC068580.5 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000229512 AC068580.5 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000229512 AC068580.5 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000229512 AC068580.5 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000229512 AC068580.5 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000229512 AC068580.5 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000235027 AC068580.6 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000235027 AC068580.6 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000235027 AC068580.6 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000235027 AC068580.6 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000235027 AC068580.6 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000235027 AC068580.6 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000235027 AC068580.6 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000235027 AC068580.6 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000235027 AC068580.6 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000235027 AC068580.6 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000235027 AC068580.6 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000235027 AC068580.6 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000235027 AC068580.6 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000235027 AC068580.6 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000230834 AC068580.7 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000230834 AC068580.7 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000230834 AC068580.7 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000230834 AC068580.7 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000230834 AC068580.7 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000230834 AC068580.7 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000230834 AC068580.7 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000230834 AC068580.7 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000230834 AC068580.7 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000230834 AC068580.7 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000230834 AC068580.7 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000230834 AC068580.7 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000230834 AC068580.7 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000230834 AC068580.7 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000238031 AC090505.1 path:04115_1 p53 signaling pathway 65 -3.55713699876328 0.000527407092041986 0.0490488595599047
GBM ENSG00000238031 AC090505.1 path:04664_96 Fc epsilon RI signaling pathway 2 -4.34638754340703 0.000180317079728335 0.0490488595599047
GBM ENSG00000238031 AC090505.1 path:05150_6 Staphylococcus aureus infection 4 -3.96738278918914 0.000381795720153409 0.0490488595599047
GBM ENSG00000238031 AC090505.1 path:05218_69 Melanoma 9 -3.61225779699334 0.000425723250615414 0.0490488595599047
GBM ENSG00000230401 AC090505.4 path:04115_1 p53 signaling pathway 65 -3.55713699876328 0.000527407092041986 0.0490488595599047
GBM ENSG00000230401 AC090505.4 path:04664_96 Fc epsilon RI signaling pathway 2 -4.34638754340703 0.000180317079728335 0.0490488595599047
GBM ENSG00000230401 AC090505.4 path:05150_6 Staphylococcus aureus infection 4 -3.96738278918914 0.000381795720153409 0.0490488595599047
GBM ENSG00000230401 AC090505.4 path:05218_69 Melanoma 9 -3.61225779699334 0.000425723250615414 0.0490488595599047
GBM ENSG00000237222 AC090505.6 path:04115_1 p53 signaling pathway 65 -3.55713699876328 0.000527407092041986 0.0490488595599047
GBM ENSG00000237222 AC090505.6 path:04664_96 Fc epsilon RI signaling pathway 2 -4.34638754340703 0.000180317079728335 0.0490488595599047
GBM ENSG00000237222 AC090505.6 path:05150_6 Staphylococcus aureus infection 4 -3.96738278918914 0.000381795720153409 0.0490488595599047
GBM ENSG00000237222 AC090505.6 path:05218_69 Melanoma 9 -3.61225779699334 0.000425723250615414 0.0490488595599047
GBM ENSG00000233987 AC106706.1 path:04115_1 p53 signaling pathway 65 -3.55713699876328 0.000527407092041986 0.0490488595599047
GBM ENSG00000233987 AC106706.1 path:04664_96 Fc epsilon RI signaling pathway 2 -4.34638754340703 0.000180317079728335 0.0490488595599047
GBM ENSG00000233987 AC106706.1 path:05150_6 Staphylococcus aureus infection 4 -3.96738278918914 0.000381795720153409 0.0490488595599047
GBM ENSG00000233987 AC106706.1 path:05218_69 Melanoma 9 -3.61225779699334 0.000425723250615414 0.0490488595599047
GBM ENSG00000244675 AC108676.1 path:04115_1 p53 signaling pathway 65 -3.55713699876328 0.000527407092041986 0.0490488595599047
GBM ENSG00000244675 AC108676.1 path:04664_96 Fc epsilon RI signaling pathway 2 -4.34638754340703 0.000180317079728335 0.0490488595599047
GBM ENSG00000244675 AC108676.1 path:05150_6 Staphylococcus aureus infection 4 -3.96738278918914 0.000381795720153409 0.0490488595599047
GBM ENSG00000244675 AC108676.1 path:05218_69 Melanoma 9 -3.61225779699334 0.000425723250615414 0.0490488595599047
GBM ENSG00000240801 AC132217.4 path:00053_1 Ascorbate and aldarate metabolism 6 3.72065031678615 0.000579663505879064 0.0462143047297844
GBM ENSG00000240801 AC132217.4 path:00330_1 Arginine and proline metabolism 50 -3.45237516632261 0.000971350602226964 0.0462143047297844
GBM ENSG00000240801 AC132217.4 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37052207980055 0.00111628755385953 0.0462143047297844
GBM ENSG00000240801 AC132217.4 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.45749772172656 0.000967554994288987 0.0462143047297844
GBM ENSG00000240801 AC132217.4 path:04650_125 Natural killer cell mediated cytotoxicity 3 -4.01150888345366 0.000156690518106735 0.0208174040863445
GBM ENSG00000240801 AC132217.4 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.27385525385521 4.32030167506117e-05 0.00894302446737662
GBM ENSG00000240801 AC132217.4 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.4312535345592 3.32642230735743e-05 0.00894302446737662
GBM ENSG00000240801 AC132217.4 path:05034_40 Alcoholism 34 3.48092763066619 0.00104854625774689 0.0462143047297844
GBM ENSG00000240801 AC132217.4 path:05145_11 Toxoplasmosis 11 -3.61186260807517 0.000699683942105843 0.0462143047297844
GBM ENSG00000240801 AC132217.4 path:05416_3 Viral myocarditis 5 -3.90463909826775 0.000201134338998498 0.0208174040863445
GBM ENSG00000178803 ADORA2A-AS1 path:00240_151 Pyrimidine metabolism 10 3.64690588885697 0.000512552329873403 0.0188246492062595
GBM ENSG00000178803 ADORA2A-AS1 path:00250_46 Alanine, aspartate and glutamate metabolism 3 -3.94140351755358 0.000142135402482837 0.0077144700497564
GBM ENSG00000178803 ADORA2A-AS1 path:00350_24 Tyrosine metabolism 10 -5.29922716686186 5.47571814673891e-07 0.000110609506564126
GBM ENSG00000178803 ADORA2A-AS1 path:03460_1 Fanconi anemia pathway 38 3.87335488604016 0.000205169465429941 0.00853527997145846
GBM ENSG00000178803 ADORA2A-AS1 path:04022_135 cGMP-PKG signaling pathway 5 -4.35184490483607 2.93490724686348e-05 0.00237140505546569
GBM ENSG00000178803 ADORA2A-AS1 path:04611_229 Platelet activation 7 -4.75800475520758 8.89908238963924e-06 0.000898807321353563
GBM ENSG00000178803 ADORA2A-AS1 path:04650_63 Natural killer cell mediated cytotoxicity 33 -3.92847511280026 0.000152761783163493 0.0077144700497564
GBM ENSG00000178803 ADORA2A-AS1 path:04722_70 Neurotrophin signaling pathway 35 -5.02739921337353 2.09048546535891e-06 0.000281518709334999
GBM ENSG00000178803 ADORA2A-AS1 path:04726_27 Serotonergic synapse 12 -3.31584794260644 0.00119419839977033 0.0402046794589345
GBM ENSG00000178803 ADORA2A-AS1 path:04916_111 Melanogenesis 10 -3.24727741730556 0.00157162824837112 0.0488413701801487
GBM ENSG00000178803 ADORA2A-AS1 path:05216_14 Thyroid cancer 4 -5.38874943787634 3.60789332483435e-07 0.000110609506564126
GBM ENSG00000178803 ADORA2A-AS1 path:05220_45 Chronic myeloid leukemia 8 -4.17534111563786 5.78277782846914e-05 0.00389373707116922
GBM ENSG00000178803 ADORA2A-AS1 path:05223_75 Non-small cell lung cancer 5 -3.81658895207301 0.000211269306224219 0.00853527997145846
GBM ENSG00000228923 AP000355.2 path:00240_151 Pyrimidine metabolism 10 3.88678733457003 0.000218964858458389 0.0110577253521486
GBM ENSG00000228923 AP000355.2 path:00250_46 Alanine, aspartate and glutamate metabolism 3 -3.70661283876875 0.000321526133048606 0.0131296293675077
GBM ENSG00000228923 AP000355.2 path:00350_24 Tyrosine metabolism 10 -4.63864309951426 9.13051604576226e-06 0.000922182120621988
GBM ENSG00000228923 AP000355.2 path:03460_1 Fanconi anemia pathway 38 3.87552404269904 0.00019435087248847 0.0110577253521486
GBM ENSG00000228923 AP000355.2 path:04022_135 cGMP-PKG signaling pathway 5 -4.03616070528317 9.64581747568057e-05 0.0077938205203499
GBM ENSG00000228923 AP000355.2 path:04611_229 Platelet activation 7 -4.88227237168663 4.95543837561412e-06 0.000922182120621988
GBM ENSG00000228923 AP000355.2 path:04650_63 Natural killer cell mediated cytotoxicity 33 -3.69493581154774 0.000341477519619927 0.0131296293675077
GBM ENSG00000228923 AP000355.2 path:04722_70 Neurotrophin signaling pathway 35 -4.70655247080611 7.43673050976456e-06 0.000922182120621988
GBM ENSG00000228923 AP000355.2 path:05216_14 Thyroid cancer 4 -5.09915581542688 1.24496687551165e-06 0.000502966617706706
GBM ENSG00000228923 AP000355.2 path:05220_45 Chronic myeloid leukemia 8 -3.92302731529231 0.000145595428880429 0.00980342554461554
GBM ENSG00000228923 AP000355.2 path:05223_75 Non-small cell lung cancer 5 -3.66667394834223 0.000357489908521249 0.0131296293675077
GBM ENSG00000227306 AP006285.6 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000227306 AP006285.6 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000227306 AP006285.6 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000227306 AP006285.6 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000227306 AP006285.6 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000227306 AP006285.6 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000227306 AP006285.6 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000227306 AP006285.6 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000227306 AP006285.6 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000227306 AP006285.6 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000227306 AP006285.6 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000227306 AP006285.6 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000227306 AP006285.6 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000227306 AP006285.6 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000231487 AP006285.7 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000231487 AP006285.7 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000231487 AP006285.7 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000231487 AP006285.7 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000231487 AP006285.7 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000231487 AP006285.7 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000231487 AP006285.7 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000231487 AP006285.7 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000231487 AP006285.7 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000231487 AP006285.7 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000231487 AP006285.7 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000231487 AP006285.7 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000231487 AP006285.7 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000231487 AP006285.7 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000255142 AP006621.6 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000255142 AP006621.6 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000255142 AP006621.6 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000255142 AP006621.6 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000255142 AP006621.6 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000255142 AP006621.6 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000255142 AP006621.6 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000255142 AP006621.6 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000255142 AP006621.6 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000255142 AP006621.6 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000255142 AP006621.6 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000255142 AP006621.6 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000255142 AP006621.6 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000255142 AP006621.6 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000255108 AP006621.8 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000255108 AP006621.8 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000255108 AP006621.8 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000255108 AP006621.8 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000255108 AP006621.8 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000255108 AP006621.8 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000255108 AP006621.8 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000255108 AP006621.8 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000255108 AP006621.8 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000255108 AP006621.8 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000255108 AP006621.8 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000255108 AP006621.8 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000255108 AP006621.8 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000255108 AP006621.8 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000269915 AP006621.9 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000269915 AP006621.9 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000269915 AP006621.9 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000269915 AP006621.9 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000269915 AP006621.9 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000269915 AP006621.9 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000269915 AP006621.9 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000269915 AP006621.9 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000269915 AP006621.9 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000269915 AP006621.9 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000269915 AP006621.9 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000269915 AP006621.9 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000269915 AP006621.9 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000269915 AP006621.9 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000254166 CASC19 path:00053_1 Ascorbate and aldarate metabolism 6 3.58385049852884 0.000858893918589114 0.0463802716038122
GBM ENSG00000254166 CASC19 path:00670_1 One carbon pool by folate 10 4.05212249129395 0.00017925885588583 0.0258132752475595
GBM ENSG00000254166 CASC19 path:04512_43 ECM-receptor interaction 28 -3.85928843330729 0.000243182811650707 0.0262637436582764
GBM ENSG00000254166 CASC19 path:04610_47 Complement and coagulation cascades 29 -3.6036257543904 0.00059727698030629 0.0377448473024779
GBM ENSG00000254166 CASC19 path:04610_70 Complement and coagulation cascades 8 -3.73180073019134 0.000391283160470677 0.0338068650646665
GBM ENSG00000254166 CASC19 path:04664_96 Fc epsilon RI signaling pathway 2 -3.57577626092919 0.000611606322030892 0.0377448473024779
GBM ENSG00000254166 CASC19 path:04971_60 Gastric acid secretion 4 -4.28546372281204 4.98321157768993e-05 0.0180499164631945
GBM ENSG00000254166 CASC19 path:05140_61 Leishmaniasis 11 -4.14810389782444 8.3564428070345e-05 0.0180499164631945
GBM ENSG00000240498 CDKN2B-AS1 path:00140_2 Steroid hormone biosynthesis 24 3.05058111025615 0.00300088976353606 0.0380435379699894
GBM ENSG00000240498 CDKN2B-AS1 path:00260_31 Glycine, serine and threonine metabolism 14 3.36450285504011 0.00104055404144449 0.0170390724286536
GBM ENSG00000240498 CDKN2B-AS1 path:00480_7 Glutathione metabolism 25 3.15444630354984 0.00204722436623678 0.028734256283252
GBM ENSG00000240498 CDKN2B-AS1 path:00591_1 Linoleic acid metabolism 18 3.68287457837808 0.000331423428585955 0.00911192443593987
GBM ENSG00000240498 CDKN2B-AS1 path:04012_56 ErbB signaling pathway 34 3.1779442601678 0.00181408128827827 0.0264049609738281
GBM ENSG00000240498 CDKN2B-AS1 path:04020_152 Calcium signaling pathway 23 3.49603223363769 0.000625852864922681 0.0130777901626386
GBM ENSG00000240498 CDKN2B-AS1 path:04060_29 Cytokine-cytokine receptor interaction 2 3.59135185481796 0.000449602401102268 0.0110433589770745
GBM ENSG00000240498 CDKN2B-AS1 path:04110_140 Cell cycle 20 -4.31805241470827 9.31927913346398e-05 0.00469467735491192
GBM ENSG00000240498 CDKN2B-AS1 path:04110_203 Cell cycle 2 -3.36028955652288 0.00138131496325455 0.0217142712223616
GBM ENSG00000240498 CDKN2B-AS1 path:04115_9 p53 signaling pathway 57 -4.17569671062627 0.000141463610056714 0.00505410897748078
GBM ENSG00000240498 CDKN2B-AS1 path:04150_1 mTOR signaling pathway 53 -3.59776280427604 0.000606238662880313 0.0130777901626386
GBM ENSG00000240498 CDKN2B-AS1 path:04151_234 PI3K-Akt signaling pathway 25 3.66350861694259 0.000347322099825717 0.00911192443593987
GBM ENSG00000240498 CDKN2B-AS1 path:04520_78 Adherens junction 4 3.44260303172663 0.000754358111127414 0.0130777901626386
GBM ENSG00000240498 CDKN2B-AS1 path:04610_79 Complement and coagulation cascades 6 3.09984856119598 0.00255933368287093 0.0346833840471819
GBM ENSG00000240498 CDKN2B-AS1 path:04611_230 Platelet activation 7 -3.51916858494372 0.000765366854302003 0.0130777901626386
GBM ENSG00000240498 CDKN2B-AS1 path:04666_66 Fc gamma R-mediated phagocytosis 49 -3.58019409289774 0.000648155811008631 0.0130777901626386
GBM ENSG00000240498 CDKN2B-AS1 path:04915_101 Estrogen signaling pathway 12 3.67596098492813 0.00033312201698324 0.00911192443593987
GBM ENSG00000240498 CDKN2B-AS1 path:05120_4 Epithelial cell signaling in Helicobacter pylori infection 23 3.66394305709461 0.000347783375417552 0.00911192443593987
GBM ENSG00000240498 CDKN2B-AS1 path:05160_47 Hepatitis C 3 3.47669297956896 0.000670462190580686 0.0130777901626386
GBM ENSG00000240498 CDKN2B-AS1 path:05161_85 Hepatitis B 6 -4.18227055419132 0.000141034620600966 0.00505410897748078
GBM ENSG00000240498 CDKN2B-AS1 path:05166_48 HTLV-I infection 10 -4.59585884704093 3.81357003927059e-05 0.00469467735491192
GBM ENSG00000240498 CDKN2B-AS1 path:05200_104 Pathways in cancer 31 -4.27180305721349 0.000107511695150655 0.00469467735491192
GBM ENSG00000240498 CDKN2B-AS1 path:05205_198 Proteoglycans in cancer 11 -3.56919207307033 0.000727995091364824 0.0130777901626386
GBM ENSG00000240498 CDKN2B-AS1 path:05212_35 Pancreatic cancer 8 -4.35884491925902 8.09737100062618e-05 0.00469467735491192
GBM ENSG00000240498 CDKN2B-AS1 path:05214_32 Glioma 11 -4.27369822707094 0.000107299376217703 0.00469467735491192
GBM ENSG00000240498 CDKN2B-AS1 path:05218_69 Melanoma 9 -4.30953165837654 9.59242807615076e-05 0.00469467735491192
GBM ENSG00000240498 CDKN2B-AS1 path:05219_6 Bladder cancer 10 -4.36175762326708 8.14389395314573e-05 0.00469467735491192
GBM ENSG00000240498 CDKN2B-AS1 path:05220_3 Chronic myeloid leukemia 56 -4.43668078895005 6.30992468273105e-05 0.00469467735491192
GBM ENSG00000240498 CDKN2B-AS1 path:05222_77 Small cell lung cancer 2 -4.40400526140395 7.02360697699352e-05 0.00469467735491192
GBM ENSG00000240498 CDKN2B-AS1 path:05223_4 Non-small cell lung cancer 44 -3.31423234592507 0.00173638133936342 0.0262460717834547
GBM ENSG00000240498 CDKN2B-AS1 path:05231_97 Choline metabolism in cancer 5 3.04533194736604 0.00276076806342289 0.0361660616308398
GBM ENSG00000253538 CTB-32P11.1 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.73515216918747 1.67050287109805e-05 0.00671542154181415
GBM ENSG00000268205 CTC-444N24.11 path:00760_1 Nicotinate and nicotinamide metabolism 20 -4.09958318904765 0.000270574628122514 0.00890641484236608
GBM ENSG00000268205 CTC-444N24.11 path:04012_31 ErbB signaling pathway 53 -3.40747340756034 0.00108842887857785 0.030709243359875
GBM ENSG00000268205 CTC-444N24.11 path:04015_98 Rap1 signaling pathway 44 -4.20970001974488 0.000107215364860955 0.00385000628364337
GBM ENSG00000268205 CTC-444N24.11 path:04060_29 Cytokine-cytokine receptor interaction 2 -5.00995852281333 1.63449474343543e-06 0.000209385001067378
GBM ENSG00000268205 CTC-444N24.11 path:04066_95 HIF-1 signaling pathway 14 -4.40207367788122 2.58747244136e-05 0.0010220516143372
GBM ENSG00000268205 CTC-444N24.11 path:04115_1 p53 signaling pathway 65 -4.91618084656197 3.00609454377527e-06 0.000209385001067378
GBM ENSG00000268205 CTC-444N24.11 path:04144_8 Endocytosis 37 -5.63538943246069 8.77927905906997e-08 3.46781522833264e-05
GBM ENSG00000268205 CTC-444N24.11 path:04713_105 Circadian entrainment 18 -3.41128886017006 0.00157505036937974 0.0388840559940622
GBM ENSG00000268205 CTC-444N24.11 path:04912_55 GnRH signaling pathway 9 -4.92700407235735 2.43686936725699e-06 0.000209385001067378
GBM ENSG00000268205 CTC-444N24.11 path:04915_101 Estrogen signaling pathway 12 -4.55277489182376 1.3729142515057e-05 0.000677876411680942
GBM ENSG00000268205 CTC-444N24.11 path:04921_178 Oxytocin signaling pathway 8 -3.68905187859486 0.000968517813653688 0.0294280412610159
GBM ENSG00000268205 CTC-444N24.11 path:05120_8 Epithelial cell signaling in Helicobacter pylori infection 17 -5.34515703990019 4.22099190706788e-07 8.33645901645905e-05
GBM ENSG00000268205 CTC-444N24.11 path:05160_41 Hepatitis C 6 -4.85240293404493 3.18053166178295e-06 0.000209385001067378
GBM ENSG00000268205 CTC-444N24.11 path:05214_27 Glioma 17 -4.58840787758267 2.45875476400915e-05 0.0010220516143372
GBM ENSG00000268205 CTC-444N24.11 path:05215_17 Prostate cancer 65 -3.42629297574164 0.001208837947199 0.0318327326095738
GBM ENSG00000268205 CTC-444N24.11 path:05223_63 Non-small cell lung cancer 8 -4.51861258743634 1.36836241965064e-05 0.000677876411680942
GBM ENSG00000268678 CTC-444N24.13 path:00760_1 Nicotinate and nicotinamide metabolism 20 -4.09958318904765 0.000270574628122514 0.00890641484236608
GBM ENSG00000268678 CTC-444N24.13 path:04012_31 ErbB signaling pathway 53 -3.40747340756034 0.00108842887857785 0.030709243359875
GBM ENSG00000268678 CTC-444N24.13 path:04015_98 Rap1 signaling pathway 44 -4.20970001974488 0.000107215364860955 0.00385000628364337
GBM ENSG00000268678 CTC-444N24.13 path:04060_29 Cytokine-cytokine receptor interaction 2 -5.00995852281333 1.63449474343543e-06 0.000209385001067378
GBM ENSG00000268678 CTC-444N24.13 path:04066_95 HIF-1 signaling pathway 14 -4.40207367788122 2.58747244136e-05 0.0010220516143372
GBM ENSG00000268678 CTC-444N24.13 path:04115_1 p53 signaling pathway 65 -4.91618084656197 3.00609454377527e-06 0.000209385001067378
GBM ENSG00000268678 CTC-444N24.13 path:04144_8 Endocytosis 37 -5.63538943246069 8.77927905906997e-08 3.46781522833264e-05
GBM ENSG00000268678 CTC-444N24.13 path:04713_105 Circadian entrainment 18 -3.41128886017006 0.00157505036937974 0.0388840559940622
GBM ENSG00000268678 CTC-444N24.13 path:04912_55 GnRH signaling pathway 9 -4.92700407235735 2.43686936725699e-06 0.000209385001067378
GBM ENSG00000268678 CTC-444N24.13 path:04915_101 Estrogen signaling pathway 12 -4.55277489182376 1.3729142515057e-05 0.000677876411680942
GBM ENSG00000268678 CTC-444N24.13 path:04921_178 Oxytocin signaling pathway 8 -3.68905187859486 0.000968517813653688 0.0294280412610159
GBM ENSG00000268678 CTC-444N24.13 path:05120_8 Epithelial cell signaling in Helicobacter pylori infection 17 -5.34515703990019 4.22099190706788e-07 8.33645901645905e-05
GBM ENSG00000268678 CTC-444N24.13 path:05160_41 Hepatitis C 6 -4.85240293404493 3.18053166178295e-06 0.000209385001067378
GBM ENSG00000268678 CTC-444N24.13 path:05214_27 Glioma 17 -4.58840787758267 2.45875476400915e-05 0.0010220516143372
GBM ENSG00000268678 CTC-444N24.13 path:05215_17 Prostate cancer 65 -3.42629297574164 0.001208837947199 0.0318327326095738
GBM ENSG00000268678 CTC-444N24.13 path:05223_63 Non-small cell lung cancer 8 -4.51861258743634 1.36836241965064e-05 0.000677876411680942
GBM ENSG00000267871 CTC-444N24.6 path:00760_1 Nicotinate and nicotinamide metabolism 20 -4.09958318904765 0.000270574628122514 0.00890641484236608
GBM ENSG00000267871 CTC-444N24.6 path:04012_31 ErbB signaling pathway 53 -3.40747340756034 0.00108842887857785 0.030709243359875
GBM ENSG00000267871 CTC-444N24.6 path:04015_98 Rap1 signaling pathway 44 -4.20970001974488 0.000107215364860955 0.00385000628364337
GBM ENSG00000267871 CTC-444N24.6 path:04060_29 Cytokine-cytokine receptor interaction 2 -5.00995852281333 1.63449474343543e-06 0.000209385001067378
GBM ENSG00000267871 CTC-444N24.6 path:04066_95 HIF-1 signaling pathway 14 -4.40207367788122 2.58747244136e-05 0.0010220516143372
GBM ENSG00000267871 CTC-444N24.6 path:04115_1 p53 signaling pathway 65 -4.91618084656197 3.00609454377527e-06 0.000209385001067378
GBM ENSG00000267871 CTC-444N24.6 path:04144_8 Endocytosis 37 -5.63538943246069 8.77927905906997e-08 3.46781522833264e-05
GBM ENSG00000267871 CTC-444N24.6 path:04713_105 Circadian entrainment 18 -3.41128886017006 0.00157505036937974 0.0388840559940622
GBM ENSG00000267871 CTC-444N24.6 path:04912_55 GnRH signaling pathway 9 -4.92700407235735 2.43686936725699e-06 0.000209385001067378
GBM ENSG00000267871 CTC-444N24.6 path:04915_101 Estrogen signaling pathway 12 -4.55277489182376 1.3729142515057e-05 0.000677876411680942
GBM ENSG00000267871 CTC-444N24.6 path:04921_178 Oxytocin signaling pathway 8 -3.68905187859486 0.000968517813653688 0.0294280412610159
GBM ENSG00000267871 CTC-444N24.6 path:05120_8 Epithelial cell signaling in Helicobacter pylori infection 17 -5.34515703990019 4.22099190706788e-07 8.33645901645905e-05
GBM ENSG00000267871 CTC-444N24.6 path:05160_41 Hepatitis C 6 -4.85240293404493 3.18053166178295e-06 0.000209385001067378
GBM ENSG00000267871 CTC-444N24.6 path:05214_27 Glioma 17 -4.58840787758267 2.45875476400915e-05 0.0010220516143372
GBM ENSG00000267871 CTC-444N24.6 path:05215_17 Prostate cancer 65 -3.42629297574164 0.001208837947199 0.0318327326095738
GBM ENSG00000267871 CTC-444N24.6 path:05223_63 Non-small cell lung cancer 8 -4.51861258743634 1.36836241965064e-05 0.000677876411680942
GBM ENSG00000268713 CTC-444N24.8 path:00760_1 Nicotinate and nicotinamide metabolism 20 -4.09958318904765 0.000270574628122514 0.00890641484236608
GBM ENSG00000268713 CTC-444N24.8 path:04012_31 ErbB signaling pathway 53 -3.40747340756034 0.00108842887857785 0.030709243359875
GBM ENSG00000268713 CTC-444N24.8 path:04015_98 Rap1 signaling pathway 44 -4.20970001974488 0.000107215364860955 0.00385000628364337
GBM ENSG00000268713 CTC-444N24.8 path:04060_29 Cytokine-cytokine receptor interaction 2 -5.00995852281333 1.63449474343543e-06 0.000209385001067378
GBM ENSG00000268713 CTC-444N24.8 path:04066_95 HIF-1 signaling pathway 14 -4.40207367788122 2.58747244136e-05 0.0010220516143372
GBM ENSG00000268713 CTC-444N24.8 path:04115_1 p53 signaling pathway 65 -4.91618084656197 3.00609454377527e-06 0.000209385001067378
GBM ENSG00000268713 CTC-444N24.8 path:04144_8 Endocytosis 37 -5.63538943246069 8.77927905906997e-08 3.46781522833264e-05
GBM ENSG00000268713 CTC-444N24.8 path:04713_105 Circadian entrainment 18 -3.41128886017006 0.00157505036937974 0.0388840559940622
GBM ENSG00000268713 CTC-444N24.8 path:04912_55 GnRH signaling pathway 9 -4.92700407235735 2.43686936725699e-06 0.000209385001067378
GBM ENSG00000268713 CTC-444N24.8 path:04915_101 Estrogen signaling pathway 12 -4.55277489182376 1.3729142515057e-05 0.000677876411680942
GBM ENSG00000268713 CTC-444N24.8 path:04921_178 Oxytocin signaling pathway 8 -3.68905187859486 0.000968517813653688 0.0294280412610159
GBM ENSG00000268713 CTC-444N24.8 path:05120_8 Epithelial cell signaling in Helicobacter pylori infection 17 -5.34515703990019 4.22099190706788e-07 8.33645901645905e-05
GBM ENSG00000268713 CTC-444N24.8 path:05160_41 Hepatitis C 6 -4.85240293404493 3.18053166178295e-06 0.000209385001067378
GBM ENSG00000268713 CTC-444N24.8 path:05214_27 Glioma 17 -4.58840787758267 2.45875476400915e-05 0.0010220516143372
GBM ENSG00000268713 CTC-444N24.8 path:05215_17 Prostate cancer 65 -3.42629297574164 0.001208837947199 0.0318327326095738
GBM ENSG00000268713 CTC-444N24.8 path:05223_63 Non-small cell lung cancer 8 -4.51861258743634 1.36836241965064e-05 0.000677876411680942
GBM ENSG00000269275 CTD-2105E13.15 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000269275 CTD-2105E13.15 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000269275 CTD-2105E13.15 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000269275 CTD-2105E13.15 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000269275 CTD-2105E13.15 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000269275 CTD-2105E13.15 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000269275 CTD-2105E13.15 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000269275 CTD-2105E13.15 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000253236 CTD-2313P7.1 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.73515216918747 1.67050287109805e-05 0.00653166622599337
GBM ENSG00000267523 CTD-2537I9.12 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000267523 CTD-2537I9.12 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000267523 CTD-2537I9.12 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000267523 CTD-2537I9.12 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000267523 CTD-2537I9.12 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000267523 CTD-2537I9.12 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000267523 CTD-2537I9.12 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000267523 CTD-2537I9.12 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000267096 CTD-2537I9.13 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000267096 CTD-2537I9.13 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000267096 CTD-2537I9.13 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000267096 CTD-2537I9.13 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000267096 CTD-2537I9.13 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000267096 CTD-2537I9.13 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000267096 CTD-2537I9.13 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000267096 CTD-2537I9.13 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000269859 CTD-2537I9.16 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000269859 CTD-2537I9.16 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000269859 CTD-2537I9.16 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000269859 CTD-2537I9.16 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000269859 CTD-2537I9.16 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000269859 CTD-2537I9.16 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000269859 CTD-2537I9.16 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000269859 CTD-2537I9.16 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000269867 CTD-2583A14.8 path:00564_41 Glycerophospholipid metabolism 28 -3.55209064343081 0.00170240662073655 0.0383041489665723
GBM ENSG00000269867 CTD-2583A14.8 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.73546729457466 0.00078391186361129 0.024421869597121
GBM ENSG00000269867 CTD-2583A14.8 path:04012_31 ErbB signaling pathway 53 -3.40747340756034 0.00108842887857785 0.0293875797216019
GBM ENSG00000269867 CTD-2583A14.8 path:04015_98 Rap1 signaling pathway 44 -4.20970001974488 0.000107215364860955 0.00394747479715333
GBM ENSG00000269867 CTD-2583A14.8 path:04020_152 Calcium signaling pathway 23 -3.77498608466707 0.000295028291021875 0.00995720482198827
GBM ENSG00000269867 CTD-2583A14.8 path:04060_29 Cytokine-cytokine receptor interaction 2 -5.00995852281333 1.63449474343543e-06 0.000214685887170349
GBM ENSG00000269867 CTD-2583A14.8 path:04066_95 HIF-1 signaling pathway 14 -4.40207367788122 2.58747244136e-05 0.0010479263387508
GBM ENSG00000269867 CTD-2583A14.8 path:04115_1 p53 signaling pathway 65 -4.91618084656197 3.00609454377527e-06 0.000214685887170349
GBM ENSG00000269867 CTD-2583A14.8 path:04144_8 Endocytosis 37 -5.63538943246069 8.77927905906997e-08 3.55560801892334e-05
GBM ENSG00000269867 CTD-2583A14.8 path:04713_105 Circadian entrainment 18 -3.41128886017006 0.00157505036937974 0.037523258799929
GBM ENSG00000269867 CTD-2583A14.8 path:04912_55 GnRH signaling pathway 9 -4.92700407235735 2.43686936725699e-06 0.000214685887170349
GBM ENSG00000269867 CTD-2583A14.8 path:04915_101 Estrogen signaling pathway 12 -4.55277489182376 1.3729142515057e-05 0.000695037839824763
GBM ENSG00000269867 CTD-2583A14.8 path:04921_178 Oxytocin signaling pathway 8 -3.68905187859486 0.000968517813653688 0.0280178367521245
GBM ENSG00000269867 CTD-2583A14.8 path:05120_8 Epithelial cell signaling in Helicobacter pylori infection 17 -5.34515703990019 4.22099190706788e-07 8.54750861181245e-05
GBM ENSG00000269867 CTD-2583A14.8 path:05160_41 Hepatitis C 6 -4.85240293404493 3.18053166178295e-06 0.000214685887170349
GBM ENSG00000269867 CTD-2583A14.8 path:05214_27 Glioma 17 -4.58840787758267 2.45875476400915e-05 0.0010479263387508
GBM ENSG00000269867 CTD-2583A14.8 path:05215_17 Prostate cancer 65 -3.42629297574164 0.001208837947199 0.0305987105384748
GBM ENSG00000269867 CTD-2583A14.8 path:05223_63 Non-small cell lung cancer 8 -4.51861258743634 1.36836241965064e-05 0.000695037839824763
GBM ENSG00000255007 CTD-2589M5.4 path:00260_29 Glycine, serine and threonine metabolism 16 -4.07497816070686 9.85385013421624e-05 0.0387256310274698
GBM ENSG00000255007 CTD-2589M5.4 path:04310_125 Wnt signaling pathway 13 -3.71675531661797 0.000303333391465212 0.0397366742819427
GBM ENSG00000255007 CTD-2589M5.4 path:04922_77 Glucagon signaling pathway 9 -3.78363565556076 0.000232590752212318 0.0397366742819427
GBM ENSG00000254639 CTD-2589M5.5 path:00260_29 Glycine, serine and threonine metabolism 16 -4.07497816070686 9.85385013421624e-05 0.0387256310274698
GBM ENSG00000254639 CTD-2589M5.5 path:04310_125 Wnt signaling pathway 13 -3.71675531661797 0.000303333391465212 0.0397366742819427
GBM ENSG00000254639 CTD-2589M5.5 path:04922_77 Glucagon signaling pathway 9 -3.78363565556076 0.000232590752212318 0.0397366742819427
GBM ENSG00000269054 CTD-2619J13.3 path:00760_1 Nicotinate and nicotinamide metabolism 20 -4.08058033047396 0.000214825918450342 0.00714296178847388
GBM ENSG00000269054 CTD-2619J13.3 path:04012_31 ErbB signaling pathway 53 -3.31104682676839 0.00134109664696 0.0334435976335649
GBM ENSG00000269054 CTD-2619J13.3 path:04015_98 Rap1 signaling pathway 44 -4.16690092050392 0.000103160657312055 0.00374191838795543
GBM ENSG00000269054 CTD-2619J13.3 path:04020_152 Calcium signaling pathway 23 -3.79787641919299 0.000247441220500115 0.00759454207534969
GBM ENSG00000269054 CTD-2619J13.3 path:04020_78 Calcium signaling pathway 53 -3.3044500297853 0.00221360823514865 0.0441614842912156
GBM ENSG00000269054 CTD-2619J13.3 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.79793327221435 4.08009771682249e-06 0.000406989747253044
GBM ENSG00000269054 CTD-2619J13.3 path:04066_95 HIF-1 signaling pathway 14 -4.26214242703253 4.16587544789515e-05 0.00166218430371016
GBM ENSG00000269054 CTD-2619J13.3 path:04115_1 p53 signaling pathway 65 -5.04218397896927 1.46822120919462e-06 0.000195273420822885
GBM ENSG00000269054 CTD-2619J13.3 path:04144_8 Endocytosis 37 -5.39935506425027 2.66153256144335e-07 0.00010619514920159
GBM ENSG00000269054 CTD-2619J13.3 path:04713_105 Circadian entrainment 18 -3.68468669863445 0.000554157753582715 0.0157934959771074
GBM ENSG00000269054 CTD-2619J13.3 path:04750_68 Inflammatory mediator regulation of TRP channels 19 -3.23924048769146 0.00220461093197183 0.0441614842912156
GBM ENSG00000269054 CTD-2619J13.3 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -3.40198037810152 0.00217441008573082 0.0441614842912156
GBM ENSG00000269054 CTD-2619J13.3 path:04912_55 GnRH signaling pathway 9 -4.69688560688882 6.48857635359176e-06 0.000517788393016622
GBM ENSG00000269054 CTD-2619J13.3 path:04915_101 Estrogen signaling pathway 12 -4.43578208939096 2.0261489105873e-05 0.00101054176915542
GBM ENSG00000269054 CTD-2619J13.3 path:04921_178 Oxytocin signaling pathway 8 -3.42852158050982 0.00163093943545138 0.0382791079261823
GBM ENSG00000269054 CTD-2619J13.3 path:05120_8 Epithelial cell signaling in Helicobacter pylori infection 17 -5.12568397858956 1.07130211978659e-06 0.000195273420822885
GBM ENSG00000269054 CTD-2619J13.3 path:05160_41 Hepatitis C 6 -4.61565950216344 8.75327540086718e-06 0.000582092814157667
GBM ENSG00000269054 CTD-2619J13.3 path:05214_27 Glioma 17 -4.65149002811612 1.40668635683234e-05 0.000801811223394436
GBM ENSG00000269054 CTD-2619J13.3 path:05215_17 Prostate cancer 65 -3.45152670967051 0.000961774511807392 0.0255832020140766
GBM ENSG00000269054 CTD-2619J13.3 path:05223_63 Non-small cell lung cancer 8 -4.30896803695558 3.16073947523895e-05 0.00140126116735594
GBM ENSG00000268230 CTD-2619J13.8 path:00760_1 Nicotinate and nicotinamide metabolism 20 -4.08058033047396 0.000214825918450342 0.00714296178847388
GBM ENSG00000268230 CTD-2619J13.8 path:04012_31 ErbB signaling pathway 53 -3.31104682676839 0.00134109664696 0.0334435976335649
GBM ENSG00000268230 CTD-2619J13.8 path:04015_98 Rap1 signaling pathway 44 -4.16690092050392 0.000103160657312055 0.00374191838795543
GBM ENSG00000268230 CTD-2619J13.8 path:04020_152 Calcium signaling pathway 23 -3.79787641919299 0.000247441220500115 0.00759454207534969
GBM ENSG00000268230 CTD-2619J13.8 path:04020_78 Calcium signaling pathway 53 -3.3044500297853 0.00221360823514865 0.0441614842912156
GBM ENSG00000268230 CTD-2619J13.8 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.79793327221435 4.08009771682249e-06 0.000406989747253044
GBM ENSG00000268230 CTD-2619J13.8 path:04066_95 HIF-1 signaling pathway 14 -4.26214242703253 4.16587544789515e-05 0.00166218430371016
GBM ENSG00000268230 CTD-2619J13.8 path:04115_1 p53 signaling pathway 65 -5.04218397896927 1.46822120919462e-06 0.000195273420822885
GBM ENSG00000268230 CTD-2619J13.8 path:04144_8 Endocytosis 37 -5.39935506425027 2.66153256144335e-07 0.00010619514920159
GBM ENSG00000268230 CTD-2619J13.8 path:04713_105 Circadian entrainment 18 -3.68468669863445 0.000554157753582715 0.0157934959771074
GBM ENSG00000268230 CTD-2619J13.8 path:04750_68 Inflammatory mediator regulation of TRP channels 19 -3.23924048769146 0.00220461093197183 0.0441614842912156
GBM ENSG00000268230 CTD-2619J13.8 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -3.40198037810152 0.00217441008573082 0.0441614842912156
GBM ENSG00000268230 CTD-2619J13.8 path:04912_55 GnRH signaling pathway 9 -4.69688560688882 6.48857635359176e-06 0.000517788393016622
GBM ENSG00000268230 CTD-2619J13.8 path:04915_101 Estrogen signaling pathway 12 -4.43578208939096 2.0261489105873e-05 0.00101054176915542
GBM ENSG00000268230 CTD-2619J13.8 path:04921_178 Oxytocin signaling pathway 8 -3.42852158050982 0.00163093943545138 0.0382791079261823
GBM ENSG00000268230 CTD-2619J13.8 path:05120_8 Epithelial cell signaling in Helicobacter pylori infection 17 -5.12568397858956 1.07130211978659e-06 0.000195273420822885
GBM ENSG00000268230 CTD-2619J13.8 path:05160_41 Hepatitis C 6 -4.61565950216344 8.75327540086718e-06 0.000582092814157667
GBM ENSG00000268230 CTD-2619J13.8 path:05214_27 Glioma 17 -4.65149002811612 1.40668635683234e-05 0.000801811223394436
GBM ENSG00000268230 CTD-2619J13.8 path:05215_17 Prostate cancer 65 -3.45152670967051 0.000961774511807392 0.0255832020140766
GBM ENSG00000268230 CTD-2619J13.8 path:05223_63 Non-small cell lung cancer 8 -4.30896803695558 3.16073947523895e-05 0.00140126116735594
GBM ENSG00000268049 CTD-2619J13.9 path:00760_1 Nicotinate and nicotinamide metabolism 20 -4.08058033047396 0.000214825918450342 0.00714296178847388
GBM ENSG00000268049 CTD-2619J13.9 path:04012_31 ErbB signaling pathway 53 -3.31104682676839 0.00134109664696 0.0334435976335649
GBM ENSG00000268049 CTD-2619J13.9 path:04015_98 Rap1 signaling pathway 44 -4.16690092050392 0.000103160657312055 0.00374191838795543
GBM ENSG00000268049 CTD-2619J13.9 path:04020_152 Calcium signaling pathway 23 -3.79787641919299 0.000247441220500115 0.00759454207534969
GBM ENSG00000268049 CTD-2619J13.9 path:04020_78 Calcium signaling pathway 53 -3.3044500297853 0.00221360823514865 0.0441614842912156
GBM ENSG00000268049 CTD-2619J13.9 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.79793327221435 4.08009771682249e-06 0.000406989747253044
GBM ENSG00000268049 CTD-2619J13.9 path:04066_95 HIF-1 signaling pathway 14 -4.26214242703253 4.16587544789515e-05 0.00166218430371016
GBM ENSG00000268049 CTD-2619J13.9 path:04115_1 p53 signaling pathway 65 -5.04218397896927 1.46822120919462e-06 0.000195273420822885
GBM ENSG00000268049 CTD-2619J13.9 path:04144_8 Endocytosis 37 -5.39935506425027 2.66153256144335e-07 0.00010619514920159
GBM ENSG00000268049 CTD-2619J13.9 path:04713_105 Circadian entrainment 18 -3.68468669863445 0.000554157753582715 0.0157934959771074
GBM ENSG00000268049 CTD-2619J13.9 path:04750_68 Inflammatory mediator regulation of TRP channels 19 -3.23924048769146 0.00220461093197183 0.0441614842912156
GBM ENSG00000268049 CTD-2619J13.9 path:04750_88 Inflammatory mediator regulation of TRP channels 5 -3.40198037810152 0.00217441008573082 0.0441614842912156
GBM ENSG00000268049 CTD-2619J13.9 path:04912_55 GnRH signaling pathway 9 -4.69688560688882 6.48857635359176e-06 0.000517788393016622
GBM ENSG00000268049 CTD-2619J13.9 path:04915_101 Estrogen signaling pathway 12 -4.43578208939096 2.0261489105873e-05 0.00101054176915542
GBM ENSG00000268049 CTD-2619J13.9 path:04921_178 Oxytocin signaling pathway 8 -3.42852158050982 0.00163093943545138 0.0382791079261823
GBM ENSG00000268049 CTD-2619J13.9 path:05120_8 Epithelial cell signaling in Helicobacter pylori infection 17 -5.12568397858956 1.07130211978659e-06 0.000195273420822885
GBM ENSG00000268049 CTD-2619J13.9 path:05160_41 Hepatitis C 6 -4.61565950216344 8.75327540086718e-06 0.000582092814157667
GBM ENSG00000268049 CTD-2619J13.9 path:05214_27 Glioma 17 -4.65149002811612 1.40668635683234e-05 0.000801811223394436
GBM ENSG00000268049 CTD-2619J13.9 path:05215_17 Prostate cancer 65 -3.45152670967051 0.000961774511807392 0.0255832020140766
GBM ENSG00000268049 CTD-2619J13.9 path:05223_63 Non-small cell lung cancer 8 -4.30896803695558 3.16073947523895e-05 0.00140126116735594
GBM ENSG00000267522 CTD-2621I17.6 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000267522 CTD-2621I17.6 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000267522 CTD-2621I17.6 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000267522 CTD-2621I17.6 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000267522 CTD-2621I17.6 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000267522 CTD-2621I17.6 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000267522 CTD-2621I17.6 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000267522 CTD-2621I17.6 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000268516 CTD-3138B18.5 path:00760_1 Nicotinate and nicotinamide metabolism 20 -4.39208041945237 9.22073450857973e-05 0.00299673871528841
GBM ENSG00000268516 CTD-3138B18.5 path:04012_31 ErbB signaling pathway 53 -3.49626285560793 0.000759634784624117 0.0185160978752129
GBM ENSG00000268516 CTD-3138B18.5 path:04015_98 Rap1 signaling pathway 44 -4.49877457909139 3.47027881710674e-05 0.00123037158061057
GBM ENSG00000268516 CTD-3138B18.5 path:04060_29 Cytokine-cytokine receptor interaction 2 -5.14318956158254 8.77724500964524e-07 0.000114104185125388
GBM ENSG00000268516 CTD-3138B18.5 path:04066_95 HIF-1 signaling pathway 14 -4.56994436299759 1.22459169279377e-05 0.000477590760189569
GBM ENSG00000268516 CTD-3138B18.5 path:04115_1 p53 signaling pathway 65 -4.99165782589135 1.96340126482721e-06 0.000127621082213769
GBM ENSG00000268516 CTD-3138B18.5 path:04144_8 Endocytosis 37 -5.71962359130438 5.82984717618263e-08 2.27364039871123e-05
GBM ENSG00000268516 CTD-3138B18.5 path:04713_105 Circadian entrainment 18 -3.63752785968374 0.000722884532884993 0.0185160978752129
GBM ENSG00000268516 CTD-3138B18.5 path:04740_16 Olfactory transduction 10 -3.5452883078104 0.00118010328210729 0.0270729576483437
GBM ENSG00000268516 CTD-3138B18.5 path:04750_68 Inflammatory mediator regulation of TRP channels 19 -3.28338639951814 0.00210846212207189 0.0432789593477915
GBM ENSG00000268516 CTD-3138B18.5 path:04912_55 GnRH signaling pathway 9 -5.07928373484436 1.20182585017448e-06 0.000117178020392012
GBM ENSG00000268516 CTD-3138B18.5 path:04915_101 Estrogen signaling pathway 12 -4.70221683124719 6.86697341074926e-06 0.000353086943800187
GBM ENSG00000268516 CTD-3138B18.5 path:04921_178 Oxytocin signaling pathway 8 -3.8892632273689 0.000471019245737389 0.0141305773721217
GBM ENSG00000268516 CTD-3138B18.5 path:05120_8 Epithelial cell signaling in Helicobacter pylori infection 17 -5.49455048392612 1.945842516757e-07 3.79439290767614e-05
GBM ENSG00000268516 CTD-3138B18.5 path:05160_41 Hepatitis C 6 -4.98622447755351 1.74382516512634e-06 0.000127621082213769
GBM ENSG00000268516 CTD-3138B18.5 path:05214_27 Glioma 17 -4.82201056645785 8.36344543739766e-06 0.000362415968953899
GBM ENSG00000268516 CTD-3138B18.5 path:05214_51 Glioma 3 -3.37427241638172 0.00201345550698937 0.0432789593477915
GBM ENSG00000268516 CTD-3138B18.5 path:05215_17 Prostate cancer 65 -3.60523691119702 0.000626478343144151 0.0174518967018728
GBM ENSG00000268516 CTD-3138B18.5 path:05223_63 Non-small cell lung cancer 8 -4.66430623103121 7.24280910359357e-06 0.000353086943800187
GBM ENSG00000268201 CTD-3138B18.6 path:00760_1 Nicotinate and nicotinamide metabolism 20 -4.39208041945237 9.22073450857973e-05 0.00299673871528841
GBM ENSG00000268201 CTD-3138B18.6 path:04012_31 ErbB signaling pathway 53 -3.49626285560793 0.000759634784624117 0.0185160978752129
GBM ENSG00000268201 CTD-3138B18.6 path:04015_98 Rap1 signaling pathway 44 -4.49877457909139 3.47027881710674e-05 0.00123037158061057
GBM ENSG00000268201 CTD-3138B18.6 path:04060_29 Cytokine-cytokine receptor interaction 2 -5.14318956158254 8.77724500964524e-07 0.000114104185125388
GBM ENSG00000268201 CTD-3138B18.6 path:04066_95 HIF-1 signaling pathway 14 -4.56994436299759 1.22459169279377e-05 0.000477590760189569
GBM ENSG00000268201 CTD-3138B18.6 path:04115_1 p53 signaling pathway 65 -4.99165782589135 1.96340126482721e-06 0.000127621082213769
GBM ENSG00000268201 CTD-3138B18.6 path:04144_8 Endocytosis 37 -5.71962359130438 5.82984717618263e-08 2.27364039871123e-05
GBM ENSG00000268201 CTD-3138B18.6 path:04713_105 Circadian entrainment 18 -3.63752785968374 0.000722884532884993 0.0185160978752129
GBM ENSG00000268201 CTD-3138B18.6 path:04740_16 Olfactory transduction 10 -3.5452883078104 0.00118010328210729 0.0270729576483437
GBM ENSG00000268201 CTD-3138B18.6 path:04750_68 Inflammatory mediator regulation of TRP channels 19 -3.28338639951814 0.00210846212207189 0.0432789593477915
GBM ENSG00000268201 CTD-3138B18.6 path:04912_55 GnRH signaling pathway 9 -5.07928373484436 1.20182585017448e-06 0.000117178020392012
GBM ENSG00000268201 CTD-3138B18.6 path:04915_101 Estrogen signaling pathway 12 -4.70221683124719 6.86697341074926e-06 0.000353086943800187
GBM ENSG00000268201 CTD-3138B18.6 path:04921_178 Oxytocin signaling pathway 8 -3.8892632273689 0.000471019245737389 0.0141305773721217
GBM ENSG00000268201 CTD-3138B18.6 path:05120_8 Epithelial cell signaling in Helicobacter pylori infection 17 -5.49455048392612 1.945842516757e-07 3.79439290767614e-05
GBM ENSG00000268201 CTD-3138B18.6 path:05160_41 Hepatitis C 6 -4.98622447755351 1.74382516512634e-06 0.000127621082213769
GBM ENSG00000268201 CTD-3138B18.6 path:05214_27 Glioma 17 -4.82201056645785 8.36344543739766e-06 0.000362415968953899
GBM ENSG00000268201 CTD-3138B18.6 path:05214_51 Glioma 3 -3.37427241638172 0.00201345550698937 0.0432789593477915
GBM ENSG00000268201 CTD-3138B18.6 path:05215_17 Prostate cancer 65 -3.60523691119702 0.000626478343144151 0.0174518967018728
GBM ENSG00000268201 CTD-3138B18.6 path:05223_63 Non-small cell lung cancer 8 -4.66430623103121 7.24280910359357e-06 0.000353086943800187
GBM ENSG00000229323 DLEU1-AS1 path:00130_1 Ubiquinone and other terpenoid-quinone biosynthesis 3 4.66904320126194 8.74990332042083e-06 0.00333060146390136
GBM ENSG00000229323 DLEU1-AS1 path:00230_207 Purine metabolism 6 3.32303779065877 0.00121197804884246 0.0149844558765977
GBM ENSG00000229323 DLEU1-AS1 path:00240_172 Pyrimidine metabolism 7 3.23567075871619 0.00167212125852549 0.0200654551023059
GBM ENSG00000229323 DLEU1-AS1 path:04015_131 Rap1 signaling pathway 19 -3.84402576254494 0.000180259445588132 0.00519021354163258
GBM ENSG00000229323 DLEU1-AS1 path:04020_81 Calcium signaling pathway 51 -3.63837535630175 0.000392447786989287 0.00752496275898343
GBM ENSG00000229323 DLEU1-AS1 path:04020_92 Calcium signaling pathway 44 -4.17821470257261 5.32969379037168e-05 0.00368578204236041
GBM ENSG00000229323 DLEU1-AS1 path:04024_50 cAMP signaling pathway 80 -2.8682066396555 0.00480527503758035 0.0478183467154337
GBM ENSG00000229323 DLEU1-AS1 path:04024_60 cAMP signaling pathway 75 -4.39039456655205 2.1931912406268e-05 0.00333060146390136
GBM ENSG00000229323 DLEU1-AS1 path:04261_74 Adrenergic signaling in cardiomyocytes 44 -3.61793288731592 0.000411026256771119 0.00752496275898343
GBM ENSG00000229323 DLEU1-AS1 path:04270_30 Vascular smooth muscle contraction 67 -3.375247827734 0.000954391726375847 0.0141654309060878
GBM ENSG00000229323 DLEU1-AS1 path:04710_8 Circadian rhythm 26 -2.90003714460712 0.00435520567390697 0.0444230978738511
GBM ENSG00000229323 DLEU1-AS1 path:04713_149 Circadian entrainment 11 -3.33719817589406 0.00110317877744353 0.0141654309060878
GBM ENSG00000229323 DLEU1-AS1 path:04713_22 Circadian entrainment 61 -3.08865826756917 0.00241075725730216 0.0265834854318725
GBM ENSG00000229323 DLEU1-AS1 path:04724_160 Glutamatergic synapse 8 -3.42576088131855 0.000804527555747911 0.0131298897098059
GBM ENSG00000229323 DLEU1-AS1 path:04724_34 Glutamatergic synapse 61 -3.94606038380664 0.000123890772728131 0.00459522138846159
GBM ENSG00000229323 DLEU1-AS1 path:04728_17 Dopaminergic synapse 93 -3.04558928647034 0.00275712454395103 0.0296028108929479
GBM ENSG00000229323 DLEU1-AS1 path:04728_187 Dopaminergic synapse 16 -3.10513757243874 0.00233937174076788 0.0265834854318725
GBM ENSG00000229323 DLEU1-AS1 path:04728_222 Dopaminergic synapse 5 -4.10336036706175 6.76976568678704e-05 0.00368578204236041
GBM ENSG00000229323 DLEU1-AS1 path:04730_41 Long-term depression 28 -3.33678891151825 0.00108182153963059 0.0141654309060878
GBM ENSG00000229323 DLEU1-AS1 path:04730_74 Long-term depression 5 -3.35653005708177 0.00102038203416214 0.0141654309060878
GBM ENSG00000229323 DLEU1-AS1 path:04740_16 Olfactory transduction 10 -3.32780652748026 0.00110840324555619 0.0141654309060878
GBM ENSG00000229323 DLEU1-AS1 path:04750_2 Inflammatory mediator regulation of TRP channels 78 -4.19437328594126 4.75917604947111e-05 0.00368578204236041
GBM ENSG00000229323 DLEU1-AS1 path:04911_33 Insulin secretion 26 -4.06266106818092 8.13040156403033e-05 0.00368578204236041
GBM ENSG00000229323 DLEU1-AS1 path:04912_45 GnRH signaling pathway 16 -3.80311160053567 0.000213787134535131 0.00519021354163258
GBM ENSG00000229323 DLEU1-AS1 path:04913_2 Ovarian steroidogenesis 26 -3.88298651772664 0.00016022274931912 0.00519021354163258
GBM ENSG00000229323 DLEU1-AS1 path:04915_56 Estrogen signaling pathway 38 -3.32758438539072 0.00111101418871277 0.0141654309060878
GBM ENSG00000229323 DLEU1-AS1 path:04918_15 Thyroid hormone synthesis 38 -4.09704437540432 7.22602301376338e-05 0.00368578204236041
GBM ENSG00000229323 DLEU1-AS1 path:04921_179 Oxytocin signaling pathway 8 -3.48725567862354 0.000653767873558468 0.011114053850494
GBM ENSG00000229323 DLEU1-AS1 path:04922_80 Glucagon signaling pathway 8 -3.10557757714572 0.00236386038179003 0.0265834854318725
GBM ENSG00000229323 DLEU1-AS1 path:04961_4 Endocrine and other factor-regulated calcium reabsorption 22 -3.66867437603695 0.000341017472291445 0.00695675643474547
GBM ENSG00000229323 DLEU1-AS1 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.68331523226427 0.000328424070041766 0.00695675643474547
GBM ENSG00000229323 DLEU1-AS1 path:04970_7 Salivary secretion 24 -4.08588165708245 7.45482440218378e-05 0.00368578204236041
GBM ENSG00000229323 DLEU1-AS1 path:04976_1 Bile secretion 15 -3.81702394368461 0.00020353215556748 0.00519021354163258
GBM ENSG00000229323 DLEU1-AS1 path:05030_1 Cocaine addiction 42 -3.61116196398534 0.000424201332001517 0.00752496275898343
GBM ENSG00000229323 DLEU1-AS1 path:05031_25 Amphetamine addiction 20 -4.36924383717567 2.44897166463335e-05 0.00333060146390136
GBM ENSG00000229323 DLEU1-AS1 path:05032_33 Morphine addiction 43 -3.79546086245724 0.000216258897568024 0.00519021354163258
GBM ENSG00000229323 DLEU1-AS1 path:05033_3 Nicotine addiction 10 -3.41045955187044 0.00085297418732325 0.0133851334010725
GBM ENSG00000229323 DLEU1-AS1 path:05034_52 Alcoholism 26 -2.93182267267155 0.00391324129814621 0.0409385243498373
GBM ENSG00000229323 DLEU1-AS1 path:05110_1 Vibrio cholerae infection 9 -3.77536166841525 0.000236804714106456 0.00536757351974634
GBM ENSG00000229323 DLEU1-AS1 path:05146_11 Amoebiasis 7 -3.83636473746288 0.000189112202756103 0.00519021354163258
GBM ENSG00000229323 DLEU1-AS1 path:05414_1 Dilated cardiomyopathy 28 -4.00031732046496 0.000103314019431679 0.00421521199281249
GBM ENSG00000231607 DLEU2 path:00130_1 Ubiquinone and other terpenoid-quinone biosynthesis 3 4.66904320126194 8.74990332042083e-06 0.00333060146390136
GBM ENSG00000231607 DLEU2 path:00230_207 Purine metabolism 6 3.32303779065877 0.00121197804884246 0.0149844558765977
GBM ENSG00000231607 DLEU2 path:00240_172 Pyrimidine metabolism 7 3.23567075871619 0.00167212125852549 0.0200654551023059
GBM ENSG00000231607 DLEU2 path:04015_131 Rap1 signaling pathway 19 -3.84402576254494 0.000180259445588132 0.00519021354163258
GBM ENSG00000231607 DLEU2 path:04020_81 Calcium signaling pathway 51 -3.63837535630175 0.000392447786989287 0.00752496275898343
GBM ENSG00000231607 DLEU2 path:04020_92 Calcium signaling pathway 44 -4.17821470257261 5.32969379037168e-05 0.00368578204236041
GBM ENSG00000231607 DLEU2 path:04024_50 cAMP signaling pathway 80 -2.8682066396555 0.00480527503758035 0.0478183467154337
GBM ENSG00000231607 DLEU2 path:04024_60 cAMP signaling pathway 75 -4.39039456655205 2.1931912406268e-05 0.00333060146390136
GBM ENSG00000231607 DLEU2 path:04261_74 Adrenergic signaling in cardiomyocytes 44 -3.61793288731592 0.000411026256771119 0.00752496275898343
GBM ENSG00000231607 DLEU2 path:04270_30 Vascular smooth muscle contraction 67 -3.375247827734 0.000954391726375847 0.0141654309060878
GBM ENSG00000231607 DLEU2 path:04710_8 Circadian rhythm 26 -2.90003714460712 0.00435520567390697 0.0444230978738511
GBM ENSG00000231607 DLEU2 path:04713_149 Circadian entrainment 11 -3.33719817589406 0.00110317877744353 0.0141654309060878
GBM ENSG00000231607 DLEU2 path:04713_22 Circadian entrainment 61 -3.08865826756917 0.00241075725730216 0.0265834854318725
GBM ENSG00000231607 DLEU2 path:04724_160 Glutamatergic synapse 8 -3.42576088131855 0.000804527555747911 0.0131298897098059
GBM ENSG00000231607 DLEU2 path:04724_34 Glutamatergic synapse 61 -3.94606038380664 0.000123890772728131 0.00459522138846159
GBM ENSG00000231607 DLEU2 path:04728_17 Dopaminergic synapse 93 -3.04558928647034 0.00275712454395103 0.0296028108929479
GBM ENSG00000231607 DLEU2 path:04728_187 Dopaminergic synapse 16 -3.10513757243874 0.00233937174076788 0.0265834854318725
GBM ENSG00000231607 DLEU2 path:04728_222 Dopaminergic synapse 5 -4.10336036706175 6.76976568678704e-05 0.00368578204236041
GBM ENSG00000231607 DLEU2 path:04730_41 Long-term depression 28 -3.33678891151825 0.00108182153963059 0.0141654309060878
GBM ENSG00000231607 DLEU2 path:04730_74 Long-term depression 5 -3.35653005708177 0.00102038203416214 0.0141654309060878
GBM ENSG00000231607 DLEU2 path:04740_16 Olfactory transduction 10 -3.32780652748026 0.00110840324555619 0.0141654309060878
GBM ENSG00000231607 DLEU2 path:04750_2 Inflammatory mediator regulation of TRP channels 78 -4.19437328594126 4.75917604947111e-05 0.00368578204236041
GBM ENSG00000231607 DLEU2 path:04911_33 Insulin secretion 26 -4.06266106818092 8.13040156403033e-05 0.00368578204236041
GBM ENSG00000231607 DLEU2 path:04912_45 GnRH signaling pathway 16 -3.80311160053567 0.000213787134535131 0.00519021354163258
GBM ENSG00000231607 DLEU2 path:04913_2 Ovarian steroidogenesis 26 -3.88298651772664 0.00016022274931912 0.00519021354163258
GBM ENSG00000231607 DLEU2 path:04915_56 Estrogen signaling pathway 38 -3.32758438539072 0.00111101418871277 0.0141654309060878
GBM ENSG00000231607 DLEU2 path:04918_15 Thyroid hormone synthesis 38 -4.09704437540432 7.22602301376338e-05 0.00368578204236041
GBM ENSG00000231607 DLEU2 path:04921_179 Oxytocin signaling pathway 8 -3.48725567862354 0.000653767873558468 0.011114053850494
GBM ENSG00000231607 DLEU2 path:04922_80 Glucagon signaling pathway 8 -3.10557757714572 0.00236386038179003 0.0265834854318725
GBM ENSG00000231607 DLEU2 path:04961_4 Endocrine and other factor-regulated calcium reabsorption 22 -3.66867437603695 0.000341017472291445 0.00695675643474547
GBM ENSG00000231607 DLEU2 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.68331523226427 0.000328424070041766 0.00695675643474547
GBM ENSG00000231607 DLEU2 path:04970_7 Salivary secretion 24 -4.08588165708245 7.45482440218378e-05 0.00368578204236041
GBM ENSG00000231607 DLEU2 path:04976_1 Bile secretion 15 -3.81702394368461 0.00020353215556748 0.00519021354163258
GBM ENSG00000231607 DLEU2 path:05030_1 Cocaine addiction 42 -3.61116196398534 0.000424201332001517 0.00752496275898343
GBM ENSG00000231607 DLEU2 path:05031_25 Amphetamine addiction 20 -4.36924383717567 2.44897166463335e-05 0.00333060146390136
GBM ENSG00000231607 DLEU2 path:05032_33 Morphine addiction 43 -3.79546086245724 0.000216258897568024 0.00519021354163258
GBM ENSG00000231607 DLEU2 path:05033_3 Nicotine addiction 10 -3.41045955187044 0.00085297418732325 0.0133851334010725
GBM ENSG00000231607 DLEU2 path:05034_52 Alcoholism 26 -2.93182267267155 0.00391324129814621 0.0409385243498373
GBM ENSG00000231607 DLEU2 path:05110_1 Vibrio cholerae infection 9 -3.77536166841525 0.000236804714106456 0.00536757351974634
GBM ENSG00000231607 DLEU2 path:05146_11 Amoebiasis 7 -3.83636473746288 0.000189112202756103 0.00519021354163258
GBM ENSG00000231607 DLEU2 path:05414_1 Dilated cardiomyopathy 28 -4.00031732046496 0.000103314019431679 0.00421521199281249
GBM ENSG00000237152 DLEU7-AS1 path:00130_1 Ubiquinone and other terpenoid-quinone biosynthesis 3 4.66904320126194 8.74990332042083e-06 0.00333060146390136
GBM ENSG00000237152 DLEU7-AS1 path:00230_207 Purine metabolism 6 3.32303779065877 0.00121197804884246 0.0149844558765977
GBM ENSG00000237152 DLEU7-AS1 path:00240_172 Pyrimidine metabolism 7 3.23567075871619 0.00167212125852549 0.0200654551023059
GBM ENSG00000237152 DLEU7-AS1 path:04015_131 Rap1 signaling pathway 19 -3.84402576254494 0.000180259445588132 0.00519021354163258
GBM ENSG00000237152 DLEU7-AS1 path:04020_81 Calcium signaling pathway 51 -3.63837535630175 0.000392447786989287 0.00752496275898343
GBM ENSG00000237152 DLEU7-AS1 path:04020_92 Calcium signaling pathway 44 -4.17821470257261 5.32969379037168e-05 0.00368578204236041
GBM ENSG00000237152 DLEU7-AS1 path:04024_50 cAMP signaling pathway 80 -2.8682066396555 0.00480527503758035 0.0478183467154337
GBM ENSG00000237152 DLEU7-AS1 path:04024_60 cAMP signaling pathway 75 -4.39039456655205 2.1931912406268e-05 0.00333060146390136
GBM ENSG00000237152 DLEU7-AS1 path:04261_74 Adrenergic signaling in cardiomyocytes 44 -3.61793288731592 0.000411026256771119 0.00752496275898343
GBM ENSG00000237152 DLEU7-AS1 path:04270_30 Vascular smooth muscle contraction 67 -3.375247827734 0.000954391726375847 0.0141654309060878
GBM ENSG00000237152 DLEU7-AS1 path:04710_8 Circadian rhythm 26 -2.90003714460712 0.00435520567390697 0.0444230978738511
GBM ENSG00000237152 DLEU7-AS1 path:04713_149 Circadian entrainment 11 -3.33719817589406 0.00110317877744353 0.0141654309060878
GBM ENSG00000237152 DLEU7-AS1 path:04713_22 Circadian entrainment 61 -3.08865826756917 0.00241075725730216 0.0265834854318725
GBM ENSG00000237152 DLEU7-AS1 path:04724_160 Glutamatergic synapse 8 -3.42576088131855 0.000804527555747911 0.0131298897098059
GBM ENSG00000237152 DLEU7-AS1 path:04724_34 Glutamatergic synapse 61 -3.94606038380664 0.000123890772728131 0.00459522138846159
GBM ENSG00000237152 DLEU7-AS1 path:04728_17 Dopaminergic synapse 93 -3.04558928647034 0.00275712454395103 0.0296028108929479
GBM ENSG00000237152 DLEU7-AS1 path:04728_187 Dopaminergic synapse 16 -3.10513757243874 0.00233937174076788 0.0265834854318725
GBM ENSG00000237152 DLEU7-AS1 path:04728_222 Dopaminergic synapse 5 -4.10336036706175 6.76976568678704e-05 0.00368578204236041
GBM ENSG00000237152 DLEU7-AS1 path:04730_41 Long-term depression 28 -3.33678891151825 0.00108182153963059 0.0141654309060878
GBM ENSG00000237152 DLEU7-AS1 path:04730_74 Long-term depression 5 -3.35653005708177 0.00102038203416214 0.0141654309060878
GBM ENSG00000237152 DLEU7-AS1 path:04740_16 Olfactory transduction 10 -3.32780652748026 0.00110840324555619 0.0141654309060878
GBM ENSG00000237152 DLEU7-AS1 path:04750_2 Inflammatory mediator regulation of TRP channels 78 -4.19437328594126 4.75917604947111e-05 0.00368578204236041
GBM ENSG00000237152 DLEU7-AS1 path:04911_33 Insulin secretion 26 -4.06266106818092 8.13040156403033e-05 0.00368578204236041
GBM ENSG00000237152 DLEU7-AS1 path:04912_45 GnRH signaling pathway 16 -3.80311160053567 0.000213787134535131 0.00519021354163258
GBM ENSG00000237152 DLEU7-AS1 path:04913_2 Ovarian steroidogenesis 26 -3.88298651772664 0.00016022274931912 0.00519021354163258
GBM ENSG00000237152 DLEU7-AS1 path:04915_56 Estrogen signaling pathway 38 -3.32758438539072 0.00111101418871277 0.0141654309060878
GBM ENSG00000237152 DLEU7-AS1 path:04918_15 Thyroid hormone synthesis 38 -4.09704437540432 7.22602301376338e-05 0.00368578204236041
GBM ENSG00000237152 DLEU7-AS1 path:04921_179 Oxytocin signaling pathway 8 -3.48725567862354 0.000653767873558468 0.011114053850494
GBM ENSG00000237152 DLEU7-AS1 path:04922_80 Glucagon signaling pathway 8 -3.10557757714572 0.00236386038179003 0.0265834854318725
GBM ENSG00000237152 DLEU7-AS1 path:04961_4 Endocrine and other factor-regulated calcium reabsorption 22 -3.66867437603695 0.000341017472291445 0.00695675643474547
GBM ENSG00000237152 DLEU7-AS1 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.68331523226427 0.000328424070041766 0.00695675643474547
GBM ENSG00000237152 DLEU7-AS1 path:04970_7 Salivary secretion 24 -4.08588165708245 7.45482440218378e-05 0.00368578204236041
GBM ENSG00000237152 DLEU7-AS1 path:04976_1 Bile secretion 15 -3.81702394368461 0.00020353215556748 0.00519021354163258
GBM ENSG00000237152 DLEU7-AS1 path:05030_1 Cocaine addiction 42 -3.61116196398534 0.000424201332001517 0.00752496275898343
GBM ENSG00000237152 DLEU7-AS1 path:05031_25 Amphetamine addiction 20 -4.36924383717567 2.44897166463335e-05 0.00333060146390136
GBM ENSG00000237152 DLEU7-AS1 path:05032_33 Morphine addiction 43 -3.79546086245724 0.000216258897568024 0.00519021354163258
GBM ENSG00000237152 DLEU7-AS1 path:05033_3 Nicotine addiction 10 -3.41045955187044 0.00085297418732325 0.0133851334010725
GBM ENSG00000237152 DLEU7-AS1 path:05034_52 Alcoholism 26 -2.93182267267155 0.00391324129814621 0.0409385243498373
GBM ENSG00000237152 DLEU7-AS1 path:05110_1 Vibrio cholerae infection 9 -3.77536166841525 0.000236804714106456 0.00536757351974634
GBM ENSG00000237152 DLEU7-AS1 path:05146_11 Amoebiasis 7 -3.83636473746288 0.000189112202756103 0.00519021354163258
GBM ENSG00000237152 DLEU7-AS1 path:05414_1 Dilated cardiomyopathy 28 -4.00031732046496 0.000103314019431679 0.00421521199281249
GBM ENSG00000142396 ENSG00000142396 path:00760_1 Nicotinate and nicotinamide metabolism 20 -4.39208041945237 9.22073450857973e-05 0.00299673871528841
GBM ENSG00000142396 ENSG00000142396 path:04012_31 ErbB signaling pathway 53 -3.49626285560793 0.000759634784624117 0.0185160978752129
GBM ENSG00000142396 ENSG00000142396 path:04015_98 Rap1 signaling pathway 44 -4.49877457909139 3.47027881710674e-05 0.00123037158061057
GBM ENSG00000142396 ENSG00000142396 path:04060_29 Cytokine-cytokine receptor interaction 2 -5.14318956158254 8.77724500964524e-07 0.000114104185125388
GBM ENSG00000142396 ENSG00000142396 path:04066_95 HIF-1 signaling pathway 14 -4.56994436299759 1.22459169279377e-05 0.000477590760189569
GBM ENSG00000142396 ENSG00000142396 path:04115_1 p53 signaling pathway 65 -4.99165782589135 1.96340126482721e-06 0.000127621082213769
GBM ENSG00000142396 ENSG00000142396 path:04144_8 Endocytosis 37 -5.71962359130438 5.82984717618263e-08 2.27364039871123e-05
GBM ENSG00000142396 ENSG00000142396 path:04713_105 Circadian entrainment 18 -3.63752785968374 0.000722884532884993 0.0185160978752129
GBM ENSG00000142396 ENSG00000142396 path:04740_16 Olfactory transduction 10 -3.5452883078104 0.00118010328210729 0.0270729576483437
GBM ENSG00000142396 ENSG00000142396 path:04750_68 Inflammatory mediator regulation of TRP channels 19 -3.28338639951814 0.00210846212207189 0.0432789593477915
GBM ENSG00000142396 ENSG00000142396 path:04912_55 GnRH signaling pathway 9 -5.07928373484436 1.20182585017448e-06 0.000117178020392012
GBM ENSG00000142396 ENSG00000142396 path:04915_101 Estrogen signaling pathway 12 -4.70221683124719 6.86697341074926e-06 0.000353086943800187
GBM ENSG00000142396 ENSG00000142396 path:04921_178 Oxytocin signaling pathway 8 -3.8892632273689 0.000471019245737389 0.0141305773721217
GBM ENSG00000142396 ENSG00000142396 path:05120_8 Epithelial cell signaling in Helicobacter pylori infection 17 -5.49455048392612 1.945842516757e-07 3.79439290767614e-05
GBM ENSG00000142396 ENSG00000142396 path:05160_41 Hepatitis C 6 -4.98622447755351 1.74382516512634e-06 0.000127621082213769
GBM ENSG00000142396 ENSG00000142396 path:05214_27 Glioma 17 -4.82201056645785 8.36344543739766e-06 0.000362415968953899
GBM ENSG00000142396 ENSG00000142396 path:05214_51 Glioma 3 -3.37427241638172 0.00201345550698937 0.0432789593477915
GBM ENSG00000142396 ENSG00000142396 path:05215_17 Prostate cancer 65 -3.60523691119702 0.000626478343144151 0.0174518967018728
GBM ENSG00000142396 ENSG00000142396 path:05223_63 Non-small cell lung cancer 8 -4.66430623103121 7.24280910359357e-06 0.000353086943800187
GBM ENSG00000267018 ENSG00000267018 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000267018 ENSG00000267018 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000267018 ENSG00000267018 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000267018 ENSG00000267018 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000267018 ENSG00000267018 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000267018 ENSG00000267018 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000267018 ENSG00000267018 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000267018 ENSG00000267018 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000267093 ENSG00000267093 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000267093 ENSG00000267093 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000267093 ENSG00000267093 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000267093 ENSG00000267093 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000267093 ENSG00000267093 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000267093 ENSG00000267093 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000267093 ENSG00000267093 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000267093 ENSG00000267093 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000267183 ENSG00000267183 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000267183 ENSG00000267183 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000267183 ENSG00000267183 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000267183 ENSG00000267183 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000267183 ENSG00000267183 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000267183 ENSG00000267183 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000267183 ENSG00000267183 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000267183 ENSG00000267183 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000267730 ENSG00000267730 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000267730 ENSG00000267730 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000267730 ENSG00000267730 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000267730 ENSG00000267730 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000267730 ENSG00000267730 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000267730 ENSG00000267730 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000267730 ENSG00000267730 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000267730 ENSG00000267730 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000267865 ENSG00000267865 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000267865 ENSG00000267865 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000267865 ENSG00000267865 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000267865 ENSG00000267865 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000267865 ENSG00000267865 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000267865 ENSG00000267865 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000267865 ENSG00000267865 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000267865 ENSG00000267865 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000269574 ENSG00000269574 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000269574 ENSG00000269574 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000269574 ENSG00000269574 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000269574 ENSG00000269574 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000269574 ENSG00000269574 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000269574 ENSG00000269574 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000269574 ENSG00000269574 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000269574 ENSG00000269574 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000269965 ENSG00000269965 path:00130_1 Ubiquinone and other terpenoid-quinone biosynthesis 3 4.6108456376724 1.07392882086475e-05 0.00242724797895806
GBM ENSG00000269965 ENSG00000269965 path:00230_207 Purine metabolism 6 3.41463478379983 0.000887473561489187 0.0113152879089871
GBM ENSG00000269965 ENSG00000269965 path:00240_172 Pyrimidine metabolism 7 3.39885571027096 0.000981049808596226 0.0117725977031547
GBM ENSG00000269965 ENSG00000269965 path:00983_2 Drug metabolism - other enzymes 16 3.11370905561217 0.0023490947276189 0.0252218591807503
GBM ENSG00000269965 ENSG00000269965 path:04015_131 Rap1 signaling pathway 19 -3.97090690453368 0.000112313373362324 0.00364965573439232
GBM ENSG00000269965 ENSG00000269965 path:04020_81 Calcium signaling pathway 51 -3.50635467280299 0.000623574051176207 0.0101767285151957
GBM ENSG00000269965 ENSG00000269965 path:04020_92 Calcium signaling pathway 44 -4.24437764894791 4.16377132089798e-05 0.00242724797895806
GBM ENSG00000269965 ENSG00000269965 path:04024_50 cAMP signaling pathway 80 -2.84811517197767 0.00508310088252344 0.0482303525597573
GBM ENSG00000269965 ENSG00000269965 path:04024_60 cAMP signaling pathway 75 -4.43288892588071 1.86064675242161e-05 0.00242724797895806
GBM ENSG00000269965 ENSG00000269965 path:04261_74 Adrenergic signaling in cardiomyocytes 44 -3.71606749391448 0.000290564197761845 0.00564524727080155
GBM ENSG00000269965 ENSG00000269965 path:04270_30 Vascular smooth muscle contraction 67 -3.46738466417476 0.000700879762146277 0.0104796246981501
GBM ENSG00000269965 ENSG00000269965 path:04710_8 Circadian rhythm 26 -3.22547297158013 0.00157941345056278 0.0184114482237033
GBM ENSG00000269965 ENSG00000269965 path:04713_149 Circadian entrainment 11 -3.42209576122081 0.000825037163085292 0.0108585536302838
GBM ENSG00000269965 ENSG00000269965 path:04713_22 Circadian entrainment 61 -3.18532630714474 0.00177343622807315 0.0200989439181624
GBM ENSG00000269965 ENSG00000269965 path:04724_160 Glutamatergic synapse 8 -3.53267198479711 0.000559463527123407 0.00951087996109792
GBM ENSG00000269965 ENSG00000269965 path:04724_34 Glutamatergic synapse 61 -3.90571351133649 0.000143622623317971 0.00364965573439232
GBM ENSG00000269965 ENSG00000269965 path:04728_17 Dopaminergic synapse 93 -3.15506990688589 0.00194894531565256 0.0214910726698985
GBM ENSG00000269965 ENSG00000269965 path:04728_187 Dopaminergic synapse 16 -2.9723064138605 0.00353583207045978 0.0351858410914046
GBM ENSG00000269965 ENSG00000269965 path:04728_222 Dopaminergic synapse 5 -4.16469173165661 5.35422348299571e-05 0.00242724797895806
GBM ENSG00000269965 ENSG00000269965 path:04730_41 Long-term depression 28 -3.43788836896864 0.00077174956569508 0.0104957940934531
GBM ENSG00000269965 ENSG00000269965 path:04730_74 Long-term depression 5 -3.47803393984781 0.000673318331754186 0.0104796246981501
GBM ENSG00000269965 ENSG00000269965 path:04740_16 Olfactory transduction 10 -3.36856054630436 0.000968275005437924 0.0117725977031547
GBM ENSG00000269965 ENSG00000269965 path:04750_2 Inflammatory mediator regulation of TRP channels 78 -4.27053623503594 3.54045938893224e-05 0.00242724797895806
GBM ENSG00000269965 ENSG00000269965 path:04911_33 Insulin secretion 26 -4.19206806637642 4.96667878136834e-05 0.00242724797895806
GBM ENSG00000269965 ENSG00000269965 path:04912_45 GnRH signaling pathway 16 -3.93299641382354 0.000132990317813788 0.00364965573439232
GBM ENSG00000269965 ENSG00000269965 path:04913_2 Ovarian steroidogenesis 26 -3.98590309630735 0.000109841725895438 0.00364965573439232
GBM ENSG00000269965 ENSG00000269965 path:04915_56 Estrogen signaling pathway 38 -3.45589253721431 0.0007191899302652 0.0104796246981501
GBM ENSG00000269965 ENSG00000269965 path:04918_15 Thyroid hormone synthesis 38 -4.22888352033549 4.37025568733996e-05 0.00242724797895806
GBM ENSG00000269965 ENSG00000269965 path:04920_60 Adipocytokine signaling pathway 12 2.96110628685926 0.00367283952084006 0.0356790124881606
GBM ENSG00000269965 ENSG00000269965 path:04921_179 Oxytocin signaling pathway 8 -3.59101882401895 0.00045793745610715 0.00812341226485728
GBM ENSG00000269965 ENSG00000269965 path:04922_80 Glucagon signaling pathway 8 -3.02119857419934 0.00308018559878091 0.0314178931075652
GBM ENSG00000269965 ENSG00000269965 path:04961_4 Endocrine and other factor-regulated calcium reabsorption 22 -3.69636123443259 0.000308756254564959 0.00572602508465925
GBM ENSG00000269965 ENSG00000269965 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.7804961180379 0.000232490466189422 0.0049924268529097
GBM ENSG00000269965 ENSG00000269965 path:04970_7 Salivary secretion 24 -4.18415032271932 5.14105154937893e-05 0.00242724797895806
GBM ENSG00000269965 ENSG00000269965 path:04976_1 Bile secretion 15 -3.92487981763626 0.000137451060438846 0.00364965573439232
GBM ENSG00000269965 ENSG00000269965 path:05030_1 Cocaine addiction 42 -3.7239515023001 0.000285100007179882 0.00564524727080155
GBM ENSG00000269965 ENSG00000269965 path:05031_25 Amphetamine addiction 20 -4.47306590742821 1.62563464183883e-05 0.00242724797895806
GBM ENSG00000269965 ENSG00000269965 path:05032_33 Morphine addiction 43 -3.88955527885881 0.000153265931999104 0.00364965573439232
GBM ENSG00000269965 ENSG00000269965 path:05033_3 Nicotine addiction 10 -3.4420535881337 0.000762339342001579 0.0104957940934531
GBM ENSG00000269965 ENSG00000269965 path:05034_52 Alcoholism 26 -3.03648476634464 0.00283594592246118 0.0296683573426708
GBM ENSG00000269965 ENSG00000269965 path:05110_1 Vibrio cholerae infection 9 -3.88211079259662 0.000161014223576132 0.00364965573439232
GBM ENSG00000269965 ENSG00000269965 path:05146_11 Amoebiasis 7 -3.94348353239864 0.000127841360627006 0.00364965573439232
GBM ENSG00000269965 ENSG00000269965 path:05414_1 Dilated cardiomyopathy 28 -4.08831132771953 7.44958946681562e-05 0.00303943250246077
GBM ENSG00000270101 ENSG00000270101 path:00130_1 Ubiquinone and other terpenoid-quinone biosynthesis 3 4.6108456376724 1.07392882086475e-05 0.00242724797895806
GBM ENSG00000270101 ENSG00000270101 path:00230_207 Purine metabolism 6 3.41463478379983 0.000887473561489187 0.0113152879089871
GBM ENSG00000270101 ENSG00000270101 path:00240_172 Pyrimidine metabolism 7 3.39885571027096 0.000981049808596226 0.0117725977031547
GBM ENSG00000270101 ENSG00000270101 path:00983_2 Drug metabolism - other enzymes 16 3.11370905561217 0.0023490947276189 0.0252218591807503
GBM ENSG00000270101 ENSG00000270101 path:04015_131 Rap1 signaling pathway 19 -3.97090690453368 0.000112313373362324 0.00364965573439232
GBM ENSG00000270101 ENSG00000270101 path:04020_81 Calcium signaling pathway 51 -3.50635467280299 0.000623574051176207 0.0101767285151957
GBM ENSG00000270101 ENSG00000270101 path:04020_92 Calcium signaling pathway 44 -4.24437764894791 4.16377132089798e-05 0.00242724797895806
GBM ENSG00000270101 ENSG00000270101 path:04024_50 cAMP signaling pathway 80 -2.84811517197767 0.00508310088252344 0.0482303525597573
GBM ENSG00000270101 ENSG00000270101 path:04024_60 cAMP signaling pathway 75 -4.43288892588071 1.86064675242161e-05 0.00242724797895806
GBM ENSG00000270101 ENSG00000270101 path:04261_74 Adrenergic signaling in cardiomyocytes 44 -3.71606749391448 0.000290564197761845 0.00564524727080155
GBM ENSG00000270101 ENSG00000270101 path:04270_30 Vascular smooth muscle contraction 67 -3.46738466417476 0.000700879762146277 0.0104796246981501
GBM ENSG00000270101 ENSG00000270101 path:04710_8 Circadian rhythm 26 -3.22547297158013 0.00157941345056278 0.0184114482237033
GBM ENSG00000270101 ENSG00000270101 path:04713_149 Circadian entrainment 11 -3.42209576122081 0.000825037163085292 0.0108585536302838
GBM ENSG00000270101 ENSG00000270101 path:04713_22 Circadian entrainment 61 -3.18532630714474 0.00177343622807315 0.0200989439181624
GBM ENSG00000270101 ENSG00000270101 path:04724_160 Glutamatergic synapse 8 -3.53267198479711 0.000559463527123407 0.00951087996109792
GBM ENSG00000270101 ENSG00000270101 path:04724_34 Glutamatergic synapse 61 -3.90571351133649 0.000143622623317971 0.00364965573439232
GBM ENSG00000270101 ENSG00000270101 path:04728_17 Dopaminergic synapse 93 -3.15506990688589 0.00194894531565256 0.0214910726698985
GBM ENSG00000270101 ENSG00000270101 path:04728_187 Dopaminergic synapse 16 -2.9723064138605 0.00353583207045978 0.0351858410914046
GBM ENSG00000270101 ENSG00000270101 path:04728_222 Dopaminergic synapse 5 -4.16469173165661 5.35422348299571e-05 0.00242724797895806
GBM ENSG00000270101 ENSG00000270101 path:04730_41 Long-term depression 28 -3.43788836896864 0.00077174956569508 0.0104957940934531
GBM ENSG00000270101 ENSG00000270101 path:04730_74 Long-term depression 5 -3.47803393984781 0.000673318331754186 0.0104796246981501
GBM ENSG00000270101 ENSG00000270101 path:04740_16 Olfactory transduction 10 -3.36856054630436 0.000968275005437924 0.0117725977031547
GBM ENSG00000270101 ENSG00000270101 path:04750_2 Inflammatory mediator regulation of TRP channels 78 -4.27053623503594 3.54045938893224e-05 0.00242724797895806
GBM ENSG00000270101 ENSG00000270101 path:04911_33 Insulin secretion 26 -4.19206806637642 4.96667878136834e-05 0.00242724797895806
GBM ENSG00000270101 ENSG00000270101 path:04912_45 GnRH signaling pathway 16 -3.93299641382354 0.000132990317813788 0.00364965573439232
GBM ENSG00000270101 ENSG00000270101 path:04913_2 Ovarian steroidogenesis 26 -3.98590309630735 0.000109841725895438 0.00364965573439232
GBM ENSG00000270101 ENSG00000270101 path:04915_56 Estrogen signaling pathway 38 -3.45589253721431 0.0007191899302652 0.0104796246981501
GBM ENSG00000270101 ENSG00000270101 path:04918_15 Thyroid hormone synthesis 38 -4.22888352033549 4.37025568733996e-05 0.00242724797895806
GBM ENSG00000270101 ENSG00000270101 path:04920_60 Adipocytokine signaling pathway 12 2.96110628685926 0.00367283952084006 0.0356790124881606
GBM ENSG00000270101 ENSG00000270101 path:04921_179 Oxytocin signaling pathway 8 -3.59101882401895 0.00045793745610715 0.00812341226485728
GBM ENSG00000270101 ENSG00000270101 path:04922_80 Glucagon signaling pathway 8 -3.02119857419934 0.00308018559878091 0.0314178931075652
GBM ENSG00000270101 ENSG00000270101 path:04961_4 Endocrine and other factor-regulated calcium reabsorption 22 -3.69636123443259 0.000308756254564959 0.00572602508465925
GBM ENSG00000270101 ENSG00000270101 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.7804961180379 0.000232490466189422 0.0049924268529097
GBM ENSG00000270101 ENSG00000270101 path:04970_7 Salivary secretion 24 -4.18415032271932 5.14105154937893e-05 0.00242724797895806
GBM ENSG00000270101 ENSG00000270101 path:04976_1 Bile secretion 15 -3.92487981763626 0.000137451060438846 0.00364965573439232
GBM ENSG00000270101 ENSG00000270101 path:05030_1 Cocaine addiction 42 -3.7239515023001 0.000285100007179882 0.00564524727080155
GBM ENSG00000270101 ENSG00000270101 path:05031_25 Amphetamine addiction 20 -4.47306590742821 1.62563464183883e-05 0.00242724797895806
GBM ENSG00000270101 ENSG00000270101 path:05032_33 Morphine addiction 43 -3.88955527885881 0.000153265931999104 0.00364965573439232
GBM ENSG00000270101 ENSG00000270101 path:05033_3 Nicotine addiction 10 -3.4420535881337 0.000762339342001579 0.0104957940934531
GBM ENSG00000270101 ENSG00000270101 path:05034_52 Alcoholism 26 -3.03648476634464 0.00283594592246118 0.0296683573426708
GBM ENSG00000270101 ENSG00000270101 path:05110_1 Vibrio cholerae infection 9 -3.88211079259662 0.000161014223576132 0.00364965573439232
GBM ENSG00000270101 ENSG00000270101 path:05146_11 Amoebiasis 7 -3.94348353239864 0.000127841360627006 0.00364965573439232
GBM ENSG00000270101 ENSG00000270101 path:05414_1 Dilated cardiomyopathy 28 -4.08831132771953 7.44958946681562e-05 0.00303943250246077
GBM ENSG00000270810 ENSG00000270810 path:00500_54 Starch and sucrose metabolism 6 5.19357338292211 8.1797868455541e-06 0.00327191473822164
GBM ENSG00000270810 ENSG00000270810 path:00760_8 Nicotinate and nicotinamide metabolism 18 4.42662249824312 6.66675112698963e-05 0.0133335022539793
GBM ENSG00000270810 ENSG00000270810 path:00983_9 Drug metabolism - other enzymes 8 4.12689145507489 0.000327503982489293 0.0327503982489293
GBM ENSG00000270810 ENSG00000270810 path:05160_31 Hepatitis C 17 4.1525800603309 0.000306676841549251 0.0327503982489293
GBM ENSG00000205866 FAM99A path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000205866 FAM99A path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000205866 FAM99A path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000205866 FAM99A path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000205866 FAM99A path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000205866 FAM99A path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000205866 FAM99A path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000205866 FAM99A path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000205866 FAM99A path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000205866 FAM99A path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000205866 FAM99A path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000205866 FAM99A path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000205866 FAM99A path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000205866 FAM99A path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000205865 FAM99B path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000205865 FAM99B path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000205865 FAM99B path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000205865 FAM99B path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000205865 FAM99B path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000205865 FAM99B path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000205865 FAM99B path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000205865 FAM99B path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000205865 FAM99B path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000205865 FAM99B path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000205865 FAM99B path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000205865 FAM99B path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000205865 FAM99B path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000205865 FAM99B path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000130600 H19 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000130600 H19 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000130600 H19 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000130600 H19 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000130600 H19 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000130600 H19 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000130600 H19 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000130600 H19 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000130600 H19 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000130600 H19 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000130600 H19 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000130600 H19 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000130600 H19 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000130600 H19 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000099869 IGF2-AS path:00053_1 Ascorbate and aldarate metabolism 6 3.72065031678615 0.000579663505879064 0.0462143047297844
GBM ENSG00000099869 IGF2-AS path:00330_1 Arginine and proline metabolism 50 -3.45237516632261 0.000971350602226964 0.0462143047297844
GBM ENSG00000099869 IGF2-AS path:00430_1 Taurine and hypotaurine metabolism 7 -3.37052207980055 0.00111628755385953 0.0462143047297844
GBM ENSG00000099869 IGF2-AS path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.45749772172656 0.000967554994288987 0.0462143047297844
GBM ENSG00000099869 IGF2-AS path:04650_125 Natural killer cell mediated cytotoxicity 3 -4.01150888345366 0.000156690518106735 0.0208174040863445
GBM ENSG00000099869 IGF2-AS path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.27385525385521 4.32030167506117e-05 0.00894302446737662
GBM ENSG00000099869 IGF2-AS path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.4312535345592 3.32642230735743e-05 0.00894302446737662
GBM ENSG00000099869 IGF2-AS path:05034_40 Alcoholism 34 3.48092763066619 0.00104854625774689 0.0462143047297844
GBM ENSG00000099869 IGF2-AS path:05145_11 Toxoplasmosis 11 -3.61186260807517 0.000699683942105843 0.0462143047297844
GBM ENSG00000099869 IGF2-AS path:05416_3 Viral myocarditis 5 -3.90463909826775 0.000201134338998498 0.0208174040863445
GBM ENSG00000236778 INTS6-AS1 path:00130_1 Ubiquinone and other terpenoid-quinone biosynthesis 3 4.6108456376724 1.07392882086475e-05 0.00242724797895806
GBM ENSG00000236778 INTS6-AS1 path:00230_207 Purine metabolism 6 3.41463478379983 0.000887473561489187 0.0113152879089871
GBM ENSG00000236778 INTS6-AS1 path:00240_172 Pyrimidine metabolism 7 3.39885571027096 0.000981049808596226 0.0117725977031547
GBM ENSG00000236778 INTS6-AS1 path:00983_2 Drug metabolism - other enzymes 16 3.11370905561217 0.0023490947276189 0.0252218591807503
GBM ENSG00000236778 INTS6-AS1 path:04015_131 Rap1 signaling pathway 19 -3.97090690453368 0.000112313373362324 0.00364965573439232
GBM ENSG00000236778 INTS6-AS1 path:04020_81 Calcium signaling pathway 51 -3.50635467280299 0.000623574051176207 0.0101767285151957
GBM ENSG00000236778 INTS6-AS1 path:04020_92 Calcium signaling pathway 44 -4.24437764894791 4.16377132089798e-05 0.00242724797895806
GBM ENSG00000236778 INTS6-AS1 path:04024_50 cAMP signaling pathway 80 -2.84811517197767 0.00508310088252344 0.0482303525597573
GBM ENSG00000236778 INTS6-AS1 path:04024_60 cAMP signaling pathway 75 -4.43288892588071 1.86064675242161e-05 0.00242724797895806
GBM ENSG00000236778 INTS6-AS1 path:04261_74 Adrenergic signaling in cardiomyocytes 44 -3.71606749391448 0.000290564197761845 0.00564524727080155
GBM ENSG00000236778 INTS6-AS1 path:04270_30 Vascular smooth muscle contraction 67 -3.46738466417476 0.000700879762146277 0.0104796246981501
GBM ENSG00000236778 INTS6-AS1 path:04710_8 Circadian rhythm 26 -3.22547297158013 0.00157941345056278 0.0184114482237033
GBM ENSG00000236778 INTS6-AS1 path:04713_149 Circadian entrainment 11 -3.42209576122081 0.000825037163085292 0.0108585536302838
GBM ENSG00000236778 INTS6-AS1 path:04713_22 Circadian entrainment 61 -3.18532630714474 0.00177343622807315 0.0200989439181624
GBM ENSG00000236778 INTS6-AS1 path:04724_160 Glutamatergic synapse 8 -3.53267198479711 0.000559463527123407 0.00951087996109792
GBM ENSG00000236778 INTS6-AS1 path:04724_34 Glutamatergic synapse 61 -3.90571351133649 0.000143622623317971 0.00364965573439232
GBM ENSG00000236778 INTS6-AS1 path:04728_17 Dopaminergic synapse 93 -3.15506990688589 0.00194894531565256 0.0214910726698985
GBM ENSG00000236778 INTS6-AS1 path:04728_187 Dopaminergic synapse 16 -2.9723064138605 0.00353583207045978 0.0351858410914046
GBM ENSG00000236778 INTS6-AS1 path:04728_222 Dopaminergic synapse 5 -4.16469173165661 5.35422348299571e-05 0.00242724797895806
GBM ENSG00000236778 INTS6-AS1 path:04730_41 Long-term depression 28 -3.43788836896864 0.00077174956569508 0.0104957940934531
GBM ENSG00000236778 INTS6-AS1 path:04730_74 Long-term depression 5 -3.47803393984781 0.000673318331754186 0.0104796246981501
GBM ENSG00000236778 INTS6-AS1 path:04740_16 Olfactory transduction 10 -3.36856054630436 0.000968275005437924 0.0117725977031547
GBM ENSG00000236778 INTS6-AS1 path:04750_2 Inflammatory mediator regulation of TRP channels 78 -4.27053623503594 3.54045938893224e-05 0.00242724797895806
GBM ENSG00000236778 INTS6-AS1 path:04911_33 Insulin secretion 26 -4.19206806637642 4.96667878136834e-05 0.00242724797895806
GBM ENSG00000236778 INTS6-AS1 path:04912_45 GnRH signaling pathway 16 -3.93299641382354 0.000132990317813788 0.00364965573439232
GBM ENSG00000236778 INTS6-AS1 path:04913_2 Ovarian steroidogenesis 26 -3.98590309630735 0.000109841725895438 0.00364965573439232
GBM ENSG00000236778 INTS6-AS1 path:04915_56 Estrogen signaling pathway 38 -3.45589253721431 0.0007191899302652 0.0104796246981501
GBM ENSG00000236778 INTS6-AS1 path:04918_15 Thyroid hormone synthesis 38 -4.22888352033549 4.37025568733996e-05 0.00242724797895806
GBM ENSG00000236778 INTS6-AS1 path:04920_60 Adipocytokine signaling pathway 12 2.96110628685926 0.00367283952084006 0.0356790124881606
GBM ENSG00000236778 INTS6-AS1 path:04921_179 Oxytocin signaling pathway 8 -3.59101882401895 0.00045793745610715 0.00812341226485728
GBM ENSG00000236778 INTS6-AS1 path:04922_80 Glucagon signaling pathway 8 -3.02119857419934 0.00308018559878091 0.0314178931075652
GBM ENSG00000236778 INTS6-AS1 path:04961_4 Endocrine and other factor-regulated calcium reabsorption 22 -3.69636123443259 0.000308756254564959 0.00572602508465925
GBM ENSG00000236778 INTS6-AS1 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.7804961180379 0.000232490466189422 0.0049924268529097
GBM ENSG00000236778 INTS6-AS1 path:04970_7 Salivary secretion 24 -4.18415032271932 5.14105154937893e-05 0.00242724797895806
GBM ENSG00000236778 INTS6-AS1 path:04976_1 Bile secretion 15 -3.92487981763626 0.000137451060438846 0.00364965573439232
GBM ENSG00000236778 INTS6-AS1 path:05030_1 Cocaine addiction 42 -3.7239515023001 0.000285100007179882 0.00564524727080155
GBM ENSG00000236778 INTS6-AS1 path:05031_25 Amphetamine addiction 20 -4.47306590742821 1.62563464183883e-05 0.00242724797895806
GBM ENSG00000236778 INTS6-AS1 path:05032_33 Morphine addiction 43 -3.88955527885881 0.000153265931999104 0.00364965573439232
GBM ENSG00000236778 INTS6-AS1 path:05033_3 Nicotine addiction 10 -3.4420535881337 0.000762339342001579 0.0104957940934531
GBM ENSG00000236778 INTS6-AS1 path:05034_52 Alcoholism 26 -3.03648476634464 0.00283594592246118 0.0296683573426708
GBM ENSG00000236778 INTS6-AS1 path:05110_1 Vibrio cholerae infection 9 -3.88211079259662 0.000161014223576132 0.00364965573439232
GBM ENSG00000236778 INTS6-AS1 path:05146_11 Amoebiasis 7 -3.94348353239864 0.000127841360627006 0.00364965573439232
GBM ENSG00000236778 INTS6-AS1 path:05414_1 Dilated cardiomyopathy 28 -4.08831132771953 7.44958946681562e-05 0.00303943250246077
GBM ENSG00000233930 KRTAP5-AS1 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000233930 KRTAP5-AS1 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000233930 KRTAP5-AS1 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000233930 KRTAP5-AS1 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000233930 KRTAP5-AS1 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000233930 KRTAP5-AS1 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000233930 KRTAP5-AS1 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000233930 KRTAP5-AS1 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000233930 KRTAP5-AS1 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000233930 KRTAP5-AS1 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000233930 KRTAP5-AS1 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000233930 KRTAP5-AS1 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000233930 KRTAP5-AS1 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000233930 KRTAP5-AS1 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000235660 LINC00345 path:00130_1 Ubiquinone and other terpenoid-quinone biosynthesis 3 4.6108456376724 1.07392882086475e-05 0.00242724797895806
GBM ENSG00000235660 LINC00345 path:00230_207 Purine metabolism 6 3.41463478379983 0.000887473561489187 0.0113152879089871
GBM ENSG00000235660 LINC00345 path:00240_172 Pyrimidine metabolism 7 3.39885571027096 0.000981049808596226 0.0117725977031547
GBM ENSG00000235660 LINC00345 path:00983_2 Drug metabolism - other enzymes 16 3.11370905561217 0.0023490947276189 0.0252218591807503
GBM ENSG00000235660 LINC00345 path:04015_131 Rap1 signaling pathway 19 -3.97090690453368 0.000112313373362324 0.00364965573439232
GBM ENSG00000235660 LINC00345 path:04020_81 Calcium signaling pathway 51 -3.50635467280299 0.000623574051176207 0.0101767285151957
GBM ENSG00000235660 LINC00345 path:04020_92 Calcium signaling pathway 44 -4.24437764894791 4.16377132089798e-05 0.00242724797895806
GBM ENSG00000235660 LINC00345 path:04024_50 cAMP signaling pathway 80 -2.84811517197767 0.00508310088252344 0.0482303525597573
GBM ENSG00000235660 LINC00345 path:04024_60 cAMP signaling pathway 75 -4.43288892588071 1.86064675242161e-05 0.00242724797895806
GBM ENSG00000235660 LINC00345 path:04261_74 Adrenergic signaling in cardiomyocytes 44 -3.71606749391448 0.000290564197761845 0.00564524727080155
GBM ENSG00000235660 LINC00345 path:04270_30 Vascular smooth muscle contraction 67 -3.46738466417476 0.000700879762146277 0.0104796246981501
GBM ENSG00000235660 LINC00345 path:04710_8 Circadian rhythm 26 -3.22547297158013 0.00157941345056278 0.0184114482237033
GBM ENSG00000235660 LINC00345 path:04713_149 Circadian entrainment 11 -3.42209576122081 0.000825037163085292 0.0108585536302838
GBM ENSG00000235660 LINC00345 path:04713_22 Circadian entrainment 61 -3.18532630714474 0.00177343622807315 0.0200989439181624
GBM ENSG00000235660 LINC00345 path:04724_160 Glutamatergic synapse 8 -3.53267198479711 0.000559463527123407 0.00951087996109792
GBM ENSG00000235660 LINC00345 path:04724_34 Glutamatergic synapse 61 -3.90571351133649 0.000143622623317971 0.00364965573439232
GBM ENSG00000235660 LINC00345 path:04728_17 Dopaminergic synapse 93 -3.15506990688589 0.00194894531565256 0.0214910726698985
GBM ENSG00000235660 LINC00345 path:04728_187 Dopaminergic synapse 16 -2.9723064138605 0.00353583207045978 0.0351858410914046
GBM ENSG00000235660 LINC00345 path:04728_222 Dopaminergic synapse 5 -4.16469173165661 5.35422348299571e-05 0.00242724797895806
GBM ENSG00000235660 LINC00345 path:04730_41 Long-term depression 28 -3.43788836896864 0.00077174956569508 0.0104957940934531
GBM ENSG00000235660 LINC00345 path:04730_74 Long-term depression 5 -3.47803393984781 0.000673318331754186 0.0104796246981501
GBM ENSG00000235660 LINC00345 path:04740_16 Olfactory transduction 10 -3.36856054630436 0.000968275005437924 0.0117725977031547
GBM ENSG00000235660 LINC00345 path:04750_2 Inflammatory mediator regulation of TRP channels 78 -4.27053623503594 3.54045938893224e-05 0.00242724797895806
GBM ENSG00000235660 LINC00345 path:04911_33 Insulin secretion 26 -4.19206806637642 4.96667878136834e-05 0.00242724797895806
GBM ENSG00000235660 LINC00345 path:04912_45 GnRH signaling pathway 16 -3.93299641382354 0.000132990317813788 0.00364965573439232
GBM ENSG00000235660 LINC00345 path:04913_2 Ovarian steroidogenesis 26 -3.98590309630735 0.000109841725895438 0.00364965573439232
GBM ENSG00000235660 LINC00345 path:04915_56 Estrogen signaling pathway 38 -3.45589253721431 0.0007191899302652 0.0104796246981501
GBM ENSG00000235660 LINC00345 path:04918_15 Thyroid hormone synthesis 38 -4.22888352033549 4.37025568733996e-05 0.00242724797895806
GBM ENSG00000235660 LINC00345 path:04920_60 Adipocytokine signaling pathway 12 2.96110628685926 0.00367283952084006 0.0356790124881606
GBM ENSG00000235660 LINC00345 path:04921_179 Oxytocin signaling pathway 8 -3.59101882401895 0.00045793745610715 0.00812341226485728
GBM ENSG00000235660 LINC00345 path:04922_80 Glucagon signaling pathway 8 -3.02119857419934 0.00308018559878091 0.0314178931075652
GBM ENSG00000235660 LINC00345 path:04961_4 Endocrine and other factor-regulated calcium reabsorption 22 -3.69636123443259 0.000308756254564959 0.00572602508465925
GBM ENSG00000235660 LINC00345 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.7804961180379 0.000232490466189422 0.0049924268529097
GBM ENSG00000235660 LINC00345 path:04970_7 Salivary secretion 24 -4.18415032271932 5.14105154937893e-05 0.00242724797895806
GBM ENSG00000235660 LINC00345 path:04976_1 Bile secretion 15 -3.92487981763626 0.000137451060438846 0.00364965573439232
GBM ENSG00000235660 LINC00345 path:05030_1 Cocaine addiction 42 -3.7239515023001 0.000285100007179882 0.00564524727080155
GBM ENSG00000235660 LINC00345 path:05031_25 Amphetamine addiction 20 -4.47306590742821 1.62563464183883e-05 0.00242724797895806
GBM ENSG00000235660 LINC00345 path:05032_33 Morphine addiction 43 -3.88955527885881 0.000153265931999104 0.00364965573439232
GBM ENSG00000235660 LINC00345 path:05033_3 Nicotine addiction 10 -3.4420535881337 0.000762339342001579 0.0104957940934531
GBM ENSG00000235660 LINC00345 path:05034_52 Alcoholism 26 -3.03648476634464 0.00283594592246118 0.0296683573426708
GBM ENSG00000235660 LINC00345 path:05110_1 Vibrio cholerae infection 9 -3.88211079259662 0.000161014223576132 0.00364965573439232
GBM ENSG00000235660 LINC00345 path:05146_11 Amoebiasis 7 -3.94348353239864 0.000127841360627006 0.00364965573439232
GBM ENSG00000235660 LINC00345 path:05414_1 Dilated cardiomyopathy 28 -4.08831132771953 7.44958946681562e-05 0.00303943250246077
GBM ENSG00000226792 LINC00371 path:00020_60 Citrate cycle (TCA cycle) 4 -3.49044899966754 0.000663677631700656 0.0129683353465915
GBM ENSG00000226792 LINC00371 path:00130_1 Ubiquinone and other terpenoid-quinone biosynthesis 3 4.36911447074934 2.77426567645463e-05 0.00862763067704109
GBM ENSG00000226792 LINC00371 path:00230_207 Purine metabolism 6 3.17660129798097 0.00191406132358621 0.0207111250911123
GBM ENSG00000226792 LINC00371 path:00240_151 Pyrimidine metabolism 10 3.4715635616409 0.000744402183658895 0.0130890717293356
GBM ENSG00000226792 LINC00371 path:00450_9 Selenocompound metabolism 2 3.31215840737179 0.00136018947098345 0.0157495684027223
GBM ENSG00000226792 LINC00371 path:00500_15 Starch and sucrose metabolism 22 3.58985413730516 0.000476169711963319 0.0125589761530325
GBM ENSG00000226792 LINC00371 path:04015_140 Rap1 signaling pathway 17 -3.74063624855111 0.000266305812157411 0.0102164593391298
GBM ENSG00000226792 LINC00371 path:04020_159 Calcium signaling pathway 21 -4.06797290020083 8.16097444265756e-05 0.00862763067704109
GBM ENSG00000226792 LINC00371 path:04020_78 Calcium signaling pathway 53 -3.33630677321898 0.00110865656809111 0.0146204084917015
GBM ENSG00000226792 LINC00371 path:04024_39 cAMP signaling pathway 95 -3.49369999704657 0.00064062708523743 0.0129683353465915
GBM ENSG00000226792 LINC00371 path:04064_70 NF-kappa B signaling pathway 4 3.90753740585552 0.000163556979659547 0.00862763067704109
GBM ENSG00000226792 LINC00371 path:04261_22 Adrenergic signaling in cardiomyocytes 110 -3.13714915201885 0.00206396906141659 0.021774873597945
GBM ENSG00000226792 LINC00371 path:04540_84 Gap junction 14 -3.37044739480109 0.000970486257158573 0.0141222482938248
GBM ENSG00000226792 LINC00371 path:04630_53 Jak-STAT signaling pathway 78 -3.92036716904876 0.000136605122401295 0.00862763067704109
GBM ENSG00000226792 LINC00371 path:04710_1 Circadian rhythm 27 -3.39240303906335 0.000906106119575388 0.0141222482938248
GBM ENSG00000226792 LINC00371 path:04713_117 Circadian entrainment 15 -3.64321469970755 0.000382741283840683 0.0115369158414834
GBM ENSG00000226792 LINC00371 path:04713_60 Circadian entrainment 32 -2.86970870830684 0.00481285661802073 0.0451338998401055
GBM ENSG00000226792 LINC00371 path:04723_39 Retrograde endocannabinoid signaling 14 -3.30104053822851 0.00121647988052861 0.0146672717023736
GBM ENSG00000226792 LINC00371 path:04724_150 Glutamatergic synapse 10 -3.47903895220879 0.000670337474195708 0.0129683353465915
GBM ENSG00000226792 LINC00371 path:04724_163 Glutamatergic synapse 7 -3.42644927262341 0.000807488050621669 0.013106152206244
GBM ENSG00000226792 LINC00371 path:04728_18 Dopaminergic synapse 93 -2.99795107154125 0.00319577048426266 0.0321098843894963
GBM ENSG00000226792 LINC00371 path:04730_53 Long-term depression 20 -3.1814247737193 0.00180371168747406 0.0200306929503698
GBM ENSG00000226792 LINC00371 path:04730_74 Long-term depression 5 -3.30937369332759 0.00118616912789795 0.0146672717023736
GBM ENSG00000226792 LINC00371 path:04750_36 Inflammatory mediator regulation of TRP channels 39 -2.93819629734224 0.00384392145845061 0.0377240664061897
GBM ENSG00000226792 LINC00371 path:04750_78 Inflammatory mediator regulation of TRP channels 13 -3.82616412247666 0.000199212127674234 0.00904799284746949
GBM ENSG00000226792 LINC00371 path:04750_99 Inflammatory mediator regulation of TRP channels 2 -3.66594835061725 0.000348171344375415 0.0113021774866481
GBM ENSG00000226792 LINC00371 path:04911_13 Insulin secretion 44 -3.98012102137569 0.000114097499486186 0.00862763067704109
GBM ENSG00000226792 LINC00371 path:04912_37 GnRH signaling pathway 29 -3.373379734783 0.00095188100204238 0.0141222482938248
GBM ENSG00000226792 LINC00371 path:04913_2 Ovarian steroidogenesis 26 -3.88297206283848 0.000162228337607758 0.00862763067704109
GBM ENSG00000226792 LINC00371 path:04915_135 Estrogen signaling pathway 5 -3.10146863045164 0.00231188555775197 0.0237955050090568
GBM ENSG00000226792 LINC00371 path:04915_50 Estrogen signaling pathway 45 -3.26359559231486 0.00138088632914863 0.0157495684027223
GBM ENSG00000226792 LINC00371 path:04921_160 Oxytocin signaling pathway 13 -3.52789425973909 0.000573678529567832 0.0129683353465915
GBM ENSG00000226792 LINC00371 path:04921_173 Oxytocin signaling pathway 9 -3.68484009437554 0.000326950269634224 0.0113021774866481
GBM ENSG00000226792 LINC00371 path:04922_72 Glucagon signaling pathway 11 -3.31582532396852 0.00117474160030524 0.0146672717023736
GBM ENSG00000226792 LINC00371 path:04961_4 Endocrine and other factor-regulated calcium reabsorption 22 -3.46073836762506 0.000706805007041715 0.0129683353465915
GBM ENSG00000226792 LINC00371 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.61866323716272 0.000416211087154359 0.0117094052519426
GBM ENSG00000226792 LINC00371 path:04970_5 Salivary secretion 28 -4.13350227443745 6.30844522902735e-05 0.00862763067704109
GBM ENSG00000226792 LINC00371 path:04971_35 Gastric acid secretion 14 -3.42750798070875 0.000807408269924543 0.013106152206244
GBM ENSG00000226792 LINC00371 path:04976_1 Bile secretion 15 -3.80566836334846 0.000214407413447144 0.00904799284746949
GBM ENSG00000226792 LINC00371 path:05030_1 Cocaine addiction 42 -3.55502782509589 0.000519714111084988 0.0129011385222273
GBM ENSG00000226792 LINC00371 path:05032_1 Morphine addiction 63 -3.34951803516984 0.00103393693076775 0.0145440461594664
GBM ENSG00000226792 LINC00371 path:05033_1 Nicotine addiction 11 -3.34114079809608 0.00107071320679245 0.0145755152666585
GBM ENSG00000226792 LINC00371 path:05146_4 Amoebiasis 9 2.91397303971617 0.00429253747281911 0.0411693366711287
GBM ENSG00000226792 LINC00371 path:05214_42 Glioma 6 -3.4755807761455 0.000677468913187346 0.0129683353465915
GBM ENSG00000226792 LINC00371 path:05414_1 Dilated cardiomyopathy 28 -3.97870498665128 0.000113632316920039 0.00862763067704109
GBM ENSG00000231473 LINC00441 path:00130_1 Ubiquinone and other terpenoid-quinone biosynthesis 3 4.48902700583504 1.84132737665989e-05 0.00751261569677235
GBM ENSG00000231473 LINC00441 path:00230_207 Purine metabolism 6 3.4451440302094 0.000820283260499293 0.0304250518439738
GBM ENSG00000231473 LINC00441 path:00240_172 Pyrimidine metabolism 7 3.22747102066501 0.00173483439660794 0.0307744536441756
GBM ENSG00000231473 LINC00441 path:04015_131 Rap1 signaling pathway 19 -3.25318065215945 0.00141792885240351 0.0307744536441756
GBM ENSG00000231473 LINC00441 path:04020_81 Calcium signaling pathway 51 -3.35870015567992 0.00101861765538521 0.0307744536441756
GBM ENSG00000231473 LINC00441 path:04020_92 Calcium signaling pathway 44 -3.52433677654756 0.000575784707690872 0.0279770157494106
GBM ENSG00000231473 LINC00441 path:04024_60 cAMP signaling pathway 75 -3.72957867345313 0.000274526716105356 0.022245088572605
GBM ENSG00000231473 LINC00441 path:04261_74 Adrenergic signaling in cardiomyocytes 44 -3.04040087997127 0.00280228746462896 0.0408333316274505
GBM ENSG00000231473 LINC00441 path:04713_149 Circadian entrainment 11 -3.27238176760732 0.00137537289323421 0.0307744536441756
GBM ENSG00000231473 LINC00441 path:04724_34 Glutamatergic synapse 61 -3.9509523980243 0.000122540846222579 0.022245088572605
GBM ENSG00000231473 LINC00441 path:04728_222 Dopaminergic synapse 5 -3.72731779294067 0.000276179446311897 0.022245088572605
GBM ENSG00000231473 LINC00441 path:04730_74 Long-term depression 5 -3.2332698612798 0.0015380982675816 0.0307744536441756
GBM ENSG00000231473 LINC00441 path:04740_16 Olfactory transduction 10 -3.00281921597526 0.00314809456846546 0.0431341805921565
GBM ENSG00000231473 LINC00441 path:04750_2 Inflammatory mediator regulation of TRP channels 78 -3.68049394492918 0.000327133655479486 0.022245088572605
GBM ENSG00000231473 LINC00441 path:04911_33 Insulin secretion 26 -3.48654769130609 0.000652736955914973 0.0279770157494106
GBM ENSG00000231473 LINC00441 path:04912_45 GnRH signaling pathway 16 -3.21403360375879 0.00161998700190271 0.0307744536441756
GBM ENSG00000231473 LINC00441 path:04913_2 Ovarian steroidogenesis 26 -3.25913912395004 0.00139929930268113 0.0307744536441756
GBM ENSG00000231473 LINC00441 path:04918_15 Thyroid hormone synthesis 38 -3.51258741436167 0.000599903434249699 0.0279770157494106
GBM ENSG00000231473 LINC00441 path:04922_80 Glucagon signaling pathway 8 -3.09117418782673 0.00246440370778038 0.0372398782509036
GBM ENSG00000231473 LINC00441 path:04961_4 Endocrine and other factor-regulated calcium reabsorption 22 -3.00116284814607 0.00317163092589386 0.0431341805921565
GBM ENSG00000231473 LINC00441 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.08533823580241 0.0024389843615013 0.0372398782509036
GBM ENSG00000231473 LINC00441 path:04970_7 Salivary secretion 24 -3.47194011724893 0.000685711170328691 0.0279770157494106
GBM ENSG00000231473 LINC00441 path:04976_1 Bile secretion 15 -3.20328073774564 0.00167679323897534 0.0307744536441756
GBM ENSG00000231473 LINC00441 path:05030_1 Cocaine addiction 42 -3.13151902197022 0.00210954042557503 0.0344276997453845
GBM ENSG00000231473 LINC00441 path:05031_25 Amphetamine addiction 20 -3.75741098906562 0.000250454654360733 0.022245088572605
GBM ENSG00000231473 LINC00441 path:05032_33 Morphine addiction 43 -3.32635212679364 0.00111389221786781 0.0307744536441756
GBM ENSG00000231473 LINC00441 path:05033_3 Nicotine addiction 10 -3.32067694577226 0.00115806975107114 0.0307744536441756
GBM ENSG00000231473 LINC00441 path:05110_1 Vibrio cholerae infection 9 -3.17634951847348 0.00182862337901018 0.0310865974431731
GBM ENSG00000231473 LINC00441 path:05146_11 Amoebiasis 7 -3.22909265473398 0.00154042259146041 0.0307744536441756
GBM ENSG00000231473 LINC00441 path:05414_1 Dilated cardiomyopathy 28 -3.3772336742769 0.000945983784205605 0.0307744536441756
GBM ENSG00000234787 LINC00458 path:00130_1 Ubiquinone and other terpenoid-quinone biosynthesis 3 4.29549578801095 3.7217632856208e-05 0.00261190429957762
GBM ENSG00000234787 LINC00458 path:00230_207 Purine metabolism 6 3.5185937484824 0.000619043575192557 0.0101027911471425
GBM ENSG00000234787 LINC00458 path:00240_172 Pyrimidine metabolism 7 3.28823558446462 0.00138905091641002 0.0181289857060709
GBM ENSG00000234787 LINC00458 path:04015_131 Rap1 signaling pathway 19 -3.91492495086787 0.000139056519071904 0.00430248702108674
GBM ENSG00000234787 LINC00458 path:04020_81 Calcium signaling pathway 51 -3.32747218088401 0.00114121047680045 0.0155204624844861
GBM ENSG00000234787 LINC00458 path:04020_92 Calcium signaling pathway 44 -4.26105742769158 3.94888707079029e-05 0.00261190429957762
GBM ENSG00000234787 LINC00458 path:04024_60 cAMP signaling pathway 75 -4.28000182988124 3.45721367563611e-05 0.00261190429957762
GBM ENSG00000234787 LINC00458 path:04261_74 Adrenergic signaling in cardiomyocytes 44 -3.71184213787752 0.000296407468963623 0.00592353764817865
GBM ENSG00000234787 LINC00458 path:04270_30 Vascular smooth muscle contraction 67 -3.53453461808557 0.000558795379577717 0.00955822304316817
GBM ENSG00000234787 LINC00458 path:04710_8 Circadian rhythm 26 -3.12931676766472 0.00214143464731693 0.0249630096030088
GBM ENSG00000234787 LINC00458 path:04713_149 Circadian entrainment 11 -3.14098876376927 0.0020718874177852 0.0249630096030088
GBM ENSG00000234787 LINC00458 path:04713_22 Circadian entrainment 61 -3.25396137802723 0.0014218812318487 0.0181289857060709
GBM ENSG00000234787 LINC00458 path:04724_160 Glutamatergic synapse 8 -3.53264164111818 0.00056224841430401 0.00955822304316817
GBM ENSG00000234787 LINC00458 path:04724_34 Glutamatergic synapse 61 -3.76488640727828 0.000241167272334912 0.00517874984803391
GBM ENSG00000234787 LINC00458 path:04728_17 Dopaminergic synapse 93 -3.12624057610169 0.00213730938102834 0.0249630096030088
GBM ENSG00000234787 LINC00458 path:04728_222 Dopaminergic synapse 5 -3.79344677596297 0.000217803441536343 0.00517874984803391
GBM ENSG00000234787 LINC00458 path:04730_41 Long-term depression 28 -3.42369077970462 0.00081301374752308 0.0122855410736821
GBM ENSG00000234787 LINC00458 path:04730_74 Long-term depression 5 -3.36825303117234 0.000974100533168202 0.0137045868114699
GBM ENSG00000234787 LINC00458 path:04740_16 Olfactory transduction 10 -3.07200818449225 0.0025399918738982 0.02759070426063
GBM ENSG00000234787 LINC00458 path:04750_2 Inflammatory mediator regulation of TRP channels 78 -4.20136344194097 4.67988507495075e-05 0.00261190429957762
GBM ENSG00000234787 LINC00458 path:04911_33 Insulin secretion 26 -4.18673960828248 5.12138097956395e-05 0.00261190429957762
GBM ENSG00000234787 LINC00458 path:04912_45 GnRH signaling pathway 16 -3.90693029845617 0.000147634358566702 0.00430248702108674
GBM ENSG00000234787 LINC00458 path:04913_2 Ovarian steroidogenesis 26 -3.98355168113435 0.000111778226025175 0.00430248702108674
GBM ENSG00000234787 LINC00458 path:04915_56 Estrogen signaling pathway 38 -3.37875353626224 0.000934003765715394 0.0136097691575672
GBM ENSG00000234787 LINC00458 path:04918_15 Thyroid hormone synthesis 38 -4.20779279646412 4.7972346904282e-05 0.00261190429957762
GBM ENSG00000234787 LINC00458 path:04921_179 Oxytocin signaling pathway 8 -3.59086183610479 0.000460709244725331 0.00854406235672432
GBM ENSG00000234787 LINC00458 path:04922_80 Glucagon signaling pathway 8 -2.9158944324278 0.00424737012905045 0.0444340259654509
GBM ENSG00000234787 LINC00458 path:04961_4 Endocrine and other factor-regulated calcium reabsorption 22 -3.46574361708329 0.000694778981966749 0.0109026855631705
GBM ENSG00000234787 LINC00458 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.78547680538042 0.000229794295958389 0.00517874984803391
GBM ENSG00000234787 LINC00458 path:04970_7 Salivary secretion 24 -4.19064369418772 5.06456551864619e-05 0.00261190429957762
GBM ENSG00000234787 LINC00458 path:04976_1 Bile secretion 15 -3.91254052328632 0.000145028769466027 0.00430248702108674
GBM ENSG00000234787 LINC00458 path:05030_1 Cocaine addiction 42 -3.70689839127271 0.000304887967185666 0.00592353764817865
GBM ENSG00000234787 LINC00458 path:05031_25 Amphetamine addiction 20 -4.39883204305229 2.21822794658455e-05 0.00261190429957762
GBM ENSG00000234787 LINC00458 path:05032_33 Morphine addiction 43 -3.87485216902645 0.000162615144798864 0.0043360254117619
GBM ENSG00000234787 LINC00458 path:05033_3 Nicotine addiction 10 -3.07625467769222 0.0025265045187535 0.02759070426063
GBM ENSG00000234787 LINC00458 path:05034_52 Alcoholism 26 -3.06820768780426 0.00256972245564691 0.02759070426063
GBM ENSG00000234787 LINC00458 path:05110_1 Vibrio cholerae infection 9 -3.86934832208732 0.000170040212225957 0.0043360254117619
GBM ENSG00000234787 LINC00458 path:05146_11 Amoebiasis 7 -3.92932146413286 0.000135814315801254 0.00430248702108674
GBM ENSG00000234787 LINC00458 path:05414_1 Dilated cardiomyopathy 28 -4.09351347158049 7.37269524452999e-05 0.0033422885108536
GBM ENSG00000261517 LINC00558 path:00130_1 Ubiquinone and other terpenoid-quinone biosynthesis 3 4.29549578801095 3.7217632856208e-05 0.00261190429957762
GBM ENSG00000261517 LINC00558 path:00230_207 Purine metabolism 6 3.5185937484824 0.000619043575192557 0.0101027911471425
GBM ENSG00000261517 LINC00558 path:00240_172 Pyrimidine metabolism 7 3.28823558446462 0.00138905091641002 0.0181289857060709
GBM ENSG00000261517 LINC00558 path:04015_131 Rap1 signaling pathway 19 -3.91492495086787 0.000139056519071904 0.00430248702108674
GBM ENSG00000261517 LINC00558 path:04020_81 Calcium signaling pathway 51 -3.32747218088401 0.00114121047680045 0.0155204624844861
GBM ENSG00000261517 LINC00558 path:04020_92 Calcium signaling pathway 44 -4.26105742769158 3.94888707079029e-05 0.00261190429957762
GBM ENSG00000261517 LINC00558 path:04024_60 cAMP signaling pathway 75 -4.28000182988124 3.45721367563611e-05 0.00261190429957762
GBM ENSG00000261517 LINC00558 path:04261_74 Adrenergic signaling in cardiomyocytes 44 -3.71184213787752 0.000296407468963623 0.00592353764817865
GBM ENSG00000261517 LINC00558 path:04270_30 Vascular smooth muscle contraction 67 -3.53453461808557 0.000558795379577717 0.00955822304316817
GBM ENSG00000261517 LINC00558 path:04710_8 Circadian rhythm 26 -3.12931676766472 0.00214143464731693 0.0249630096030088
GBM ENSG00000261517 LINC00558 path:04713_149 Circadian entrainment 11 -3.14098876376927 0.0020718874177852 0.0249630096030088
GBM ENSG00000261517 LINC00558 path:04713_22 Circadian entrainment 61 -3.25396137802723 0.0014218812318487 0.0181289857060709
GBM ENSG00000261517 LINC00558 path:04724_160 Glutamatergic synapse 8 -3.53264164111818 0.00056224841430401 0.00955822304316817
GBM ENSG00000261517 LINC00558 path:04724_34 Glutamatergic synapse 61 -3.76488640727828 0.000241167272334912 0.00517874984803391
GBM ENSG00000261517 LINC00558 path:04728_17 Dopaminergic synapse 93 -3.12624057610169 0.00213730938102834 0.0249630096030088
GBM ENSG00000261517 LINC00558 path:04728_222 Dopaminergic synapse 5 -3.79344677596297 0.000217803441536343 0.00517874984803391
GBM ENSG00000261517 LINC00558 path:04730_41 Long-term depression 28 -3.42369077970462 0.00081301374752308 0.0122855410736821
GBM ENSG00000261517 LINC00558 path:04730_74 Long-term depression 5 -3.36825303117234 0.000974100533168202 0.0137045868114699
GBM ENSG00000261517 LINC00558 path:04740_16 Olfactory transduction 10 -3.07200818449225 0.0025399918738982 0.02759070426063
GBM ENSG00000261517 LINC00558 path:04750_2 Inflammatory mediator regulation of TRP channels 78 -4.20136344194097 4.67988507495075e-05 0.00261190429957762
GBM ENSG00000261517 LINC00558 path:04911_33 Insulin secretion 26 -4.18673960828248 5.12138097956395e-05 0.00261190429957762
GBM ENSG00000261517 LINC00558 path:04912_45 GnRH signaling pathway 16 -3.90693029845617 0.000147634358566702 0.00430248702108674
GBM ENSG00000261517 LINC00558 path:04913_2 Ovarian steroidogenesis 26 -3.98355168113435 0.000111778226025175 0.00430248702108674
GBM ENSG00000261517 LINC00558 path:04915_56 Estrogen signaling pathway 38 -3.37875353626224 0.000934003765715394 0.0136097691575672
GBM ENSG00000261517 LINC00558 path:04918_15 Thyroid hormone synthesis 38 -4.20779279646412 4.7972346904282e-05 0.00261190429957762
GBM ENSG00000261517 LINC00558 path:04921_179 Oxytocin signaling pathway 8 -3.59086183610479 0.000460709244725331 0.00854406235672432
GBM ENSG00000261517 LINC00558 path:04922_80 Glucagon signaling pathway 8 -2.9158944324278 0.00424737012905045 0.0444340259654509
GBM ENSG00000261517 LINC00558 path:04961_4 Endocrine and other factor-regulated calcium reabsorption 22 -3.46574361708329 0.000694778981966749 0.0109026855631705
GBM ENSG00000261517 LINC00558 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.78547680538042 0.000229794295958389 0.00517874984803391
GBM ENSG00000261517 LINC00558 path:04970_7 Salivary secretion 24 -4.19064369418772 5.06456551864619e-05 0.00261190429957762
GBM ENSG00000261517 LINC00558 path:04976_1 Bile secretion 15 -3.91254052328632 0.000145028769466027 0.00430248702108674
GBM ENSG00000261517 LINC00558 path:05030_1 Cocaine addiction 42 -3.70689839127271 0.000304887967185666 0.00592353764817865
GBM ENSG00000261517 LINC00558 path:05031_25 Amphetamine addiction 20 -4.39883204305229 2.21822794658455e-05 0.00261190429957762
GBM ENSG00000261517 LINC00558 path:05032_33 Morphine addiction 43 -3.87485216902645 0.000162615144798864 0.0043360254117619
GBM ENSG00000261517 LINC00558 path:05033_3 Nicotine addiction 10 -3.07625467769222 0.0025265045187535 0.02759070426063
GBM ENSG00000261517 LINC00558 path:05034_52 Alcoholism 26 -3.06820768780426 0.00256972245564691 0.02759070426063
GBM ENSG00000261517 LINC00558 path:05110_1 Vibrio cholerae infection 9 -3.86934832208732 0.000170040212225957 0.0043360254117619
GBM ENSG00000261517 LINC00558 path:05146_11 Amoebiasis 7 -3.92932146413286 0.000135814315801254 0.00430248702108674
GBM ENSG00000261517 LINC00558 path:05414_1 Dilated cardiomyopathy 28 -4.09351347158049 7.37269524452999e-05 0.0033422885108536
GBM ENSG00000234854 LINC00676 path:05142_41 Chagas disease (American trypanosomiasis) 6 -4.12030457967563 0.000117638273344424 0.04999626617138
GBM ENSG00000233058 LINC00884 path:04115_1 p53 signaling pathway 65 -3.55713699876328 0.000527407092041986 0.0490488595599047
GBM ENSG00000233058 LINC00884 path:04664_96 Fc epsilon RI signaling pathway 2 -4.34638754340703 0.000180317079728335 0.0490488595599047
GBM ENSG00000233058 LINC00884 path:05150_6 Staphylococcus aureus infection 4 -3.96738278918914 0.000381795720153409 0.0490488595599047
GBM ENSG00000233058 LINC00884 path:05218_69 Melanoma 9 -3.61225779699334 0.000425723250615414 0.0490488595599047
GBM ENSG00000214145 LINC00887 path:04115_1 p53 signaling pathway 65 -3.55713699876328 0.000527407092041986 0.0490488595599047
GBM ENSG00000214145 LINC00887 path:04664_96 Fc epsilon RI signaling pathway 2 -4.34638754340703 0.000180317079728335 0.0490488595599047
GBM ENSG00000214145 LINC00887 path:05150_6 Staphylococcus aureus infection 4 -3.96738278918914 0.000381795720153409 0.0490488595599047
GBM ENSG00000214145 LINC00887 path:05218_69 Melanoma 9 -3.61225779699334 0.000425723250615414 0.0490488595599047
GBM ENSG00000237092 LINC01065 path:00130_1 Ubiquinone and other terpenoid-quinone biosynthesis 3 4.6108456376724 1.07392882086475e-05 0.00242724797895806
GBM ENSG00000237092 LINC01065 path:00230_207 Purine metabolism 6 3.41463478379983 0.000887473561489187 0.0113152879089871
GBM ENSG00000237092 LINC01065 path:00240_172 Pyrimidine metabolism 7 3.39885571027096 0.000981049808596226 0.0117725977031547
GBM ENSG00000237092 LINC01065 path:00983_2 Drug metabolism - other enzymes 16 3.11370905561217 0.0023490947276189 0.0252218591807503
GBM ENSG00000237092 LINC01065 path:04015_131 Rap1 signaling pathway 19 -3.97090690453368 0.000112313373362324 0.00364965573439232
GBM ENSG00000237092 LINC01065 path:04020_81 Calcium signaling pathway 51 -3.50635467280299 0.000623574051176207 0.0101767285151957
GBM ENSG00000237092 LINC01065 path:04020_92 Calcium signaling pathway 44 -4.24437764894791 4.16377132089798e-05 0.00242724797895806
GBM ENSG00000237092 LINC01065 path:04024_50 cAMP signaling pathway 80 -2.84811517197767 0.00508310088252344 0.0482303525597573
GBM ENSG00000237092 LINC01065 path:04024_60 cAMP signaling pathway 75 -4.43288892588071 1.86064675242161e-05 0.00242724797895806
GBM ENSG00000237092 LINC01065 path:04261_74 Adrenergic signaling in cardiomyocytes 44 -3.71606749391448 0.000290564197761845 0.00564524727080155
GBM ENSG00000237092 LINC01065 path:04270_30 Vascular smooth muscle contraction 67 -3.46738466417476 0.000700879762146277 0.0104796246981501
GBM ENSG00000237092 LINC01065 path:04710_8 Circadian rhythm 26 -3.22547297158013 0.00157941345056278 0.0184114482237033
GBM ENSG00000237092 LINC01065 path:04713_149 Circadian entrainment 11 -3.42209576122081 0.000825037163085292 0.0108585536302838
GBM ENSG00000237092 LINC01065 path:04713_22 Circadian entrainment 61 -3.18532630714474 0.00177343622807315 0.0200989439181624
GBM ENSG00000237092 LINC01065 path:04724_160 Glutamatergic synapse 8 -3.53267198479711 0.000559463527123407 0.00951087996109792
GBM ENSG00000237092 LINC01065 path:04724_34 Glutamatergic synapse 61 -3.90571351133649 0.000143622623317971 0.00364965573439232
GBM ENSG00000237092 LINC01065 path:04728_17 Dopaminergic synapse 93 -3.15506990688589 0.00194894531565256 0.0214910726698985
GBM ENSG00000237092 LINC01065 path:04728_187 Dopaminergic synapse 16 -2.9723064138605 0.00353583207045978 0.0351858410914046
GBM ENSG00000237092 LINC01065 path:04728_222 Dopaminergic synapse 5 -4.16469173165661 5.35422348299571e-05 0.00242724797895806
GBM ENSG00000237092 LINC01065 path:04730_41 Long-term depression 28 -3.43788836896864 0.00077174956569508 0.0104957940934531
GBM ENSG00000237092 LINC01065 path:04730_74 Long-term depression 5 -3.47803393984781 0.000673318331754186 0.0104796246981501
GBM ENSG00000237092 LINC01065 path:04740_16 Olfactory transduction 10 -3.36856054630436 0.000968275005437924 0.0117725977031547
GBM ENSG00000237092 LINC01065 path:04750_2 Inflammatory mediator regulation of TRP channels 78 -4.27053623503594 3.54045938893224e-05 0.00242724797895806
GBM ENSG00000237092 LINC01065 path:04911_33 Insulin secretion 26 -4.19206806637642 4.96667878136834e-05 0.00242724797895806
GBM ENSG00000237092 LINC01065 path:04912_45 GnRH signaling pathway 16 -3.93299641382354 0.000132990317813788 0.00364965573439232
GBM ENSG00000237092 LINC01065 path:04913_2 Ovarian steroidogenesis 26 -3.98590309630735 0.000109841725895438 0.00364965573439232
GBM ENSG00000237092 LINC01065 path:04915_56 Estrogen signaling pathway 38 -3.45589253721431 0.0007191899302652 0.0104796246981501
GBM ENSG00000237092 LINC01065 path:04918_15 Thyroid hormone synthesis 38 -4.22888352033549 4.37025568733996e-05 0.00242724797895806
GBM ENSG00000237092 LINC01065 path:04920_60 Adipocytokine signaling pathway 12 2.96110628685926 0.00367283952084006 0.0356790124881606
GBM ENSG00000237092 LINC01065 path:04921_179 Oxytocin signaling pathway 8 -3.59101882401895 0.00045793745610715 0.00812341226485728
GBM ENSG00000237092 LINC01065 path:04922_80 Glucagon signaling pathway 8 -3.02119857419934 0.00308018559878091 0.0314178931075652
GBM ENSG00000237092 LINC01065 path:04961_4 Endocrine and other factor-regulated calcium reabsorption 22 -3.69636123443259 0.000308756254564959 0.00572602508465925
GBM ENSG00000237092 LINC01065 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.7804961180379 0.000232490466189422 0.0049924268529097
GBM ENSG00000237092 LINC01065 path:04970_7 Salivary secretion 24 -4.18415032271932 5.14105154937893e-05 0.00242724797895806
GBM ENSG00000237092 LINC01065 path:04976_1 Bile secretion 15 -3.92487981763626 0.000137451060438846 0.00364965573439232
GBM ENSG00000237092 LINC01065 path:05030_1 Cocaine addiction 42 -3.7239515023001 0.000285100007179882 0.00564524727080155
GBM ENSG00000237092 LINC01065 path:05031_25 Amphetamine addiction 20 -4.47306590742821 1.62563464183883e-05 0.00242724797895806
GBM ENSG00000237092 LINC01065 path:05032_33 Morphine addiction 43 -3.88955527885881 0.000153265931999104 0.00364965573439232
GBM ENSG00000237092 LINC01065 path:05033_3 Nicotine addiction 10 -3.4420535881337 0.000762339342001579 0.0104957940934531
GBM ENSG00000237092 LINC01065 path:05034_52 Alcoholism 26 -3.03648476634464 0.00283594592246118 0.0296683573426708
GBM ENSG00000237092 LINC01065 path:05110_1 Vibrio cholerae infection 9 -3.88211079259662 0.000161014223576132 0.00364965573439232
GBM ENSG00000237092 LINC01065 path:05146_11 Amoebiasis 7 -3.94348353239864 0.000127841360627006 0.00364965573439232
GBM ENSG00000237092 LINC01065 path:05414_1 Dilated cardiomyopathy 28 -4.08831132771953 7.44958946681562e-05 0.00303943250246077
GBM ENSG00000229671 LINC01150 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000229671 LINC01150 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000229671 LINC01150 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000229671 LINC01150 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000229671 LINC01150 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000229671 LINC01150 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000229671 LINC01150 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000229671 LINC01150 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000229671 LINC01150 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000229671 LINC01150 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000229671 LINC01150 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000229671 LINC01150 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000229671 LINC01150 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000229671 LINC01150 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000232987 LINC01219 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000232987 LINC01219 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000232987 LINC01219 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000232987 LINC01219 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000232987 LINC01219 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000232987 LINC01219 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000232987 LINC01219 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000232987 LINC01219 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000232987 LINC01219 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000232987 LINC01219 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000232987 LINC01219 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000232987 LINC01219 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000232987 LINC01219 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000232987 LINC01219 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000234840 LINC01239 path:04110_140 Cell cycle 20 -4.07932623215989 0.000161762399343029 0.00756851525649634
GBM ENSG00000234840 LINC01239 path:04115_9 p53 signaling pathway 57 -3.76257175707536 0.000431544909445902 0.013377892192823
GBM ENSG00000234840 LINC01239 path:04151_230 PI3K-Akt signaling pathway 26 4.08997435052779 7.19214854110331e-05 0.00756851525649634
GBM ENSG00000234840 LINC01239 path:04151_99 PI3K-Akt signaling pathway 123 -4.45505554423199 3.90665706790668e-05 0.00756851525649634
GBM ENSG00000234840 LINC01239 path:04744_1 Phototransduction 10 -3.73641699588975 0.000306000855355397 0.010348392562928
GBM ENSG00000234840 LINC01239 path:05166_48 HTLV-I infection 10 -4.28988897922613 8.03721758581368e-05 0.00756851525649634
GBM ENSG00000234840 LINC01239 path:05200_104 Pathways in cancer 31 -3.99457556158343 0.000211906873582613 0.00788293569727321
GBM ENSG00000234840 LINC01239 path:05212_35 Pancreatic cancer 8 -4.11287287447386 0.000143196815880487 0.00756851525649634
GBM ENSG00000234840 LINC01239 path:05214_32 Glioma 11 -4.03277833564147 0.000188229223224787 0.00778014122662454
GBM ENSG00000234840 LINC01239 path:05218_69 Melanoma 9 -4.08157153308146 0.000160898901228234 0.00756851525649634
GBM ENSG00000234840 LINC01239 path:05219_6 Bladder cancer 10 -4.10481663529285 0.000149320439548518 0.00756851525649634
GBM ENSG00000234840 LINC01239 path:05220_3 Chronic myeloid leukemia 56 -4.07291067769425 0.00016276376895691 0.00756851525649634
GBM ENSG00000268654 MIMT1 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000268654 MIMT1 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000268654 MIMT1 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000268654 MIMT1 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000268654 MIMT1 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000268654 MIMT1 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000268654 MIMT1 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000268654 MIMT1 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000247095 MIR210HG path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000247095 MIR210HG path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000247095 MIR210HG path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000247095 MIR210HG path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000247095 MIR210HG path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000247095 MIR210HG path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000247095 MIR210HG path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000247095 MIR210HG path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000247095 MIR210HG path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000247095 MIR210HG path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000247095 MIR210HG path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000247095 MIR210HG path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000247095 MIR210HG path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000247095 MIR210HG path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000171889 MIR31HG path:00140_11 Steroid hormone biosynthesis 14 3.14071669001603 0.00225114974399958 0.0406473789135179
GBM ENSG00000171889 MIR31HG path:00591_28 Linoleic acid metabolism 4 3.89571011405465 0.000166332058874268 0.00520443511087201
GBM ENSG00000171889 MIR31HG path:04110_140 Cell cycle 20 -4.1459516545223 0.00014131025096483 0.00520443511087201
GBM ENSG00000171889 MIR31HG path:04110_203 Cell cycle 2 -3.28257941668256 0.00166877158521147 0.036516648805804
GBM ENSG00000171889 MIR31HG path:04115_9 p53 signaling pathway 57 -3.8885712201869 0.000310393709002626 0.00888203536530592
GBM ENSG00000171889 MIR31HG path:04150_1 mTOR signaling pathway 53 -3.72914538519121 0.000391489693462784 0.0104024404262968
GBM ENSG00000171889 MIR31HG path:04151_211 PI3K-Akt signaling pathway 34 -3.26577641462644 0.00198597946535607 0.0406473789135179
GBM ENSG00000171889 MIR31HG path:04151_230 PI3K-Akt signaling pathway 26 4.42695830716759 1.86310975506321e-05 0.00231025609627838
GBM ENSG00000171889 MIR31HG path:04151_99 PI3K-Akt signaling pathway 123 -4.96906619413743 7.37205024703271e-06 0.00231025609627838
GBM ENSG00000171889 MIR31HG path:04666_6 Fc gamma R-mediated phagocytosis 76 -3.3995353697801 0.00101695017343196 0.023644091532293
GBM ENSG00000171889 MIR31HG path:04727_2 GABAergic synapse 60 -3.19814377465965 0.00212025230013108 0.0406473789135179
GBM ENSG00000171889 MIR31HG path:04742_1 Taste transduction 14 -3.5679189931085 0.000651799117617769 0.0161646181169207
GBM ENSG00000171889 MIR31HG path:04744_1 Phototransduction 10 -4.59192846058146 1.66197643835836e-05 0.00231025609627838
GBM ENSG00000171889 MIR31HG path:04910_10 Insulin signaling pathway 118 -3.1326380970241 0.00249340510469444 0.0421612135884696
GBM ENSG00000171889 MIR31HG path:05166_48 HTLV-I infection 10 -4.44409133112409 5.32731310984601e-05 0.00495440119215679
GBM ENSG00000171889 MIR31HG path:05200_104 Pathways in cancer 31 -4.09114821054762 0.000167885003576517 0.00520443511087201
GBM ENSG00000171889 MIR31HG path:05200_149 Pathways in cancer 18 3.14177623257438 0.00229461009995665 0.0406473789135179
GBM ENSG00000171889 MIR31HG path:05212_35 Pancreatic cancer 8 -4.23317538939079 0.00010555754709268 0.00520443511087201
GBM ENSG00000171889 MIR31HG path:05214_32 Glioma 11 -4.13796757702808 0.000145261667941264 0.00520443511087201
GBM ENSG00000171889 MIR31HG path:05218_69 Melanoma 9 -4.16108545876883 0.000134935808771584 0.00520443511087201
GBM ENSG00000171889 MIR31HG path:05219_6 Bladder cancer 10 -4.23365472232635 0.000107026557339829 0.00520443511087201
GBM ENSG00000171889 MIR31HG path:05220_3 Chronic myeloid leukemia 56 -4.29575484435639 8.61872865421037e-05 0.00520443511087201
GBM ENSG00000226416 MRPL23-AS1 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000226416 MRPL23-AS1 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000226416 MRPL23-AS1 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000226416 MRPL23-AS1 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000226416 MRPL23-AS1 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000226416 MRPL23-AS1 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000226416 MRPL23-AS1 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000226416 MRPL23-AS1 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000226416 MRPL23-AS1 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000226416 MRPL23-AS1 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000226416 MRPL23-AS1 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000226416 MRPL23-AS1 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000226416 MRPL23-AS1 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000226416 MRPL23-AS1 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000253264 PCAT2 path:00053_1 Ascorbate and aldarate metabolism 6 3.58385049852884 0.000858893918589114 0.0463802716038122
GBM ENSG00000253264 PCAT2 path:00670_1 One carbon pool by folate 10 4.05212249129395 0.00017925885588583 0.0258132752475595
GBM ENSG00000253264 PCAT2 path:04512_43 ECM-receptor interaction 28 -3.85928843330729 0.000243182811650707 0.0262637436582764
GBM ENSG00000253264 PCAT2 path:04610_47 Complement and coagulation cascades 29 -3.6036257543904 0.00059727698030629 0.0377448473024779
GBM ENSG00000253264 PCAT2 path:04610_70 Complement and coagulation cascades 8 -3.73180073019134 0.000391283160470677 0.0338068650646665
GBM ENSG00000253264 PCAT2 path:04664_96 Fc epsilon RI signaling pathway 2 -3.57577626092919 0.000611606322030892 0.0377448473024779
GBM ENSG00000253264 PCAT2 path:04971_60 Gastric acid secretion 4 -4.28546372281204 4.98321157768993e-05 0.0180499164631945
GBM ENSG00000253264 PCAT2 path:05140_61 Leishmaniasis 11 -4.14810389782444 8.3564428070345e-05 0.0180499164631945
GBM ENSG00000233672 RNASEH2B-AS1 path:00130_1 Ubiquinone and other terpenoid-quinone biosynthesis 3 4.66904320126194 8.74990332042083e-06 0.00333060146390136
GBM ENSG00000233672 RNASEH2B-AS1 path:00230_207 Purine metabolism 6 3.32303779065877 0.00121197804884246 0.0149844558765977
GBM ENSG00000233672 RNASEH2B-AS1 path:00240_172 Pyrimidine metabolism 7 3.23567075871619 0.00167212125852549 0.0200654551023059
GBM ENSG00000233672 RNASEH2B-AS1 path:04015_131 Rap1 signaling pathway 19 -3.84402576254494 0.000180259445588132 0.00519021354163258
GBM ENSG00000233672 RNASEH2B-AS1 path:04020_81 Calcium signaling pathway 51 -3.63837535630175 0.000392447786989287 0.00752496275898343
GBM ENSG00000233672 RNASEH2B-AS1 path:04020_92 Calcium signaling pathway 44 -4.17821470257261 5.32969379037168e-05 0.00368578204236041
GBM ENSG00000233672 RNASEH2B-AS1 path:04024_50 cAMP signaling pathway 80 -2.8682066396555 0.00480527503758035 0.0478183467154337
GBM ENSG00000233672 RNASEH2B-AS1 path:04024_60 cAMP signaling pathway 75 -4.39039456655205 2.1931912406268e-05 0.00333060146390136
GBM ENSG00000233672 RNASEH2B-AS1 path:04261_74 Adrenergic signaling in cardiomyocytes 44 -3.61793288731592 0.000411026256771119 0.00752496275898343
GBM ENSG00000233672 RNASEH2B-AS1 path:04270_30 Vascular smooth muscle contraction 67 -3.375247827734 0.000954391726375847 0.0141654309060878
GBM ENSG00000233672 RNASEH2B-AS1 path:04710_8 Circadian rhythm 26 -2.90003714460712 0.00435520567390697 0.0444230978738511
GBM ENSG00000233672 RNASEH2B-AS1 path:04713_149 Circadian entrainment 11 -3.33719817589406 0.00110317877744353 0.0141654309060878
GBM ENSG00000233672 RNASEH2B-AS1 path:04713_22 Circadian entrainment 61 -3.08865826756917 0.00241075725730216 0.0265834854318725
GBM ENSG00000233672 RNASEH2B-AS1 path:04724_160 Glutamatergic synapse 8 -3.42576088131855 0.000804527555747911 0.0131298897098059
GBM ENSG00000233672 RNASEH2B-AS1 path:04724_34 Glutamatergic synapse 61 -3.94606038380664 0.000123890772728131 0.00459522138846159
GBM ENSG00000233672 RNASEH2B-AS1 path:04728_17 Dopaminergic synapse 93 -3.04558928647034 0.00275712454395103 0.0296028108929479
GBM ENSG00000233672 RNASEH2B-AS1 path:04728_187 Dopaminergic synapse 16 -3.10513757243874 0.00233937174076788 0.0265834854318725
GBM ENSG00000233672 RNASEH2B-AS1 path:04728_222 Dopaminergic synapse 5 -4.10336036706175 6.76976568678704e-05 0.00368578204236041
GBM ENSG00000233672 RNASEH2B-AS1 path:04730_41 Long-term depression 28 -3.33678891151825 0.00108182153963059 0.0141654309060878
GBM ENSG00000233672 RNASEH2B-AS1 path:04730_74 Long-term depression 5 -3.35653005708177 0.00102038203416214 0.0141654309060878
GBM ENSG00000233672 RNASEH2B-AS1 path:04740_16 Olfactory transduction 10 -3.32780652748026 0.00110840324555619 0.0141654309060878
GBM ENSG00000233672 RNASEH2B-AS1 path:04750_2 Inflammatory mediator regulation of TRP channels 78 -4.19437328594126 4.75917604947111e-05 0.00368578204236041
GBM ENSG00000233672 RNASEH2B-AS1 path:04911_33 Insulin secretion 26 -4.06266106818092 8.13040156403033e-05 0.00368578204236041
GBM ENSG00000233672 RNASEH2B-AS1 path:04912_45 GnRH signaling pathway 16 -3.80311160053567 0.000213787134535131 0.00519021354163258
GBM ENSG00000233672 RNASEH2B-AS1 path:04913_2 Ovarian steroidogenesis 26 -3.88298651772664 0.00016022274931912 0.00519021354163258
GBM ENSG00000233672 RNASEH2B-AS1 path:04915_56 Estrogen signaling pathway 38 -3.32758438539072 0.00111101418871277 0.0141654309060878
GBM ENSG00000233672 RNASEH2B-AS1 path:04918_15 Thyroid hormone synthesis 38 -4.09704437540432 7.22602301376338e-05 0.00368578204236041
GBM ENSG00000233672 RNASEH2B-AS1 path:04921_179 Oxytocin signaling pathway 8 -3.48725567862354 0.000653767873558468 0.011114053850494
GBM ENSG00000233672 RNASEH2B-AS1 path:04922_80 Glucagon signaling pathway 8 -3.10557757714572 0.00236386038179003 0.0265834854318725
GBM ENSG00000233672 RNASEH2B-AS1 path:04961_4 Endocrine and other factor-regulated calcium reabsorption 22 -3.66867437603695 0.000341017472291445 0.00695675643474547
GBM ENSG00000233672 RNASEH2B-AS1 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.68331523226427 0.000328424070041766 0.00695675643474547
GBM ENSG00000233672 RNASEH2B-AS1 path:04970_7 Salivary secretion 24 -4.08588165708245 7.45482440218378e-05 0.00368578204236041
GBM ENSG00000233672 RNASEH2B-AS1 path:04976_1 Bile secretion 15 -3.81702394368461 0.00020353215556748 0.00519021354163258
GBM ENSG00000233672 RNASEH2B-AS1 path:05030_1 Cocaine addiction 42 -3.61116196398534 0.000424201332001517 0.00752496275898343
GBM ENSG00000233672 RNASEH2B-AS1 path:05031_25 Amphetamine addiction 20 -4.36924383717567 2.44897166463335e-05 0.00333060146390136
GBM ENSG00000233672 RNASEH2B-AS1 path:05032_33 Morphine addiction 43 -3.79546086245724 0.000216258897568024 0.00519021354163258
GBM ENSG00000233672 RNASEH2B-AS1 path:05033_3 Nicotine addiction 10 -3.41045955187044 0.00085297418732325 0.0133851334010725
GBM ENSG00000233672 RNASEH2B-AS1 path:05034_52 Alcoholism 26 -2.93182267267155 0.00391324129814621 0.0409385243498373
GBM ENSG00000233672 RNASEH2B-AS1 path:05110_1 Vibrio cholerae infection 9 -3.77536166841525 0.000236804714106456 0.00536757351974634
GBM ENSG00000233672 RNASEH2B-AS1 path:05146_11 Amoebiasis 7 -3.83636473746288 0.000189112202756103 0.00519021354163258
GBM ENSG00000233672 RNASEH2B-AS1 path:05414_1 Dilated cardiomyopathy 28 -4.00031732046496 0.000103314019431679 0.00421521199281249
GBM ENSG00000250829 RP11-11N5.1 path:05204_24 Chemical carcinogenesis 10 -4.56076945414986 5.64423709574014e-05 0.0218996399314718
GBM ENSG00000272218 RP11-11N5.3 path:05204_24 Chemical carcinogenesis 10 -4.56076945414986 5.64423709574014e-05 0.0218996399314718
GBM ENSG00000265380 RP11-126K15.1 path:04921_200 Oxytocin signaling pathway 5 -4.62655513362527 2.19314030161469e-05 0.00813655051899052
GBM ENSG00000232874 RP11-135A1.2 path:04115_1 p53 signaling pathway 65 -3.55713699876328 0.000527407092041986 0.0490488595599047
GBM ENSG00000232874 RP11-135A1.2 path:04664_96 Fc epsilon RI signaling pathway 2 -4.34638754340703 0.000180317079728335 0.0490488595599047
GBM ENSG00000232874 RP11-135A1.2 path:05150_6 Staphylococcus aureus infection 4 -3.96738278918914 0.000381795720153409 0.0490488595599047
GBM ENSG00000232874 RP11-135A1.2 path:05218_69 Melanoma 9 -3.61225779699334 0.000425723250615414 0.0490488595599047
GBM ENSG00000250658 RP11-138B4.1 path:05204_24 Chemical carcinogenesis 10 -4.56076945414986 5.64423709574014e-05 0.0218996399314718
GBM ENSG00000250397 RP11-1391J7.1 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000250397 RP11-1391J7.1 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000250397 RP11-1391J7.1 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000250397 RP11-1391J7.1 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000250397 RP11-1391J7.1 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000250397 RP11-1391J7.1 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000250397 RP11-1391J7.1 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000250397 RP11-1391J7.1 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000250397 RP11-1391J7.1 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000250397 RP11-1391J7.1 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000250397 RP11-1391J7.1 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000250397 RP11-1391J7.1 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000250397 RP11-1391J7.1 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000250397 RP11-1391J7.1 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000266371 RP11-142O6.1 path:00052_2 Galactose metabolism 21 3.38182776169844 0.00318217739507864 0.0458967893520957
GBM ENSG00000266371 RP11-142O6.1 path:00130_1 Ubiquinone and other terpenoid-quinone biosynthesis 3 3.36975574890573 0.00298878446406707 0.0458967893520957
GBM ENSG00000266371 RP11-142O6.1 path:00240_87 Pyrimidine metabolism 30 4.87422538404833 8.88230730790986e-05 0.0205443396587595
GBM ENSG00000266371 RP11-142O6.1 path:00310_39 Lysine degradation 11 3.33890698720437 0.00282993755835972 0.0458967893520957
GBM ENSG00000266371 RP11-142O6.1 path:00500_10 Starch and sucrose metabolism 27 4.56191880952773 0.000181372495718315 0.0212182071339936
GBM ENSG00000266371 RP11-142O6.1 path:00510_51 N-Glycan biosynthesis 14 3.39835575689193 0.00257202976687377 0.0458967893520957
GBM ENSG00000266371 RP11-142O6.1 path:00520_1 Amino sugar and nucleotide sugar metabolism 30 3.84318052932186 0.00107075966491847 0.0284806949447942
GBM ENSG00000266371 RP11-142O6.1 path:00750_1 Vitamin B6 metabolism 3 -3.53940082885816 0.00122344061964872 0.0286743895230168
GBM ENSG00000266371 RP11-142O6.1 path:00900_12 Terpenoid backbone biosynthesis 8 4.25796418655133 0.000326980818194951 0.0212182071339936
GBM ENSG00000266371 RP11-142O6.1 path:00983_9 Drug metabolism - other enzymes 8 3.35631623364586 0.00313199624590221 0.0458967893520957
GBM ENSG00000266371 RP11-142O6.1 path:04064_70 NF-kappa B signaling pathway 4 4.03987030593409 0.000658253586365069 0.0274272327652112
GBM ENSG00000266371 RP11-142O6.1 path:04110_95 Cell cycle 41 -3.07434294143207 0.00256771575698337 0.0458967893520957
GBM ENSG00000266371 RP11-142O6.1 path:04510_351 Focal adhesion 3 -3.44092859700126 0.00110331792233344 0.0284806949447942
GBM ENSG00000266371 RP11-142O6.1 path:04664_89 Fc epsilon RI signaling pathway 4 -4.0182692980625 0.000339491314143898 0.0212182071339936
GBM ENSG00000266371 RP11-142O6.1 path:04713_60 Circadian entrainment 32 -3.79206744253799 0.000521554138928886 0.0244478502622915
GBM ENSG00000266371 RP11-142O6.1 path:04723_39 Retrograde endocannabinoid signaling 14 -4.07034826221189 0.000419084351200801 0.0224509473857572
GBM ENSG00000266371 RP11-142O6.1 path:04724_150 Glutamatergic synapse 10 -4.23679104196292 0.00025344591036977 0.0212182071339936
GBM ENSG00000266371 RP11-142O6.1 path:04730_74 Long-term depression 5 -4.53653496687439 0.000109569811513384 0.0205443396587595
GBM ENSG00000266371 RP11-142O6.1 path:04911_50 Insulin secretion 8 -3.32844180684611 0.00225584088141105 0.0458967893520957
GBM ENSG00000266371 RP11-142O6.1 path:04922_60 Glucagon signaling pathway 23 3.56524994800136 0.00173252789009646 0.0382175269874219
GBM ENSG00000266371 RP11-142O6.1 path:05166_49 HTLV-I infection 9 -3.33187432731649 0.00109603615498603 0.0284806949447942
GBM ENSG00000266371 RP11-142O6.1 path:05214_32 Glioma 11 -3.32111505875018 0.0011339279804623 0.0284806949447942
GBM ENSG00000266371 RP11-142O6.1 path:05215_92 Prostate cancer 7 -3.0313445923003 0.00291546658204911 0.0458967893520957
GBM ENSG00000266371 RP11-142O6.1 path:05218_69 Melanoma 9 -3.4500693141071 0.000734412539302404 0.0275404702238402
GBM ENSG00000266371 RP11-142O6.1 path:05219_6 Bladder cancer 10 -3.32017620168853 0.00113922779779177 0.0284806949447942
GBM ENSG00000266371 RP11-142O6.1 path:05220_3 Chronic myeloid leukemia 56 -3.0951781075863 0.00236503067045343 0.0458967893520957
GBM ENSG00000266446 RP11-149I2.4 path:00140_2 Steroid hormone biosynthesis 24 3.05058111025615 0.00300088976353606 0.0380435379699894
GBM ENSG00000266446 RP11-149I2.4 path:00260_31 Glycine, serine and threonine metabolism 14 3.36450285504011 0.00104055404144449 0.0170390724286536
GBM ENSG00000266446 RP11-149I2.4 path:00480_7 Glutathione metabolism 25 3.15444630354984 0.00204722436623678 0.028734256283252
GBM ENSG00000266446 RP11-149I2.4 path:00591_1 Linoleic acid metabolism 18 3.68287457837808 0.000331423428585955 0.00911192443593987
GBM ENSG00000266446 RP11-149I2.4 path:04012_56 ErbB signaling pathway 34 3.1779442601678 0.00181408128827827 0.0264049609738281
GBM ENSG00000266446 RP11-149I2.4 path:04020_152 Calcium signaling pathway 23 3.49603223363769 0.000625852864922681 0.0130777901626386
GBM ENSG00000266446 RP11-149I2.4 path:04060_29 Cytokine-cytokine receptor interaction 2 3.59135185481796 0.000449602401102268 0.0110433589770745
GBM ENSG00000266446 RP11-149I2.4 path:04110_140 Cell cycle 20 -4.31805241470827 9.31927913346398e-05 0.00469467735491192
GBM ENSG00000266446 RP11-149I2.4 path:04110_203 Cell cycle 2 -3.36028955652288 0.00138131496325455 0.0217142712223616
GBM ENSG00000266446 RP11-149I2.4 path:04115_9 p53 signaling pathway 57 -4.17569671062627 0.000141463610056714 0.00505410897748078
GBM ENSG00000266446 RP11-149I2.4 path:04150_1 mTOR signaling pathway 53 -3.59776280427604 0.000606238662880313 0.0130777901626386
GBM ENSG00000266446 RP11-149I2.4 path:04151_234 PI3K-Akt signaling pathway 25 3.66350861694259 0.000347322099825717 0.00911192443593987
GBM ENSG00000266446 RP11-149I2.4 path:04520_78 Adherens junction 4 3.44260303172663 0.000754358111127414 0.0130777901626386
GBM ENSG00000266446 RP11-149I2.4 path:04610_79 Complement and coagulation cascades 6 3.09984856119598 0.00255933368287093 0.0346833840471819
GBM ENSG00000266446 RP11-149I2.4 path:04611_230 Platelet activation 7 -3.51916858494372 0.000765366854302003 0.0130777901626386
GBM ENSG00000266446 RP11-149I2.4 path:04666_66 Fc gamma R-mediated phagocytosis 49 -3.58019409289774 0.000648155811008631 0.0130777901626386
GBM ENSG00000266446 RP11-149I2.4 path:04915_101 Estrogen signaling pathway 12 3.67596098492813 0.00033312201698324 0.00911192443593987
GBM ENSG00000266446 RP11-149I2.4 path:05120_4 Epithelial cell signaling in Helicobacter pylori infection 23 3.66394305709461 0.000347783375417552 0.00911192443593987
GBM ENSG00000266446 RP11-149I2.4 path:05160_47 Hepatitis C 3 3.47669297956896 0.000670462190580686 0.0130777901626386
GBM ENSG00000266446 RP11-149I2.4 path:05161_85 Hepatitis B 6 -4.18227055419132 0.000141034620600966 0.00505410897748078
GBM ENSG00000266446 RP11-149I2.4 path:05166_48 HTLV-I infection 10 -4.59585884704093 3.81357003927059e-05 0.00469467735491192
GBM ENSG00000266446 RP11-149I2.4 path:05200_104 Pathways in cancer 31 -4.27180305721349 0.000107511695150655 0.00469467735491192
GBM ENSG00000266446 RP11-149I2.4 path:05205_198 Proteoglycans in cancer 11 -3.56919207307033 0.000727995091364824 0.0130777901626386
GBM ENSG00000266446 RP11-149I2.4 path:05212_35 Pancreatic cancer 8 -4.35884491925902 8.09737100062618e-05 0.00469467735491192
GBM ENSG00000266446 RP11-149I2.4 path:05214_32 Glioma 11 -4.27369822707094 0.000107299376217703 0.00469467735491192
GBM ENSG00000266446 RP11-149I2.4 path:05218_69 Melanoma 9 -4.30953165837654 9.59242807615076e-05 0.00469467735491192
GBM ENSG00000266446 RP11-149I2.4 path:05219_6 Bladder cancer 10 -4.36175762326708 8.14389395314573e-05 0.00469467735491192
GBM ENSG00000266446 RP11-149I2.4 path:05220_3 Chronic myeloid leukemia 56 -4.43668078895005 6.30992468273105e-05 0.00469467735491192
GBM ENSG00000266446 RP11-149I2.4 path:05222_77 Small cell lung cancer 2 -4.40400526140395 7.02360697699352e-05 0.00469467735491192
GBM ENSG00000266446 RP11-149I2.4 path:05223_4 Non-small cell lung cancer 44 -3.31423234592507 0.00173638133936342 0.0262460717834547
GBM ENSG00000266446 RP11-149I2.4 path:05231_97 Choline metabolism in cancer 5 3.04533194736604 0.00276076806342289 0.0361660616308398
GBM ENSG00000240758 RP11-155G14.6 path:00500_54 Starch and sucrose metabolism 6 5.19357338292211 8.1797868455541e-06 0.00327191473822164
GBM ENSG00000240758 RP11-155G14.6 path:00760_8 Nicotinate and nicotinamide metabolism 18 4.42662249824312 6.66675112698963e-05 0.0133335022539793
GBM ENSG00000240758 RP11-155G14.6 path:00983_9 Drug metabolism - other enzymes 8 4.12689145507489 0.000327503982489293 0.0327503982489293
GBM ENSG00000240758 RP11-155G14.6 path:05160_31 Hepatitis C 17 4.1525800603309 0.000306676841549251 0.0327503982489293
GBM ENSG00000273270 RP11-212P7.2 path:00500_54 Starch and sucrose metabolism 6 5.19357338292211 8.1797868455541e-06 0.00327191473822164
GBM ENSG00000273270 RP11-212P7.2 path:00760_8 Nicotinate and nicotinamide metabolism 18 4.42662249824312 6.66675112698963e-05 0.0133335022539793
GBM ENSG00000273270 RP11-212P7.2 path:00983_9 Drug metabolism - other enzymes 8 4.12689145507489 0.000327503982489293 0.0327503982489293
GBM ENSG00000273270 RP11-212P7.2 path:05160_31 Hepatitis C 17 4.1525800603309 0.000306676841549251 0.0327503982489293
GBM ENSG00000273184 RP11-212P7.3 path:00500_54 Starch and sucrose metabolism 6 5.19357338292211 8.1797868455541e-06 0.00327191473822164
GBM ENSG00000273184 RP11-212P7.3 path:00760_8 Nicotinate and nicotinamide metabolism 18 4.42662249824312 6.66675112698963e-05 0.0133335022539793
GBM ENSG00000273184 RP11-212P7.3 path:00983_9 Drug metabolism - other enzymes 8 4.12689145507489 0.000327503982489293 0.0327503982489293
GBM ENSG00000273184 RP11-212P7.3 path:05160_31 Hepatitis C 17 4.1525800603309 0.000306676841549251 0.0327503982489293
GBM ENSG00000249742 RP11-217E13.1 path:05204_24 Chemical carcinogenesis 10 -4.56076945414986 5.64423709574014e-05 0.0218996399314718
GBM ENSG00000217576 RP11-248G5.8 path:00130_1 Ubiquinone and other terpenoid-quinone biosynthesis 3 4.6108456376724 1.07392882086475e-05 0.00242724797895806
GBM ENSG00000217576 RP11-248G5.8 path:00230_207 Purine metabolism 6 3.41463478379983 0.000887473561489187 0.0113152879089871
GBM ENSG00000217576 RP11-248G5.8 path:00240_172 Pyrimidine metabolism 7 3.39885571027096 0.000981049808596226 0.0117725977031547
GBM ENSG00000217576 RP11-248G5.8 path:00983_2 Drug metabolism - other enzymes 16 3.11370905561217 0.0023490947276189 0.0252218591807503
GBM ENSG00000217576 RP11-248G5.8 path:04015_131 Rap1 signaling pathway 19 -3.97090690453368 0.000112313373362324 0.00364965573439232
GBM ENSG00000217576 RP11-248G5.8 path:04020_81 Calcium signaling pathway 51 -3.50635467280299 0.000623574051176207 0.0101767285151957
GBM ENSG00000217576 RP11-248G5.8 path:04020_92 Calcium signaling pathway 44 -4.24437764894791 4.16377132089798e-05 0.00242724797895806
GBM ENSG00000217576 RP11-248G5.8 path:04024_50 cAMP signaling pathway 80 -2.84811517197767 0.00508310088252344 0.0482303525597573
GBM ENSG00000217576 RP11-248G5.8 path:04024_60 cAMP signaling pathway 75 -4.43288892588071 1.86064675242161e-05 0.00242724797895806
GBM ENSG00000217576 RP11-248G5.8 path:04261_74 Adrenergic signaling in cardiomyocytes 44 -3.71606749391448 0.000290564197761845 0.00564524727080155
GBM ENSG00000217576 RP11-248G5.8 path:04270_30 Vascular smooth muscle contraction 67 -3.46738466417476 0.000700879762146277 0.0104796246981501
GBM ENSG00000217576 RP11-248G5.8 path:04710_8 Circadian rhythm 26 -3.22547297158013 0.00157941345056278 0.0184114482237033
GBM ENSG00000217576 RP11-248G5.8 path:04713_149 Circadian entrainment 11 -3.42209576122081 0.000825037163085292 0.0108585536302838
GBM ENSG00000217576 RP11-248G5.8 path:04713_22 Circadian entrainment 61 -3.18532630714474 0.00177343622807315 0.0200989439181624
GBM ENSG00000217576 RP11-248G5.8 path:04724_160 Glutamatergic synapse 8 -3.53267198479711 0.000559463527123407 0.00951087996109792
GBM ENSG00000217576 RP11-248G5.8 path:04724_34 Glutamatergic synapse 61 -3.90571351133649 0.000143622623317971 0.00364965573439232
GBM ENSG00000217576 RP11-248G5.8 path:04728_17 Dopaminergic synapse 93 -3.15506990688589 0.00194894531565256 0.0214910726698985
GBM ENSG00000217576 RP11-248G5.8 path:04728_187 Dopaminergic synapse 16 -2.9723064138605 0.00353583207045978 0.0351858410914046
GBM ENSG00000217576 RP11-248G5.8 path:04728_222 Dopaminergic synapse 5 -4.16469173165661 5.35422348299571e-05 0.00242724797895806
GBM ENSG00000217576 RP11-248G5.8 path:04730_41 Long-term depression 28 -3.43788836896864 0.00077174956569508 0.0104957940934531
GBM ENSG00000217576 RP11-248G5.8 path:04730_74 Long-term depression 5 -3.47803393984781 0.000673318331754186 0.0104796246981501
GBM ENSG00000217576 RP11-248G5.8 path:04740_16 Olfactory transduction 10 -3.36856054630436 0.000968275005437924 0.0117725977031547
GBM ENSG00000217576 RP11-248G5.8 path:04750_2 Inflammatory mediator regulation of TRP channels 78 -4.27053623503594 3.54045938893224e-05 0.00242724797895806
GBM ENSG00000217576 RP11-248G5.8 path:04911_33 Insulin secretion 26 -4.19206806637642 4.96667878136834e-05 0.00242724797895806
GBM ENSG00000217576 RP11-248G5.8 path:04912_45 GnRH signaling pathway 16 -3.93299641382354 0.000132990317813788 0.00364965573439232
GBM ENSG00000217576 RP11-248G5.8 path:04913_2 Ovarian steroidogenesis 26 -3.98590309630735 0.000109841725895438 0.00364965573439232
GBM ENSG00000217576 RP11-248G5.8 path:04915_56 Estrogen signaling pathway 38 -3.45589253721431 0.0007191899302652 0.0104796246981501
GBM ENSG00000217576 RP11-248G5.8 path:04918_15 Thyroid hormone synthesis 38 -4.22888352033549 4.37025568733996e-05 0.00242724797895806
GBM ENSG00000217576 RP11-248G5.8 path:04920_60 Adipocytokine signaling pathway 12 2.96110628685926 0.00367283952084006 0.0356790124881606
GBM ENSG00000217576 RP11-248G5.8 path:04921_179 Oxytocin signaling pathway 8 -3.59101882401895 0.00045793745610715 0.00812341226485728
GBM ENSG00000217576 RP11-248G5.8 path:04922_80 Glucagon signaling pathway 8 -3.02119857419934 0.00308018559878091 0.0314178931075652
GBM ENSG00000217576 RP11-248G5.8 path:04961_4 Endocrine and other factor-regulated calcium reabsorption 22 -3.69636123443259 0.000308756254564959 0.00572602508465925
GBM ENSG00000217576 RP11-248G5.8 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.7804961180379 0.000232490466189422 0.0049924268529097
GBM ENSG00000217576 RP11-248G5.8 path:04970_7 Salivary secretion 24 -4.18415032271932 5.14105154937893e-05 0.00242724797895806
GBM ENSG00000217576 RP11-248G5.8 path:04976_1 Bile secretion 15 -3.92487981763626 0.000137451060438846 0.00364965573439232
GBM ENSG00000217576 RP11-248G5.8 path:05030_1 Cocaine addiction 42 -3.7239515023001 0.000285100007179882 0.00564524727080155
GBM ENSG00000217576 RP11-248G5.8 path:05031_25 Amphetamine addiction 20 -4.47306590742821 1.62563464183883e-05 0.00242724797895806
GBM ENSG00000217576 RP11-248G5.8 path:05032_33 Morphine addiction 43 -3.88955527885881 0.000153265931999104 0.00364965573439232
GBM ENSG00000217576 RP11-248G5.8 path:05033_3 Nicotine addiction 10 -3.4420535881337 0.000762339342001579 0.0104957940934531
GBM ENSG00000217576 RP11-248G5.8 path:05034_52 Alcoholism 26 -3.03648476634464 0.00283594592246118 0.0296683573426708
GBM ENSG00000217576 RP11-248G5.8 path:05110_1 Vibrio cholerae infection 9 -3.88211079259662 0.000161014223576132 0.00364965573439232
GBM ENSG00000217576 RP11-248G5.8 path:05146_11 Amoebiasis 7 -3.94348353239864 0.000127841360627006 0.00364965573439232
GBM ENSG00000217576 RP11-248G5.8 path:05414_1 Dilated cardiomyopathy 28 -4.08831132771953 7.44958946681562e-05 0.00303943250246077
GBM ENSG00000263655 RP11-25L3.3 path:04921_200 Oxytocin signaling pathway 5 -4.62655513362527 2.19314030161469e-05 0.00813655051899052
GBM ENSG00000271553 RP11-274B21.10 path:00500_54 Starch and sucrose metabolism 6 5.19357338292211 8.1797868455541e-06 0.00327191473822164
GBM ENSG00000271553 RP11-274B21.10 path:00760_8 Nicotinate and nicotinamide metabolism 18 4.42662249824312 6.66675112698963e-05 0.0133335022539793
GBM ENSG00000271553 RP11-274B21.10 path:00983_9 Drug metabolism - other enzymes 8 4.12689145507489 0.000327503982489293 0.0327503982489293
GBM ENSG00000271553 RP11-274B21.10 path:05160_31 Hepatitis C 17 4.1525800603309 0.000306676841549251 0.0327503982489293
GBM ENSG00000271344 RP11-274B21.9 path:00500_54 Starch and sucrose metabolism 6 5.19357338292211 8.1797868455541e-06 0.00327191473822164
GBM ENSG00000271344 RP11-274B21.9 path:00760_8 Nicotinate and nicotinamide metabolism 18 4.42662249824312 6.66675112698963e-05 0.0133335022539793
GBM ENSG00000271344 RP11-274B21.9 path:00983_9 Drug metabolism - other enzymes 8 4.12689145507489 0.000327503982489293 0.0327503982489293
GBM ENSG00000271344 RP11-274B21.9 path:05160_31 Hepatitis C 17 4.1525800603309 0.000306676841549251 0.0327503982489293
GBM ENSG00000249747 RP11-308K2.1 path:05204_24 Chemical carcinogenesis 10 -4.56076945414986 5.64423709574014e-05 0.0218996399314718
GBM ENSG00000233906 RP11-315I14.2 path:04062_164 Chemokine signaling pathway 28 -3.47501076534402 0.000803509822553855 0.0295691614699818
GBM ENSG00000233906 RP11-315I14.2 path:04070_38 Phosphatidylinositol signaling system 21 -3.80688338453736 0.000307247963146341 0.018032605107238
GBM ENSG00000233906 RP11-315I14.2 path:04110_107 Cell cycle 34 -4.13696605534562 0.000113725564960005 0.018032605107238
GBM ENSG00000233906 RP11-315I14.2 path:04115_1 p53 signaling pathway 65 -3.7238502988726 0.000430900023942606 0.018032605107238
GBM ENSG00000233906 RP11-315I14.2 path:04150_2 mTOR signaling pathway 52 -3.66779800964996 0.000406690771607083 0.018032605107238
GBM ENSG00000233906 RP11-315I14.2 path:04151_99 PI3K-Akt signaling pathway 123 -4.67807162239014 1.37563966065101e-05 0.0050623539511957
GBM ENSG00000233906 RP11-315I14.2 path:04210_54 Apoptosis 25 3.64012693164944 0.000441014798818321 0.018032605107238
GBM ENSG00000233906 RP11-315I14.2 path:04530_1 Tight junction 101 -3.69708409336393 0.000353546422905013 0.018032605107238
GBM ENSG00000233906 RP11-315I14.2 path:04713_114 Circadian entrainment 16 -3.85724454860511 0.000227168869373088 0.018032605107238
GBM ENSG00000233906 RP11-315I14.2 path:05222_51 Small cell lung cancer 11 -3.9604162692913 0.000202606779389765 0.018032605107238
GBM ENSG00000231856 RP11-327P2.5 path:00130_1 Ubiquinone and other terpenoid-quinone biosynthesis 3 4.6108456376724 1.07392882086475e-05 0.00242724797895806
GBM ENSG00000231856 RP11-327P2.5 path:00230_207 Purine metabolism 6 3.41463478379983 0.000887473561489187 0.0113152879089871
GBM ENSG00000231856 RP11-327P2.5 path:00240_172 Pyrimidine metabolism 7 3.39885571027096 0.000981049808596226 0.0117725977031547
GBM ENSG00000231856 RP11-327P2.5 path:00983_2 Drug metabolism - other enzymes 16 3.11370905561217 0.0023490947276189 0.0252218591807503
GBM ENSG00000231856 RP11-327P2.5 path:04015_131 Rap1 signaling pathway 19 -3.97090690453368 0.000112313373362324 0.00364965573439232
GBM ENSG00000231856 RP11-327P2.5 path:04020_81 Calcium signaling pathway 51 -3.50635467280299 0.000623574051176207 0.0101767285151957
GBM ENSG00000231856 RP11-327P2.5 path:04020_92 Calcium signaling pathway 44 -4.24437764894791 4.16377132089798e-05 0.00242724797895806
GBM ENSG00000231856 RP11-327P2.5 path:04024_50 cAMP signaling pathway 80 -2.84811517197767 0.00508310088252344 0.0482303525597573
GBM ENSG00000231856 RP11-327P2.5 path:04024_60 cAMP signaling pathway 75 -4.43288892588071 1.86064675242161e-05 0.00242724797895806
GBM ENSG00000231856 RP11-327P2.5 path:04261_74 Adrenergic signaling in cardiomyocytes 44 -3.71606749391448 0.000290564197761845 0.00564524727080155
GBM ENSG00000231856 RP11-327P2.5 path:04270_30 Vascular smooth muscle contraction 67 -3.46738466417476 0.000700879762146277 0.0104796246981501
GBM ENSG00000231856 RP11-327P2.5 path:04710_8 Circadian rhythm 26 -3.22547297158013 0.00157941345056278 0.0184114482237033
GBM ENSG00000231856 RP11-327P2.5 path:04713_149 Circadian entrainment 11 -3.42209576122081 0.000825037163085292 0.0108585536302838
GBM ENSG00000231856 RP11-327P2.5 path:04713_22 Circadian entrainment 61 -3.18532630714474 0.00177343622807315 0.0200989439181624
GBM ENSG00000231856 RP11-327P2.5 path:04724_160 Glutamatergic synapse 8 -3.53267198479711 0.000559463527123407 0.00951087996109792
GBM ENSG00000231856 RP11-327P2.5 path:04724_34 Glutamatergic synapse 61 -3.90571351133649 0.000143622623317971 0.00364965573439232
GBM ENSG00000231856 RP11-327P2.5 path:04728_17 Dopaminergic synapse 93 -3.15506990688589 0.00194894531565256 0.0214910726698985
GBM ENSG00000231856 RP11-327P2.5 path:04728_187 Dopaminergic synapse 16 -2.9723064138605 0.00353583207045978 0.0351858410914046
GBM ENSG00000231856 RP11-327P2.5 path:04728_222 Dopaminergic synapse 5 -4.16469173165661 5.35422348299571e-05 0.00242724797895806
GBM ENSG00000231856 RP11-327P2.5 path:04730_41 Long-term depression 28 -3.43788836896864 0.00077174956569508 0.0104957940934531
GBM ENSG00000231856 RP11-327P2.5 path:04730_74 Long-term depression 5 -3.47803393984781 0.000673318331754186 0.0104796246981501
GBM ENSG00000231856 RP11-327P2.5 path:04740_16 Olfactory transduction 10 -3.36856054630436 0.000968275005437924 0.0117725977031547
GBM ENSG00000231856 RP11-327P2.5 path:04750_2 Inflammatory mediator regulation of TRP channels 78 -4.27053623503594 3.54045938893224e-05 0.00242724797895806
GBM ENSG00000231856 RP11-327P2.5 path:04911_33 Insulin secretion 26 -4.19206806637642 4.96667878136834e-05 0.00242724797895806
GBM ENSG00000231856 RP11-327P2.5 path:04912_45 GnRH signaling pathway 16 -3.93299641382354 0.000132990317813788 0.00364965573439232
GBM ENSG00000231856 RP11-327P2.5 path:04913_2 Ovarian steroidogenesis 26 -3.98590309630735 0.000109841725895438 0.00364965573439232
GBM ENSG00000231856 RP11-327P2.5 path:04915_56 Estrogen signaling pathway 38 -3.45589253721431 0.0007191899302652 0.0104796246981501
GBM ENSG00000231856 RP11-327P2.5 path:04918_15 Thyroid hormone synthesis 38 -4.22888352033549 4.37025568733996e-05 0.00242724797895806
GBM ENSG00000231856 RP11-327P2.5 path:04920_60 Adipocytokine signaling pathway 12 2.96110628685926 0.00367283952084006 0.0356790124881606
GBM ENSG00000231856 RP11-327P2.5 path:04921_179 Oxytocin signaling pathway 8 -3.59101882401895 0.00045793745610715 0.00812341226485728
GBM ENSG00000231856 RP11-327P2.5 path:04922_80 Glucagon signaling pathway 8 -3.02119857419934 0.00308018559878091 0.0314178931075652
GBM ENSG00000231856 RP11-327P2.5 path:04961_4 Endocrine and other factor-regulated calcium reabsorption 22 -3.69636123443259 0.000308756254564959 0.00572602508465925
GBM ENSG00000231856 RP11-327P2.5 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.7804961180379 0.000232490466189422 0.0049924268529097
GBM ENSG00000231856 RP11-327P2.5 path:04970_7 Salivary secretion 24 -4.18415032271932 5.14105154937893e-05 0.00242724797895806
GBM ENSG00000231856 RP11-327P2.5 path:04976_1 Bile secretion 15 -3.92487981763626 0.000137451060438846 0.00364965573439232
GBM ENSG00000231856 RP11-327P2.5 path:05030_1 Cocaine addiction 42 -3.7239515023001 0.000285100007179882 0.00564524727080155
GBM ENSG00000231856 RP11-327P2.5 path:05031_25 Amphetamine addiction 20 -4.47306590742821 1.62563464183883e-05 0.00242724797895806
GBM ENSG00000231856 RP11-327P2.5 path:05032_33 Morphine addiction 43 -3.88955527885881 0.000153265931999104 0.00364965573439232
GBM ENSG00000231856 RP11-327P2.5 path:05033_3 Nicotine addiction 10 -3.4420535881337 0.000762339342001579 0.0104957940934531
GBM ENSG00000231856 RP11-327P2.5 path:05034_52 Alcoholism 26 -3.03648476634464 0.00283594592246118 0.0296683573426708
GBM ENSG00000231856 RP11-327P2.5 path:05110_1 Vibrio cholerae infection 9 -3.88211079259662 0.000161014223576132 0.00364965573439232
GBM ENSG00000231856 RP11-327P2.5 path:05146_11 Amoebiasis 7 -3.94348353239864 0.000127841360627006 0.00364965573439232
GBM ENSG00000231856 RP11-327P2.5 path:05414_1 Dilated cardiomyopathy 28 -4.08831132771953 7.44958946681562e-05 0.00303943250246077
GBM ENSG00000235872 RP11-335O4.3 path:04724_104 Glutamatergic synapse 19 -4.06887630738975 0.000319011934724748 0.0421095753836667
GBM ENSG00000235872 RP11-335O4.3 path:04971_34 Gastric acid secretion 14 -4.22486223464691 0.000197217749940545 0.0421095753836667
GBM ENSG00000235872 RP11-335O4.3 path:04972_6 Pancreatic secretion 12 -4.15294195752858 0.000244630308601739 0.0421095753836667
GBM ENSG00000261696 RP11-354P17.15 path:00524_1 Butirosin and neomycin biosynthesis 4 -3.29339675427082 0.00157611376474703 0.0390876213657263
GBM ENSG00000261696 RP11-354P17.15 path:04110_140 Cell cycle 20 -4.05839452735752 0.00017729892027825 0.00659551983435091
GBM ENSG00000261696 RP11-354P17.15 path:04115_9 p53 signaling pathway 57 -3.80181558492254 0.000389387769531827 0.0120710208554866
GBM ENSG00000261696 RP11-354P17.15 path:04150_1 mTOR signaling pathway 53 -3.6900198110978 0.000424814958777309 0.0121562434357815
GBM ENSG00000261696 RP11-354P17.15 path:04151_230 PI3K-Akt signaling pathway 26 4.35668250054109 2.4941695704814e-05 0.00430295354470572
GBM ENSG00000261696 RP11-354P17.15 path:04151_99 PI3K-Akt signaling pathway 123 -4.70718075430197 1.69019106410052e-05 0.00430295354470572
GBM ENSG00000261696 RP11-354P17.15 path:04742_1 Taste transduction 14 -3.4165093153893 0.00101981211162941 0.0270978646804385
GBM ENSG00000261696 RP11-354P17.15 path:04744_1 Phototransduction 10 -4.37517162878063 3.47012382637558e-05 0.00430295354470572
GBM ENSG00000261696 RP11-354P17.15 path:05166_48 HTLV-I infection 10 -4.34855955382649 6.8255765261415e-05 0.00634778616931159
GBM ENSG00000261696 RP11-354P17.15 path:05200_104 Pathways in cancer 31 -4.00750737723097 0.000208160770553209 0.00703961878598124
GBM ENSG00000261696 RP11-354P17.15 path:05212_35 Pancreatic cancer 8 -4.15713012095855 0.00012740739425762 0.00659551983435091
GBM ENSG00000261696 RP11-354P17.15 path:05214_32 Glioma 11 -4.06287003122484 0.000175137377584521 0.00659551983435091
GBM ENSG00000261696 RP11-354P17.15 path:05218_69 Melanoma 9 -4.09510977544684 0.000157920210777197 0.00659551983435091
GBM ENSG00000261696 RP11-354P17.15 path:05219_6 Bladder cancer 10 -4.15832217644668 0.000128912037907841 0.00659551983435091
GBM ENSG00000261696 RP11-354P17.15 path:05220_3 Chronic myeloid leukemia 56 -4.22194947503806 0.00010313438358418 0.00659551983435091
GBM ENSG00000224549 RP11-370B11.3 path:00524_1 Butirosin and neomycin biosynthesis 4 -3.24816774759613 0.00174320579804741 0.0498825043748951
GBM ENSG00000224549 RP11-370B11.3 path:04110_140 Cell cycle 20 -3.99639912446481 0.000201972174228901 0.00936381118508589
GBM ENSG00000224549 RP11-370B11.3 path:04115_9 p53 signaling pathway 57 -3.67428206955959 0.000548633649193183 0.0170076431249887
GBM ENSG00000224549 RP11-370B11.3 path:04151_230 PI3K-Akt signaling pathway 26 3.98090357185092 0.000109972042098789 0.00936381118508589
GBM ENSG00000224549 RP11-370B11.3 path:04151_99 PI3K-Akt signaling pathway 123 -4.21728312444711 8.34837948040601e-05 0.00936381118508589
GBM ENSG00000224549 RP11-370B11.3 path:04744_1 Phototransduction 10 -3.70136754973092 0.000337260054847278 0.0114055218548352
GBM ENSG00000224549 RP11-370B11.3 path:05166_48 HTLV-I infection 10 -4.19472632223368 0.000104276704681982 0.00936381118508589
GBM ENSG00000224549 RP11-370B11.3 path:05200_104 Pathways in cancer 31 -3.90999496652407 0.000266128301157576 0.00989997280306182
GBM ENSG00000224549 RP11-370B11.3 path:05212_35 Pancreatic cancer 8 -4.03350110838425 0.000176669652411867 0.00936381118508589
GBM ENSG00000224549 RP11-370B11.3 path:05214_32 Glioma 11 -3.96133166505509 0.000226543818994013 0.00936381118508589
GBM ENSG00000224549 RP11-370B11.3 path:05218_69 Melanoma 9 -4.01514585797103 0.000190419063656771 0.00936381118508589
GBM ENSG00000224549 RP11-370B11.3 path:05219_6 Bladder cancer 10 -4.04103955808982 0.000175146126088314 0.00936381118508589
GBM ENSG00000224549 RP11-370B11.3 path:05220_3 Chronic myeloid leukemia 56 -3.9731248018721 0.0002146821267907 0.00936381118508589
GBM ENSG00000259287 RP11-3D4.2 path:04261_162 Adrenergic signaling in cardiomyocytes 3 -4.05148049194444 0.000125392785696786 0.049780935921624
GBM ENSG00000236921 RP11-408N14.1 path:00591_1 Linoleic acid metabolism 18 3.26962796893257 0.00134974611166654 0.0332037543469969
GBM ENSG00000236921 RP11-408N14.1 path:04110_140 Cell cycle 20 -4.13275274261187 0.000147395613330264 0.00545685017012752
GBM ENSG00000236921 RP11-408N14.1 path:04115_9 p53 signaling pathway 57 -3.98292539741087 0.00023063702276301 0.00654654318458082
GBM ENSG00000236921 RP11-408N14.1 path:04151_230 PI3K-Akt signaling pathway 26 4.10758075623611 6.65217843645621e-05 0.00545685017012752
GBM ENSG00000236921 RP11-408N14.1 path:04151_99 PI3K-Akt signaling pathway 123 -4.44215032152215 4.58186319850952e-05 0.00545685017012752
GBM ENSG00000236921 RP11-408N14.1 path:04744_1 Phototransduction 10 -3.45299026655864 0.000835646222139166 0.0220252468549537
GBM ENSG00000236921 RP11-408N14.1 path:05161_85 Hepatitis B 6 -4.02029221176994 0.000208277303488195 0.00640452708226199
GBM ENSG00000236921 RP11-408N14.1 path:05166_48 HTLV-I infection 10 -4.3724730486205 6.73068679485793e-05 0.00545685017012752
GBM ENSG00000236921 RP11-408N14.1 path:05200_104 Pathways in cancer 31 -4.10101931958443 0.000162670330274804 0.00545685017012752
GBM ENSG00000236921 RP11-408N14.1 path:05212_35 Pancreatic cancer 8 -4.17406375776071 0.000127590378975265 0.00545685017012752
GBM ENSG00000236921 RP11-408N14.1 path:05214_32 Glioma 11 -4.10297960405213 0.000162314310993175 0.00545685017012752
GBM ENSG00000236921 RP11-408N14.1 path:05218_69 Melanoma 9 -4.15082400254782 0.000139413893909881 0.00545685017012752
GBM ENSG00000236921 RP11-408N14.1 path:05219_6 Bladder cancer 10 -4.20507413777542 0.000117275753089821 0.00545685017012752
GBM ENSG00000236921 RP11-408N14.1 path:05220_3 Chronic myeloid leukemia 56 -4.14719163698686 0.000138883385075258 0.00545685017012752
GBM ENSG00000236921 RP11-408N14.1 path:05222_77 Small cell lung cancer 2 -4.27024978801879 9.36324517714322e-05 0.00545685017012752
GBM ENSG00000250704 RP11-423J7.1 path:00270_62 Cysteine and methionine metabolism 6 -4.32313180369843 0.000156503276624547 0.0316136618781584
GBM ENSG00000250704 RP11-423J7.1 path:05204_22 Chemical carcinogenesis 11 -5.50601689242852 4.29991934232734e-06 0.00173716741430025
GBM ENSG00000255970 RP11-43N5.1 path:04724_104 Glutamatergic synapse 19 -4.06887630738975 0.000319011934724748 0.0421095753836667
GBM ENSG00000255970 RP11-43N5.1 path:04971_34 Gastric acid secretion 14 -4.22486223464691 0.000197217749940545 0.0421095753836667
GBM ENSG00000255970 RP11-43N5.1 path:04972_6 Pancreatic secretion 12 -4.15294195752858 0.000244630308601739 0.0421095753836667
GBM ENSG00000233021 RP11-490E15.2 path:00760_1 Nicotinate and nicotinamide metabolism 20 4.48908299746777 5.03507125654741e-05 0.0198885314633623
GBM ENSG00000254815 RP11-496I9.1 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000254815 RP11-496I9.1 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000254815 RP11-496I9.1 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000254815 RP11-496I9.1 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000254815 RP11-496I9.1 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000254815 RP11-496I9.1 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000254815 RP11-496I9.1 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000254815 RP11-496I9.1 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000254815 RP11-496I9.1 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000254815 RP11-496I9.1 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000254815 RP11-496I9.1 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000254815 RP11-496I9.1 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000254815 RP11-496I9.1 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000254815 RP11-496I9.1 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000250357 RP11-503L19.1 path:05204_24 Chemical carcinogenesis 10 -4.79391285508539 2.31037149188857e-05 0.00974976769576975
GBM ENSG00000228271 RP11-513G11.2 path:04115_1 p53 signaling pathway 65 -3.55713699876328 0.000527407092041986 0.0490488595599047
GBM ENSG00000228271 RP11-513G11.2 path:04664_96 Fc epsilon RI signaling pathway 2 -4.34638754340703 0.000180317079728335 0.0490488595599047
GBM ENSG00000228271 RP11-513G11.2 path:05150_6 Staphylococcus aureus infection 4 -3.96738278918914 0.000381795720153409 0.0490488595599047
GBM ENSG00000228271 RP11-513G11.2 path:05218_69 Melanoma 9 -3.61225779699334 0.000425723250615414 0.0490488595599047
GBM ENSG00000238097 RP11-513G11.3 path:04115_1 p53 signaling pathway 65 -3.55713699876328 0.000527407092041986 0.0490488595599047
GBM ENSG00000238097 RP11-513G11.3 path:04664_96 Fc epsilon RI signaling pathway 2 -4.34638754340703 0.000180317079728335 0.0490488595599047
GBM ENSG00000238097 RP11-513G11.3 path:05150_6 Staphylococcus aureus infection 4 -3.96738278918914 0.000381795720153409 0.0490488595599047
GBM ENSG00000238097 RP11-513G11.3 path:05218_69 Melanoma 9 -3.61225779699334 0.000425723250615414 0.0490488595599047
GBM ENSG00000225742 RP11-513G11.4 path:04115_1 p53 signaling pathway 65 -3.55713699876328 0.000527407092041986 0.0490488595599047
GBM ENSG00000225742 RP11-513G11.4 path:04664_96 Fc epsilon RI signaling pathway 2 -4.34638754340703 0.000180317079728335 0.0490488595599047
GBM ENSG00000225742 RP11-513G11.4 path:05150_6 Staphylococcus aureus infection 4 -3.96738278918914 0.000381795720153409 0.0490488595599047
GBM ENSG00000225742 RP11-513G11.4 path:05218_69 Melanoma 9 -3.61225779699334 0.000425723250615414 0.0490488595599047
GBM ENSG00000234828 RP11-526A4.1 path:05204_24 Chemical carcinogenesis 10 -5.1447030822782 1.08832345495269e-05 0.00444035969620698
GBM ENSG00000255177 RP11-532E4.2 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000255177 RP11-532E4.2 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000255177 RP11-532E4.2 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000255177 RP11-532E4.2 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000255177 RP11-532E4.2 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000255177 RP11-532E4.2 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000255177 RP11-532E4.2 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000255177 RP11-532E4.2 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000255177 RP11-532E4.2 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000255177 RP11-532E4.2 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000255177 RP11-532E4.2 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000255177 RP11-532E4.2 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000255177 RP11-532E4.2 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000255177 RP11-532E4.2 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000251336 RP11-540E16.2 path:00982_13 Drug metabolism - cytochrome P450 15 -3.97114429296999 0.00026508335765235 0.0356978921638498
GBM ENSG00000251336 RP11-540E16.2 path:04310_89 Wnt signaling pathway 24 -3.84368272753394 0.00036321491868906 0.0366847067875951
GBM ENSG00000251336 RP11-540E16.2 path:04650_125 Natural killer cell mediated cytotoxicity 3 -5.69751287529106 1.4068782564847e-06 0.00056837881561982
GBM ENSG00000251336 RP11-540E16.2 path:05204_24 Chemical carcinogenesis 10 -4.42791098645371 9.48664198454927e-05 0.0191630168087895
GBM ENSG00000256325 RP11-611O2.1 path:04010_174 MAPK signaling pathway 2 -4.09842900632138 8.46233547405103e-05 0.0161591159625051
GBM ENSG00000256325 RP11-611O2.1 path:04610_42 Complement and coagulation cascades 32 -3.85080509331898 0.000197850871292289 0.0249951600732591
GBM ENSG00000256325 RP11-611O2.1 path:04664_37 Fc epsilon RI signaling pathway 28 -4.10288445220272 8.52723797493674e-05 0.0161591159625051
GBM ENSG00000257181 RP11-611O2.5 path:04010_174 MAPK signaling pathway 2 -4.09842900632138 8.46233547405103e-05 0.0161591159625051
GBM ENSG00000257181 RP11-611O2.5 path:04610_42 Complement and coagulation cascades 32 -3.85080509331898 0.000197850871292289 0.0249951600732591
GBM ENSG00000257181 RP11-611O2.5 path:04664_37 Fc epsilon RI signaling pathway 28 -4.10288445220272 8.52723797493674e-05 0.0161591159625051
GBM ENSG00000250971 RP11-696F12.1 path:05204_24 Chemical carcinogenesis 10 -4.56076945414986 5.64423709574014e-05 0.0218996399314718
GBM ENSG00000255314 RP11-702F3.3 path:00260_29 Glycine, serine and threonine metabolism 16 -4.07497816070686 9.85385013421624e-05 0.0387256310274698
GBM ENSG00000255314 RP11-702F3.3 path:04310_125 Wnt signaling pathway 13 -3.71675531661797 0.000303333391465212 0.0397366742819427
GBM ENSG00000255314 RP11-702F3.3 path:04922_77 Glucagon signaling pathway 9 -3.78363565556076 0.000232590752212318 0.0397366742819427
GBM ENSG00000255269 RP11-702F3.4 path:00260_29 Glycine, serine and threonine metabolism 16 -4.07497816070686 9.85385013421624e-05 0.0387256310274698
GBM ENSG00000255269 RP11-702F3.4 path:04310_125 Wnt signaling pathway 13 -3.71675531661797 0.000303333391465212 0.0397366742819427
GBM ENSG00000255269 RP11-702F3.4 path:04922_77 Glucagon signaling pathway 9 -3.78363565556076 0.000232590752212318 0.0397366742819427
GBM ENSG00000265194 RP11-70L8.4 path:00140_11 Steroid hormone biosynthesis 14 3.27497259207475 0.00145604612485705 0.0235445290571024
GBM ENSG00000265194 RP11-70L8.4 path:00480_7 Glutathione metabolism 25 3.1793643137588 0.00186545937339811 0.0261164312275735
GBM ENSG00000265194 RP11-70L8.4 path:00591_1 Linoleic acid metabolism 18 3.83843871883517 0.00018589171068375 0.00520496789914499
GBM ENSG00000265194 RP11-70L8.4 path:04020_152 Calcium signaling pathway 23 3.72245676790327 0.000281693675997751 0.00649552476418343
GBM ENSG00000265194 RP11-70L8.4 path:04060_29 Cytokine-cytokine receptor interaction 2 3.7627920604559 0.000244744181860911 0.00599623245559232
GBM ENSG00000265194 RP11-70L8.4 path:04110_140 Cell cycle 20 -4.2354663962199 0.000112914156917494 0.00508350258429883
GBM ENSG00000265194 RP11-70L8.4 path:04110_203 Cell cycle 2 -3.04609752213349 0.00340097955926555 0.0430059350720031
GBM ENSG00000265194 RP11-70L8.4 path:04115_9 p53 signaling pathway 57 -4.01553779030482 0.000219654047704861 0.00574029244668702
GBM ENSG00000265194 RP11-70L8.4 path:04150_1 mTOR signaling pathway 53 -3.59746411732025 0.000576372471026217 0.0107589527924894
GBM ENSG00000265194 RP11-70L8.4 path:04151_234 PI3K-Akt signaling pathway 25 3.93446660294422 0.00012873872948915 0.00508350258429883
GBM ENSG00000265194 RP11-70L8.4 path:04520_78 Adherens junction 4 3.52440041493038 0.000572718071126462 0.0107589527924894
GBM ENSG00000265194 RP11-70L8.4 path:04666_16 Fc gamma R-mediated phagocytosis 70 -3.688593408548 0.00041442029627853 0.0085501450600623
GBM ENSG00000265194 RP11-70L8.4 path:04727_2 GABAergic synapse 60 -3.03331931479222 0.00352782668889753 0.0432158769389947
GBM ENSG00000265194 RP11-70L8.4 path:04742_1 Taste transduction 14 -3.33623111645014 0.00136450767524918 0.0232559568998991
GBM ENSG00000265194 RP11-70L8.4 path:04910_10 Insulin signaling pathway 118 -3.26105668780408 0.00171183363777856 0.024853288370711
GBM ENSG00000265194 RP11-70L8.4 path:04915_101 Estrogen signaling pathway 12 3.88606548292974 0.000155617426049964 0.00508350258429883
GBM ENSG00000265194 RP11-70L8.4 path:05120_4 Epithelial cell signaling in Helicobacter pylori infection 23 3.98330929368862 0.000106922790612565 0.00508350258429883
GBM ENSG00000265194 RP11-70L8.4 path:05160_47 Hepatitis C 3 3.62757119871249 0.00039810039596658 0.0085501450600623
GBM ENSG00000265194 RP11-70L8.4 path:05161_85 Hepatitis B 6 -4.08839059534187 0.000177659523581354 0.00520496789914499
GBM ENSG00000265194 RP11-70L8.4 path:05166_48 HTLV-I infection 10 -4.47770773572053 5.13820187009528e-05 0.00508350258429883
GBM ENSG00000265194 RP11-70L8.4 path:05200_104 Pathways in cancer 31 -4.15595882003602 0.000144888534644667 0.00508350258429883
GBM ENSG00000265194 RP11-70L8.4 path:05200_149 Pathways in cancer 18 3.2876170234347 0.00150156435313153 0.0235445290571024
GBM ENSG00000265194 RP11-70L8.4 path:05205_198 Proteoglycans in cancer 11 -3.5936870156658 0.00064077426307636 0.011417432323906
GBM ENSG00000265194 RP11-70L8.4 path:05212_35 Pancreatic cancer 8 -4.24883730971729 0.000106938448022838 0.00508350258429883
GBM ENSG00000265194 RP11-70L8.4 path:05213_36 Endometrial cancer 4 3.05109238970648 0.00270909159372094 0.0366194449909865
GBM ENSG00000265194 RP11-70L8.4 path:05214_32 Glioma 11 -4.17230686621759 0.000138137354800837 0.00508350258429883
GBM ENSG00000265194 RP11-70L8.4 path:05218_69 Melanoma 9 -4.21226002824477 0.000121791632590233 0.00508350258429883
GBM ENSG00000265194 RP11-70L8.4 path:05219_6 Bladder cancer 10 -4.26814156874672 0.000102071340142252 0.00508350258429883
GBM ENSG00000265194 RP11-70L8.4 path:05220_3 Chronic myeloid leukemia 56 -4.31311648865998 8.68814919787876e-05 0.00508350258429883
GBM ENSG00000265194 RP11-70L8.4 path:05222_77 Small cell lung cancer 2 -4.32868090835153 8.29066323937632e-05 0.00508350258429883
GBM ENSG00000265194 RP11-70L8.4 path:05223_4 Non-small cell lung cancer 44 -3.13738945504743 0.00280374373514885 0.036635584805945
GBM ENSG00000265194 RP11-70L8.4 path:05231_97 Choline metabolism in cancer 5 3.20642556681181 0.00165144561594587 0.024853288370711
GBM ENSG00000255158 RP11-754B17.1 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000255158 RP11-754B17.1 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000255158 RP11-754B17.1 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000255158 RP11-754B17.1 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000255158 RP11-754B17.1 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000255158 RP11-754B17.1 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000255158 RP11-754B17.1 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000255158 RP11-754B17.1 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000255158 RP11-754B17.1 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000255158 RP11-754B17.1 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000255158 RP11-754B17.1 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000255158 RP11-754B17.1 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000255158 RP11-754B17.1 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000255158 RP11-754B17.1 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000250354 RP11-76G10.1 path:00071_32 Fatty acid degradation 7 -4.06548647591359 0.000193668267949153 0.0309958629108072
GBM ENSG00000250354 RP11-76G10.1 path:00920_1 Sulfur metabolism 5 -4.02685828912577 0.000217302129590275 0.0309958629108072
GBM ENSG00000250354 RP11-76G10.1 path:00982_13 Drug metabolism - cytochrome P450 15 -4.00462237996227 0.00022903346978429 0.0309958629108072
GBM ENSG00000244471 RP11-78J21.4 path:00130_1 Ubiquinone and other terpenoid-quinone biosynthesis 3 4.6108456376724 1.07392882086475e-05 0.00242724797895806
GBM ENSG00000244471 RP11-78J21.4 path:00230_207 Purine metabolism 6 3.41463478379983 0.000887473561489187 0.0113152879089871
GBM ENSG00000244471 RP11-78J21.4 path:00240_172 Pyrimidine metabolism 7 3.39885571027096 0.000981049808596226 0.0117725977031547
GBM ENSG00000244471 RP11-78J21.4 path:00983_2 Drug metabolism - other enzymes 16 3.11370905561217 0.0023490947276189 0.0252218591807503
GBM ENSG00000244471 RP11-78J21.4 path:04015_131 Rap1 signaling pathway 19 -3.97090690453368 0.000112313373362324 0.00364965573439232
GBM ENSG00000244471 RP11-78J21.4 path:04020_81 Calcium signaling pathway 51 -3.50635467280299 0.000623574051176207 0.0101767285151957
GBM ENSG00000244471 RP11-78J21.4 path:04020_92 Calcium signaling pathway 44 -4.24437764894791 4.16377132089798e-05 0.00242724797895806
GBM ENSG00000244471 RP11-78J21.4 path:04024_50 cAMP signaling pathway 80 -2.84811517197767 0.00508310088252344 0.0482303525597573
GBM ENSG00000244471 RP11-78J21.4 path:04024_60 cAMP signaling pathway 75 -4.43288892588071 1.86064675242161e-05 0.00242724797895806
GBM ENSG00000244471 RP11-78J21.4 path:04261_74 Adrenergic signaling in cardiomyocytes 44 -3.71606749391448 0.000290564197761845 0.00564524727080155
GBM ENSG00000244471 RP11-78J21.4 path:04270_30 Vascular smooth muscle contraction 67 -3.46738466417476 0.000700879762146277 0.0104796246981501
GBM ENSG00000244471 RP11-78J21.4 path:04710_8 Circadian rhythm 26 -3.22547297158013 0.00157941345056278 0.0184114482237033
GBM ENSG00000244471 RP11-78J21.4 path:04713_149 Circadian entrainment 11 -3.42209576122081 0.000825037163085292 0.0108585536302838
GBM ENSG00000244471 RP11-78J21.4 path:04713_22 Circadian entrainment 61 -3.18532630714474 0.00177343622807315 0.0200989439181624
GBM ENSG00000244471 RP11-78J21.4 path:04724_160 Glutamatergic synapse 8 -3.53267198479711 0.000559463527123407 0.00951087996109792
GBM ENSG00000244471 RP11-78J21.4 path:04724_34 Glutamatergic synapse 61 -3.90571351133649 0.000143622623317971 0.00364965573439232
GBM ENSG00000244471 RP11-78J21.4 path:04728_17 Dopaminergic synapse 93 -3.15506990688589 0.00194894531565256 0.0214910726698985
GBM ENSG00000244471 RP11-78J21.4 path:04728_187 Dopaminergic synapse 16 -2.9723064138605 0.00353583207045978 0.0351858410914046
GBM ENSG00000244471 RP11-78J21.4 path:04728_222 Dopaminergic synapse 5 -4.16469173165661 5.35422348299571e-05 0.00242724797895806
GBM ENSG00000244471 RP11-78J21.4 path:04730_41 Long-term depression 28 -3.43788836896864 0.00077174956569508 0.0104957940934531
GBM ENSG00000244471 RP11-78J21.4 path:04730_74 Long-term depression 5 -3.47803393984781 0.000673318331754186 0.0104796246981501
GBM ENSG00000244471 RP11-78J21.4 path:04740_16 Olfactory transduction 10 -3.36856054630436 0.000968275005437924 0.0117725977031547
GBM ENSG00000244471 RP11-78J21.4 path:04750_2 Inflammatory mediator regulation of TRP channels 78 -4.27053623503594 3.54045938893224e-05 0.00242724797895806
GBM ENSG00000244471 RP11-78J21.4 path:04911_33 Insulin secretion 26 -4.19206806637642 4.96667878136834e-05 0.00242724797895806
GBM ENSG00000244471 RP11-78J21.4 path:04912_45 GnRH signaling pathway 16 -3.93299641382354 0.000132990317813788 0.00364965573439232
GBM ENSG00000244471 RP11-78J21.4 path:04913_2 Ovarian steroidogenesis 26 -3.98590309630735 0.000109841725895438 0.00364965573439232
GBM ENSG00000244471 RP11-78J21.4 path:04915_56 Estrogen signaling pathway 38 -3.45589253721431 0.0007191899302652 0.0104796246981501
GBM ENSG00000244471 RP11-78J21.4 path:04918_15 Thyroid hormone synthesis 38 -4.22888352033549 4.37025568733996e-05 0.00242724797895806
GBM ENSG00000244471 RP11-78J21.4 path:04920_60 Adipocytokine signaling pathway 12 2.96110628685926 0.00367283952084006 0.0356790124881606
GBM ENSG00000244471 RP11-78J21.4 path:04921_179 Oxytocin signaling pathway 8 -3.59101882401895 0.00045793745610715 0.00812341226485728
GBM ENSG00000244471 RP11-78J21.4 path:04922_80 Glucagon signaling pathway 8 -3.02119857419934 0.00308018559878091 0.0314178931075652
GBM ENSG00000244471 RP11-78J21.4 path:04961_4 Endocrine and other factor-regulated calcium reabsorption 22 -3.69636123443259 0.000308756254564959 0.00572602508465925
GBM ENSG00000244471 RP11-78J21.4 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.7804961180379 0.000232490466189422 0.0049924268529097
GBM ENSG00000244471 RP11-78J21.4 path:04970_7 Salivary secretion 24 -4.18415032271932 5.14105154937893e-05 0.00242724797895806
GBM ENSG00000244471 RP11-78J21.4 path:04976_1 Bile secretion 15 -3.92487981763626 0.000137451060438846 0.00364965573439232
GBM ENSG00000244471 RP11-78J21.4 path:05030_1 Cocaine addiction 42 -3.7239515023001 0.000285100007179882 0.00564524727080155
GBM ENSG00000244471 RP11-78J21.4 path:05031_25 Amphetamine addiction 20 -4.47306590742821 1.62563464183883e-05 0.00242724797895806
GBM ENSG00000244471 RP11-78J21.4 path:05032_33 Morphine addiction 43 -3.88955527885881 0.000153265931999104 0.00364965573439232
GBM ENSG00000244471 RP11-78J21.4 path:05033_3 Nicotine addiction 10 -3.4420535881337 0.000762339342001579 0.0104957940934531
GBM ENSG00000244471 RP11-78J21.4 path:05034_52 Alcoholism 26 -3.03648476634464 0.00283594592246118 0.0296683573426708
GBM ENSG00000244471 RP11-78J21.4 path:05110_1 Vibrio cholerae infection 9 -3.88211079259662 0.000161014223576132 0.00364965573439232
GBM ENSG00000244471 RP11-78J21.4 path:05146_11 Amoebiasis 7 -3.94348353239864 0.000127841360627006 0.00364965573439232
GBM ENSG00000244471 RP11-78J21.4 path:05414_1 Dilated cardiomyopathy 28 -4.08831132771953 7.44958946681562e-05 0.00303943250246077
GBM ENSG00000225140 RP11-809C18.3 path:00760_1 Nicotinate and nicotinamide metabolism 20 4.48908299746777 5.03507125654741e-05 0.0198885314633623
GBM ENSG00000264107 RP11-848P1.5 path:00240_87 Pyrimidine metabolism 30 4.87422538404833 8.88230730790986e-05 0.0118430764105465
GBM ENSG00000264107 RP11-848P1.5 path:00500_3 Starch and sucrose metabolism 31 4.55758222692424 0.000182978256967691 0.0163782029301095
GBM ENSG00000264107 RP11-848P1.5 path:00510_21 N-Glycan biosynthesis 23 3.58952435981695 0.0016529881700589 0.0364566040758099
GBM ENSG00000264107 RP11-848P1.5 path:00590_61 Arachidonic acid metabolism 12 -3.48367816715059 0.000693246503246621 0.0325493656511933
GBM ENSG00000264107 RP11-848P1.5 path:00750_1 Vitamin B6 metabolism 3 -3.53940082885816 0.00122344061964872 0.0326250831906324
GBM ENSG00000264107 RP11-848P1.5 path:04115_17 p53 signaling pathway 9 -3.8123392656973 0.000204727536626369 0.0163782029301095
GBM ENSG00000264107 RP11-848P1.5 path:04130_7 SNARE interactions in vesicular transport 4 -3.43611524074625 0.00109409394569797 0.0325493656511933
GBM ENSG00000264107 RP11-848P1.5 path:04144_41 Endocytosis 4 -3.11115996894387 0.00226254450421536 0.0451710596750078
GBM ENSG00000264107 RP11-848P1.5 path:04210_47 Apoptosis 29 -3.46765119202257 0.00137687801672548 0.034421950418137
GBM ENSG00000264107 RP11-848P1.5 path:04520_20 Adherens junction 53 3.62205362380534 0.00104451349802088 0.0325493656511933
GBM ENSG00000264107 RP11-848P1.5 path:04713_199 Circadian entrainment 4 -5.09489038808754 1.7801245443154e-05 0.00712049817726161
GBM ENSG00000264107 RP11-848P1.5 path:04724_168 Glutamatergic synapse 6 -4.77560606342913 6.29820665868534e-05 0.0118430764105465
GBM ENSG00000264107 RP11-848P1.5 path:04750_36 Inflammatory mediator regulation of TRP channels 39 -3.3153763810713 0.00248440828212543 0.0451710596750078
GBM ENSG00000264107 RP11-848P1.5 path:05162_44 Measles 5 -3.34658459201116 0.00148022106184081 0.0348287308668426
GBM ENSG00000264107 RP11-848P1.5 path:05205_262 Proteoglycans in cancer 2 -3.29864651176781 0.00173168869360097 0.0364566040758099
GBM ENSG00000264107 RP11-848P1.5 path:05214_32 Glioma 11 -3.32111505875018 0.0011339279804623 0.0325493656511933
GBM ENSG00000264107 RP11-848P1.5 path:05218_10 Melanoma 32 -3.38650617296402 0.000909788545016391 0.0325493656511933
GBM ENSG00000264107 RP11-848P1.5 path:05219_6 Bladder cancer 10 -3.32017620168853 0.00113922779779177 0.0325493656511933
GBM ENSG00000264107 RP11-848P1.5 path:05220_44 Chronic myeloid leukemia 9 -3.54969336840453 0.000521735511035229 0.0298134577734417
GBM ENSG00000264107 RP11-848P1.5 path:05222_20 Small cell lung cancer 41 -3.75148766628427 0.000256747513840538 0.0171165009227026
GBM ENSG00000264107 RP11-848P1.5 path:05223_42 Non-small cell lung cancer 19 -3.44854983063149 0.000736817062251078 0.0325493656511933
GBM ENSG00000264107 RP11-848P1.5 path:05321_36 Inflammatory bowel disease (IBD) 14 3.30508343154306 0.002432212038338 0.0451710596750078
GBM ENSG00000250042 RP11-91J3.2 path:05204_24 Chemical carcinogenesis 10 -4.56076945414986 5.64423709574014e-05 0.0218996399314718
GBM ENSG00000250620 RP11-91J3.3 path:05204_24 Chemical carcinogenesis 10 -4.56076945414986 5.64423709574014e-05 0.0218996399314718
GBM ENSG00000255237 RP13-317D12.3 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000255237 RP13-317D12.3 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000255237 RP13-317D12.3 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000255237 RP13-317D12.3 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000255237 RP13-317D12.3 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000255237 RP13-317D12.3 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000255237 RP13-317D12.3 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000255237 RP13-317D12.3 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000255237 RP13-317D12.3 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000255237 RP13-317D12.3 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000255237 RP13-317D12.3 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000255237 RP13-317D12.3 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000255237 RP13-317D12.3 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000255237 RP13-317D12.3 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000271564 RP13-444H2.1 path:00130_1 Ubiquinone and other terpenoid-quinone biosynthesis 3 4.6108456376724 1.07392882086475e-05 0.00242724797895806
GBM ENSG00000271564 RP13-444H2.1 path:00230_207 Purine metabolism 6 3.41463478379983 0.000887473561489187 0.0113152879089871
GBM ENSG00000271564 RP13-444H2.1 path:00240_172 Pyrimidine metabolism 7 3.39885571027096 0.000981049808596226 0.0117725977031547
GBM ENSG00000271564 RP13-444H2.1 path:00983_2 Drug metabolism - other enzymes 16 3.11370905561217 0.0023490947276189 0.0252218591807503
GBM ENSG00000271564 RP13-444H2.1 path:04015_131 Rap1 signaling pathway 19 -3.97090690453368 0.000112313373362324 0.00364965573439232
GBM ENSG00000271564 RP13-444H2.1 path:04020_81 Calcium signaling pathway 51 -3.50635467280299 0.000623574051176207 0.0101767285151957
GBM ENSG00000271564 RP13-444H2.1 path:04020_92 Calcium signaling pathway 44 -4.24437764894791 4.16377132089798e-05 0.00242724797895806
GBM ENSG00000271564 RP13-444H2.1 path:04024_50 cAMP signaling pathway 80 -2.84811517197767 0.00508310088252344 0.0482303525597573
GBM ENSG00000271564 RP13-444H2.1 path:04024_60 cAMP signaling pathway 75 -4.43288892588071 1.86064675242161e-05 0.00242724797895806
GBM ENSG00000271564 RP13-444H2.1 path:04261_74 Adrenergic signaling in cardiomyocytes 44 -3.71606749391448 0.000290564197761845 0.00564524727080155
GBM ENSG00000271564 RP13-444H2.1 path:04270_30 Vascular smooth muscle contraction 67 -3.46738466417476 0.000700879762146277 0.0104796246981501
GBM ENSG00000271564 RP13-444H2.1 path:04710_8 Circadian rhythm 26 -3.22547297158013 0.00157941345056278 0.0184114482237033
GBM ENSG00000271564 RP13-444H2.1 path:04713_149 Circadian entrainment 11 -3.42209576122081 0.000825037163085292 0.0108585536302838
GBM ENSG00000271564 RP13-444H2.1 path:04713_22 Circadian entrainment 61 -3.18532630714474 0.00177343622807315 0.0200989439181624
GBM ENSG00000271564 RP13-444H2.1 path:04724_160 Glutamatergic synapse 8 -3.53267198479711 0.000559463527123407 0.00951087996109792
GBM ENSG00000271564 RP13-444H2.1 path:04724_34 Glutamatergic synapse 61 -3.90571351133649 0.000143622623317971 0.00364965573439232
GBM ENSG00000271564 RP13-444H2.1 path:04728_17 Dopaminergic synapse 93 -3.15506990688589 0.00194894531565256 0.0214910726698985
GBM ENSG00000271564 RP13-444H2.1 path:04728_187 Dopaminergic synapse 16 -2.9723064138605 0.00353583207045978 0.0351858410914046
GBM ENSG00000271564 RP13-444H2.1 path:04728_222 Dopaminergic synapse 5 -4.16469173165661 5.35422348299571e-05 0.00242724797895806
GBM ENSG00000271564 RP13-444H2.1 path:04730_41 Long-term depression 28 -3.43788836896864 0.00077174956569508 0.0104957940934531
GBM ENSG00000271564 RP13-444H2.1 path:04730_74 Long-term depression 5 -3.47803393984781 0.000673318331754186 0.0104796246981501
GBM ENSG00000271564 RP13-444H2.1 path:04740_16 Olfactory transduction 10 -3.36856054630436 0.000968275005437924 0.0117725977031547
GBM ENSG00000271564 RP13-444H2.1 path:04750_2 Inflammatory mediator regulation of TRP channels 78 -4.27053623503594 3.54045938893224e-05 0.00242724797895806
GBM ENSG00000271564 RP13-444H2.1 path:04911_33 Insulin secretion 26 -4.19206806637642 4.96667878136834e-05 0.00242724797895806
GBM ENSG00000271564 RP13-444H2.1 path:04912_45 GnRH signaling pathway 16 -3.93299641382354 0.000132990317813788 0.00364965573439232
GBM ENSG00000271564 RP13-444H2.1 path:04913_2 Ovarian steroidogenesis 26 -3.98590309630735 0.000109841725895438 0.00364965573439232
GBM ENSG00000271564 RP13-444H2.1 path:04915_56 Estrogen signaling pathway 38 -3.45589253721431 0.0007191899302652 0.0104796246981501
GBM ENSG00000271564 RP13-444H2.1 path:04918_15 Thyroid hormone synthesis 38 -4.22888352033549 4.37025568733996e-05 0.00242724797895806
GBM ENSG00000271564 RP13-444H2.1 path:04920_60 Adipocytokine signaling pathway 12 2.96110628685926 0.00367283952084006 0.0356790124881606
GBM ENSG00000271564 RP13-444H2.1 path:04921_179 Oxytocin signaling pathway 8 -3.59101882401895 0.00045793745610715 0.00812341226485728
GBM ENSG00000271564 RP13-444H2.1 path:04922_80 Glucagon signaling pathway 8 -3.02119857419934 0.00308018559878091 0.0314178931075652
GBM ENSG00000271564 RP13-444H2.1 path:04961_4 Endocrine and other factor-regulated calcium reabsorption 22 -3.69636123443259 0.000308756254564959 0.00572602508465925
GBM ENSG00000271564 RP13-444H2.1 path:04962_1 Vasopressin-regulated water reabsorption 19 -3.7804961180379 0.000232490466189422 0.0049924268529097
GBM ENSG00000271564 RP13-444H2.1 path:04970_7 Salivary secretion 24 -4.18415032271932 5.14105154937893e-05 0.00242724797895806
GBM ENSG00000271564 RP13-444H2.1 path:04976_1 Bile secretion 15 -3.92487981763626 0.000137451060438846 0.00364965573439232
GBM ENSG00000271564 RP13-444H2.1 path:05030_1 Cocaine addiction 42 -3.7239515023001 0.000285100007179882 0.00564524727080155
GBM ENSG00000271564 RP13-444H2.1 path:05031_25 Amphetamine addiction 20 -4.47306590742821 1.62563464183883e-05 0.00242724797895806
GBM ENSG00000271564 RP13-444H2.1 path:05032_33 Morphine addiction 43 -3.88955527885881 0.000153265931999104 0.00364965573439232
GBM ENSG00000271564 RP13-444H2.1 path:05033_3 Nicotine addiction 10 -3.4420535881337 0.000762339342001579 0.0104957940934531
GBM ENSG00000271564 RP13-444H2.1 path:05034_52 Alcoholism 26 -3.03648476634464 0.00283594592246118 0.0296683573426708
GBM ENSG00000271564 RP13-444H2.1 path:05110_1 Vibrio cholerae infection 9 -3.88211079259662 0.000161014223576132 0.00364965573439232
GBM ENSG00000271564 RP13-444H2.1 path:05146_11 Amoebiasis 7 -3.94348353239864 0.000127841360627006 0.00364965573439232
GBM ENSG00000271564 RP13-444H2.1 path:05414_1 Dilated cardiomyopathy 28 -4.08831132771953 7.44958946681562e-05 0.00303943250246077
GBM ENSG00000254739 RP13-46H24.1 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000254739 RP13-46H24.1 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000254739 RP13-46H24.1 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000254739 RP13-46H24.1 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000254739 RP13-46H24.1 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000254739 RP13-46H24.1 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000254739 RP13-46H24.1 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000254739 RP13-46H24.1 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000254739 RP13-46H24.1 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000254739 RP13-46H24.1 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000254739 RP13-46H24.1 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000254739 RP13-46H24.1 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000254739 RP13-46H24.1 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000254739 RP13-46H24.1 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000254872 RP13-870H17.3 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000254872 RP13-870H17.3 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000254872 RP13-870H17.3 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000254872 RP13-870H17.3 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000254872 RP13-870H17.3 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000254872 RP13-870H17.3 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000254872 RP13-870H17.3 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000254872 RP13-870H17.3 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000254872 RP13-870H17.3 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000254872 RP13-870H17.3 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000254872 RP13-870H17.3 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000254872 RP13-870H17.3 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000254872 RP13-870H17.3 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000254872 RP13-870H17.3 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000255153 TOLLIP-AS1 path:00053_1 Ascorbate and aldarate metabolism 6 3.96441060647868 0.00026710432658801 0.0223299217027576
GBM ENSG00000255153 TOLLIP-AS1 path:00062_4 Fatty acid elongation 4 -3.31493796321685 0.00164898537070055 0.049233991782345
GBM ENSG00000255153 TOLLIP-AS1 path:00330_1 Arginine and proline metabolism 50 -3.31308753785379 0.00146434235000192 0.0470842386385234
GBM ENSG00000255153 TOLLIP-AS1 path:00430_1 Taurine and hypotaurine metabolism 7 -3.37811135168911 0.00106432126774744 0.0422405821557766
GBM ENSG00000255153 TOLLIP-AS1 path:00980_74 Metabolism of xenobiotics by cytochrome P450 11 -3.64282075990069 0.000518974324200763 0.0295764272134233
GBM ENSG00000255153 TOLLIP-AS1 path:00982_2 Drug metabolism - cytochrome P450 21 -3.49066891374949 0.000800098933868107 0.0371601504840965
GBM ENSG00000255153 TOLLIP-AS1 path:04650_125 Natural killer cell mediated cytotoxicity 3 -3.89244607217981 0.000225433832790191 0.0223299217027576
GBM ENSG00000255153 TOLLIP-AS1 path:05014_24 Amyotrophic lateral sclerosis (ALS) 10 -4.49391702342194 1.78548951743673e-05 0.00373167309144277
GBM ENSG00000255153 TOLLIP-AS1 path:05014_25 Amyotrophic lateral sclerosis (ALS) 8 -4.58258419680139 1.77268757063667e-05 0.00373167309144277
GBM ENSG00000255153 TOLLIP-AS1 path:05034_40 Alcoholism 34 3.67160739202863 0.000566056023223412 0.0295764272134233
GBM ENSG00000255153 TOLLIP-AS1 path:05134_13 Legionellosis 4 -3.38146299096814 0.00111159426725728 0.0422405821557766
GBM ENSG00000255153 TOLLIP-AS1 path:05145_11 Toxoplasmosis 11 -3.79177509299442 0.000384296268374913 0.026772640030119
GBM ENSG00000255153 TOLLIP-AS1 path:05205_183 Proteoglycans in cancer 13 3.40266835529011 0.00140424071891311 0.0470842386385234
GBM ENSG00000255153 TOLLIP-AS1 path:05416_3 Viral myocarditis 5 -4.03450420074143 0.000122037672400628 0.0170039156878209
GBM ENSG00000269793 ZIM2-AS1 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000269793 ZIM2-AS1 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000269793 ZIM2-AS1 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000269793 ZIM2-AS1 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000269793 ZIM2-AS1 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000269793 ZIM2-AS1 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000269793 ZIM2-AS1 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000269793 ZIM2-AS1 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000267454 ZNF582-AS1 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000267454 ZNF582-AS1 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000267454 ZNF582-AS1 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000267454 ZNF582-AS1 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000267454 ZNF582-AS1 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000267454 ZNF582-AS1 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000267454 ZNF582-AS1 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000267454 ZNF582-AS1 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966
GBM ENSG00000166770 ZNF667-AS1 path:00760_8 Nicotinate and nicotinamide metabolism 18 -3.74825070161443 0.000788557029421718 0.0410292537739388
GBM ENSG00000166770 ZNF667-AS1 path:04015_98 Rap1 signaling pathway 44 -4.18052055723228 0.000158489046060645 0.0103017879939419
GBM ENSG00000166770 ZNF667-AS1 path:04060_29 Cytokine-cytokine receptor interaction 2 -4.98478686447559 1.8152335666209e-06 0.000459704786085954
GBM ENSG00000166770 ZNF667-AS1 path:04066_95 HIF-1 signaling pathway 14 -4.13693965101754 7.39501834718184e-05 0.00576811431080184
GBM ENSG00000166770 ZNF667-AS1 path:04912_55 GnRH signaling pathway 9 -4.93469167607731 2.35746044146643e-06 0.000459704786085954
GBM ENSG00000166770 ZNF667-AS1 path:04970_21 Salivary secretion 15 -3.64452376663769 0.000841625718439769 0.0410292537739388
GBM ENSG00000166770 ZNF667-AS1 path:05214_27 Glioma 17 -4.4603565746534 4.01589171093173e-05 0.00391549441815844
GBM ENSG00000166770 ZNF667-AS1 path:05223_63 Non-small cell lung cancer 8 -4.49986976116285 1.47214015441512e-05 0.00191378220073966